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Abstract 
LINE-1 Retrotransposition in Human Genomic Variation 
by 
Christine R. Beck 
 
Chair: John V. Moran 
 
 
Long interspersed element-1 (LINE-1 or L1) is a ubiquitous mobile element 
in mammalian genomes. There are ~500,000 copies of L1 throughout the human 
genome, comprising ~17% of our DNA. Interestingly, though the majority of these 
elements are inactive due to 5' truncation or mutations in the two L1-encoded 
open reading frames (ORF1 and ORF2), a small number of L1s (~80-100 per 
human genome) are capable of mobilization by the copy and paste mechanism 
of retrotransposition termed target-site primed reverse transcription (TPRT). As 
L1s rely upon their encoded proteins (ORF1p and ORF2p) for mobility, only 
intact, full-length L1s are potentially active. Previous analysis of the human 
genome reference sequence (HGR) showed that 90 L1s contained intact ORFs, 
and that 6 of these were responsible for >80% of the retrotransposition activity. 
These 6 highly active L1s were polymorphic in humans. Therefore, I
xi	  
hypothesized that low allele frequency L1s comprise the majority of activity in 
human populations.  
I used fosmid libraries developed from six geographically diverse individuals 
to identify 68 full-length L1s absent from the HGR. Approximately 55% (37/68) 
were highly active when tested in a cultured cell assay. To determine the allele 
frequency of the L1s in the population, 26 of the 68 elements were examined in 
genotyping panels. Four of the 26 were either private or African specific when 
typed on the H952 subset of the human genome diversity panel. The sequences 
of the 68 L1s showed that 53 (37 highly active and 16 low-level or inactive L1s) 
contained intact ORF1 and ORF2. The sixteen L1s were then examined for 
changes that led to their inability to retrotranspose with high efficiency in cell 
culture. Using sequence comparisons and functional assays, I identified a novel 
amino acid change in the ORF2-encoded protein of one element and a splicing 
mutation in the 5' untranslated region of another L1.  
My examination of individual genomes readily identified highly active, rare 
L1s, and suggests that L1 activity in humans is more prevalent than previously 
appreciated. The sequences of these elements present future opportunities for 
the elucidation of L1 biology. 
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Chapter 1 
 
LINE-1 Elements in Structural Variation and Disease 
 
Overview 
This thesis is centered on the role of L1 in generating human variation, and 
the insights into L1 biology that can be gained through the study of human-
specific elements. Here, I present an introductory chapter (Chapter 1) followed by 
a published manuscript (Chapter 2), additional experimental data (Chapter 3), 
and a concluding chapter (Chapter 4).  
The first chapter, entitled “LINE-1 Elements in Structural Variation and 
Disease” is an introduction to the various classes of mobile elements that exist in 
human genomes and the roles they play in inter-individual human variation and 
disease. This chapter was published as a review in the 2011 volume of The 
Annual Review of Genomics and Human Genetics. The second chapter, “LINE-1 
Retrotransposition Activity in Human Genomes”, examines the human-specific, 
polymorphic L1s present in 6 individuals. This publication appeared as an article 
in Cell, and was prepared in collaboration with the laboratories of Dr. Evan 
Eichler and Dr. Richard Badge. Both Chapters 1 and 2 were presented with 
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permission from the publishers. Chapter 3 discusses experimental data and other 
analysis regarding the mutations present in the L1s examined in Chapter 2. This 
Chapter includes experiments that are a part of a manuscript in preparation from 
the Badge lab regarding transduction-specific amplification typing of L1 active 
subfamilies (TS-ATLAS). Chapter 4 discusses conclusions and future directions 
of the studies presented herein. 
Abstract 
 The completion of the human genome reference sequence ushered in a 
new era for the study and discovery of human transposable elements. It now is 
undeniable that transposable elements, historically dismissed as junk DNA, have 
had an instrumental role in sculpting the structure and function of our genomes. 
In particular, long interspersed element-1 (LINE-1 or L1) and short interspersed 
elements (SINEs) continue to affect our genome, and their movement can lead to 
sporadic cases of disease. Here, we briefly review the types of transposable 
elements present in the human genome and their mechanisms of mobility. We 
next highlight how advances in DNA sequencing and genomic technologies have 
enabled the discovery of novel retrotransposons in individual genomes. Finally, 
we discuss how L1-mediated retrotransposition events impact human genomes. 
Introduction 
Approximately 45% of the human genome is derived from transposable 
elements (Lander et al., 2001). These include DNA transposons, long terminal 
repeat (LTR) retrotransposons, and non-LTR retrotransposons. Although most 
3 
transposable elements have been rendered inactive through mutation, long 
interspersed element-1 (LINE-1 or L1) retrotransposition continues to diversify 
human genomes. 
L1s comprise ~17% of human DNA (Lander et al., 2001). The L1-encoded 
proteins (ORF1p and ORF2p) can mobilize non-autonomous retrotransposons, 
other non-coding RNAs, and messenger RNAs, leading to the generation of 
processed pseudogenes (Buzdin et al., 2002; Dewannieux et al., 2003; Esnault 
et al., 2000; Garcia-Perez et al., 2007a; Gilbert et al., 2005; Hancks et al., 2011; 
Wei et al., 2001). Thus, in total, L1-mediated retrotransposition has generated a 
third of our genome.   
In 1988, an examination of 240 unrelated males afflicted with hemophilia A 
revealed that independent mutagenic L1 insertions into exon 14 of the Factor VIII 
gene were responsible for the disease in two individuals (Kazazian et al., 1988). 
Heroic efforts to isolate an active progenitor L1 (Dombroski et al., 1991) and the 
development of a cultured cell retrotransposition assay (Moran et al., 1996) then 
helped elucidate the molecular mechanism of L1 retrotransposition. It now is 
apparent that L1s are alive and well in human populations, and that L1-mediated 
retrotransposition events account for approximately 1 of every 1,000 of 
spontaneous, disease-producing insertions in man (Chen et al., 2005a; Kazazian 
and Moran, 1998).  
Several reviews have discussed aspects of human retrotransposon biology 
and how the host genome defends itself from retrotransposon activity (Babushok 
and Kazazian, 2007; Belancio et al., 2008a; Cordaux and Batzer, 2009; Goodier 
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and Kazazian, 2008; O'Donnell and Burns, 2010; Ostertag and Kazazian, 2001). 
Here, we discuss recent progress in understanding the mechanism of L1 
retrotransposition. We then highlight how new genomic technologies have 
illuminated the impact of L1-mediated retrotransposition events on human 
genetic variation and genome structure.  
Mobile Elements in Human Genomes  
Transposable elements are classified by whether they mobilize via a DNA 
(DNA transposons) or an RNA (retrotransposons) intermediate (Figure 1.1). They 
further are distinguished by whether they encode proteins to mediate their own 
mobility (autonomous elements) or rely upon proteins encoded by other elements 
(nonautonomous elements).  
DNA Transposons 
DNA transposons generally move via a cut-and-paste mechanism. They 
tend to have a limited lifespan in higher eukaryotic genomes (Lander et al., 2001; 
Smit, 1996), which likely is due to the accumulation of non-autonomous deletion 
derivatives that compete for the transposase encoded by autonomous elements. 
In most cases, transposase binds at DNA transposon inverted repeat sequences, 
“cuts” the transposon from its existing location, and then “pastes” it into a new 
genomic location (reviewed in (Craig et al., 2002)).  
DNA transposons comprise ~3% of the human genome reference 
sequence (HGR, NCBI 36/hg18). Sequence divergence among paralogous 
copies indicates that virtually all DNA transposons mobilized prior to the 
5 
eutherian radiation, whereas a composite method indicates they have been 
extinct in the primate lineage for at least 37 million years (Lander et al., 2001; 
Pace and Feschotte, 2007). Nevertheless, DNA transposons have had an 
enduring effect on the human genome. For example, the recombination 
activating genes, RAG1 and RAG2, which are critical for V(D)J recombination 
and immune system development, likely were domesticated from the Transib 
family of DNA transposons ~500 million years ago (Kapitonov and Jurka, 2005; 
Zhou et al., 2004).  
Engineered DNA transposons have practical applications, and can be 
exploited for useful purposes. For example, a reanimated salmon DNA 
transposon, Sleeping Beauty, has been used to discover genes implicated in 
cancer progression and shows promise as a delivery vehicle in gene therapy 
studies (Collier and Largaespada, 2005; Hackett et al., 2010; Ivics et al., 1997, 
2009). Similarly, an insect DNA transposon, piggyBac, has been used to create 
gene-specific knockouts in mouse embryonic stem cells (Ding et al., 2005; Sun et 
al., 2008). Finally, a zebrafish transposon, Tol2, shows promise as a mutagen in 
both the mouse and zebrafish germ line (Kawakami, 2005; Keng et al., 2009).  
Retrotransposons 
Retrotransposons mobilize via an RNA intermediate by a copy-and-paste 
mechanism and remain active in most mammalian genomes. They can be 
subdivided into two general classes, depending on whether they contain or lack 
LTRs (Figure 1.1). 
6 
Long Terminal Repeat Retrotransposons: Human Endogenous Retroviruses 
LTR-containing elements, such as human endogenous retroviruses 
(HERVs), resemble retroviruses in both their structure and mobility mechanism. 
Most HERVs contain a non-functional envelope (ENV) gene, which relegates 
them to an intracellular existence (Bannert and Kurth, 2006).  
HERVs and their non-autonomous derivatives comprise ~8% of the human 
genome (Lander et al., 2001). Virtually all HERVs are retrotransposition-
defective; however, a small number of HERV-K elements (where K denotes the 
host lysine transfer RNA (tRNA) that presumably initiates HERV-K (-) strand 
complementary DNA (cDNA) synthesis) are polymorphic with respect to 
presence/absence status in humans, indicating that they have retrotransposed 
since the human-chimpanzee divergence (Belshaw et al., 2005; Kidd et al., 2010; 
Macfarlane and Simmonds, 2004; Moyes et al., 2007). Moreover, some HERV-K 
elements contain intact open reading frames (ORFs) (Mayer et al., 1997), and a 
reanimated HERV-K virus is infectious in cultured cell assays (Dewannieux et al., 
2006; Lee and Bieniasz, 2007). Thus, it is formally possible that rare HERV-K 
alleles retain the ability to move in modern humans.   
Recent studies indicate that HERV-K retrotransposons are expressed in 
certain tumors, and chromosomal rearrangements involving HERV-K sequences 
have been implicated in prostate cancer (Moyes et al., 2007; Tomlins et al., 
2007). HERV expression also has been implicated in the etiology of certain 
autoimmune and neurological diseases; however, these data remain 
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controversial and causal links between HERV expression and disease require 
additional experiments (reviewed in Moyes et al., 2007). 
Although apparently immobile in humans, the remnants of endogenous 
retroviruses also can impact the function of mammalian genomes. A growing 
number of examples indicate that cis-acting sequences derived from endogenous 
retroviruses can play roles in the transcription, splicing, and/or epigenetic 
regulation of endogenous genes (Cohen et al., 2009; Maksakova et al., 2006; 
Michaud et al., 1994; Robins and Samuelson, 1992). Moreover, sequences 
derived from endogenous retroviruses have been exapted by mammalian 
genomes, and now play important roles in placental development (e.g., Syncytin 
and peg10 (Mi et al., 2000; Ono et al., 2006)).  
Non-Long Terminal Repeat Retrotransposons: LINE-1 Elements 
L1s are the only known autonomously active human retrotransposons, and 
account for approximately one-sixth of our genome (Lander et al., 2001). Over 
99.9% of L1s have been rendered inactive by 5' truncations, inversions, and/or 
point mutations within the two L1-encoded ORFs (Grimaldi et al., 1984; Lander et 
al., 2001; Ostertag et al., 2001b). However, a consensus sequence derived from 
human genomic L1s suggested the existence of full-length, retrotransposition-
competent L1s (RC-L1s) (Scott et al., 1987). Indeed, the subsequent isolation of 
the progenitors of mutagenic L1 insertions into the Factor VIII and dystrophin 
genes revealed that a cohort of L1s continue to mobilize in our genome 
(Dombroski et al., 1991; Holmes et al., 1994). 
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The Structure and Mobility Mechanism of Retrotransposition-Competent LINE-1s  
RC-L1s are ~6 kb in length and contain a 5' untranslated region (UTR), two 
ORFs, and a 3' UTR that is punctuated by a poly(A) tail (Scott et al., 1987) 
(Figure 1.1). The L1 5' UTR houses an internal RNA polymerase II promoter that 
directs transcription from the 5' end of the element (Swergold, 1990); it also 
contains cis-acting binding sites for multiple transcription factors (Athanikar et al., 
2004; Becker et al., 1993; Kuwabara et al., 2009; Minakami et al., 1992; Tchenio 
et al., 2000; Yang et al., 2003).  
Recent studies have demonstrated that the L1 5' UTR contains a potent 
anti-sense promoter (L1 ASP). Transcription from the L1 ASP can lead to 
chimeric transcripts that contain a portion of the L1 5' UTR and genomic 
sequences flanking the 5' end of the L1 (Nigumann et al., 2002; Speek, 2001). It 
is further speculated that these chimeric transcripts may either function in gene 
regulation or promote the formation of double-stranded L1 RNAs that regulate L1 
retrotransposition by RNA interference-based mechanisms (Matlik et al., 2006; 
Yang and Kazazian, 2006). Interestingly, L1 ASP-derived chimeric transcripts 
have proven useful in the identification of expressed L1s from human embryonic 
stem cells, embryonic carcinoma cell lines, and somatic human tissues (Faulkner 
et al., 2009; Macia et al., 2011; Speek, 2001).  
Human ORF1 encodes a ~40-kDa protein (ORF1p) required for L1 
retrotransposition (Holmes et al., 1992; Moran et al., 1996). ORF1p has an 
amino-terminal coiled-coil domain (Holmes et al., 1992), a centrally located RNA 
recognition motif, and a basic carboxyl-terminal domain (Khazina and 
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Weichenrieder, 2009; Moran et al., 1996). Biochemical experiments with mouse 
and human ORF1p demonstrate that the amino-terminal coiled-coil domain 
facilitates ORF1p trimer formation (Khazina and Weichenrieder, 2009; Martin et 
al., 2003). Structural and biochemical analyses also suggest that the RNA 
recognition motif and carboxyl-terminal domain play critical roles in ORF1p 
binding to nucleic acids (Basame et al., 2006; Januszyk et al., 2007; Khazina and 
Weichenrieder, 2009; Kolosha and Martin, 1997). Finally, ORF1p has nucleic 
acid chaperone activity, which may be important for L1 integration (Martin and 
Bushman, 2001). 
ORF2 encodes a ~150-kDa protein (ORF2p), which has endonuclease and 
reverse transcriptase activities that are critical for L1 retrotransposition (Ergun et 
al., 2004; Feng et al., 1996; Martin et al., 1995; Mathias et al., 1991; Moran et al., 
1996). ORF2p also contains a cysteine-rich domain of unknown function near its 
carboxyl terminus that is required for retrotransposition (Fanning and Singer, 
1987; Moran et al., 1996). Recent experiments suggest that human ORF2 
translation occurs by an unconventional termination-reinitiation mechanism, and 
that the putative ORF2 AUG initiation codon is dispensable for translation, 
although it is conserved in all human L1s examined thus far (Alisch et al., 2006; 
Dmitriev et al., 2007; McMillan and Singer, 1993).  
The analysis of mutagenic L1 insertions in conjunction with biochemical and 
genetic assays has demonstrated that human ORF1p and ORF2p preferentially 
associate with their encoding messenger RNA (mRNA) (Dombroski et al., 1991; 
Esnault et al., 2000; Kulpa and Moran, 2006; Wei et al., 2001). This association, 
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termed cis-preference, leads to the generation of an L1 ribonucleoprotein (RNP) 
particle (Hohjoh and Singer, 1996; Kulpa and Moran, 2005; Martin, 1991). 
ORF1p is detectable in cytoplasmic RNPs from embryonic stem cells, embryonic 
carcinoma cell lines, and HeLa cells that overexpress engineered L1 elements 
(Garcia-Perez et al., 2007b, 2010; Hohjoh and Singer, 1996; Kulpa and Moran, 
2005; Martin, 1991). ORF1p and/or L1 RNA also have been detected in human 
oocytes, in some human somatic cells, and at select times during human and 
mouse germ cell development (Belancio et al., 2010b; Branciforte and Martin, 
1994; Coufal et al., 2009; Georgiou et al., 2009; Trelogan and Martin, 1995). In 
contrast, ORF2p appears to be much less abundant than ORF1p in L1 RNPs, 
and its detection has relied largely upon an assay to detect L1 reverse 
transcriptase activity in RNPs (Kulpa and Moran, 2006). However, epitope-
tagging strategies recently have allowed reliable ORF2p detection in RNPs 
derived from cells transfected with L1 expression constructs by both Western 
blotting and immunofluorescence (Doucet et al., 2010; Goodier et al., 2010). L1 
RNPs also associate with stress granules, although determining whether this 
association is important for L1 retrotransposition requires further study (Doucet et 
al., 2010; Goodier et al., 2007). 
Experiments using adenovirus-based vectors suggest that L1 
retrotransposition can occur in the absence of cell division (Kubo et al., 2006). 
Thus, some components of L1 RNPs may enter the nucleus in the absence of 
nuclear envelope breakdown. L1 retrotransposition then likely occurs by target-
site primed reverse transcription (TPRT) (Cost et al., 2002; Feng et al., 1996; 
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Luan et al., 1993). During TPRT, the L1-encoded endonuclease generates a 
single-strand endonucleolytic nick in genomic DNA to expose a 3'-OH (Feng et 
al., 1996). The liberated 3'-OH is then used as a primer by the L1 reverse 
transcriptase to initiate cDNA synthesis using the L1 mRNA as a template (Cost 
et al., 2002; Feng et al., 1996; Kulpa et al., 2006). Molecular details regarding 
second-strand target-site cleavage and second-strand L1 cDNA synthesis 
require elucidation, but insights about both these steps in TPRT have arisen from 
studying a related retrotransposon, R2, from Bombyx mori (Christensen and 
Eickbush, 2005). The process of TPRT generates a new L1 copy that generally is 
flanked by ~7-20 base pair (bp) target-site duplications (TSDs) (Kazazian and 
Moran, 1998) (Figure 1.2).  
Nonautonomous Retrotransposons: Alu and SVA Elements 
The human genome also contains numerous nonautonomous 
retrotransposons that rely upon activity of L1-encoded proteins to mediate their 
mobility. These non-autonomous elements consist primarily of the small 
interspersed element (SINE), Alu, which accounts for ~10% of sequence in the 
HGR (Lander et al., 2001).  
Alu elements arose in mammalian genomes ~65 million years ago and 
contain two monomeric sequences derived from the signal recognition particle 
(SRP) 7SL RNA (Batzer and Deininger, 2002; Ullu et al., 1982). Active Alu 
elements are ~280 bp in length and end in an A-rich tail. The left monomer 
contains an internal RNA polymerase III promoter (Batzer and Deininger, 2002) 
and is separated from the right monomer by an adenosine-rich sequence (Figure 
12 
1.1). However, flanking genomic sequences also can influence Alu transcriptional 
initiation and termination (Chu et al., 1995; Comeaux et al., 2009; Dewannieux 
and Heidmann, 2005; Goodier and Maraia, 1998; Liu and Schmid, 1993; Ullu and 
Weiner, 1985). Like L1s, Alu elements can be stratified into subfamilies 
(Deininger et al., 1992). Recent computational analyses and studies in cultured 
cells suggest that there may be thousands of active Alu “core” elements in the 
HGR (Bennett et al., 2008; Cordaux et al., 2004). However, Alu Y elements, most 
notably Ya5 and Yb8 subfamily members, account for the vast majority of 
disease-producing insertions in humans (Carroll et al., 2001). 
Alu elements rely upon L1 ORF2p to facilitate their retrotransposition in 
trans (Dewannieux et al., 2003). Mutations that either block Alu transcription or 
interfere with SRP9/14 protein binding adversely affect Alu retrotransposition in 
vitro (Bennett et al., 2008). Indeed, the ability of the SRP9/14 proteins to interact 
with Alu RNA may be intimately tied to the evolution of active Alu subfamilies 
(Bennett et al., 2008; Sarrowa et al., 1997).  
Alu elements can also be co-opted to play roles in gene expression. For 
example, inverted Alu elements within the 3' UTRs of some cellular mRNAs can 
result in adenosine-to-inosine RNA editing and preferential nuclear retention of 
the resultant edited mRNAs in the nuclei of differentiated cells (Chen and 
Carmichael, 2009). Additionally, Alu elements can be incorporated into existing 
transcription units by a process known as exonization, which may serve to 
enhance transcriptome diversification (Lev-Maor et al., 2003; Sela et al., 2010; 
Shen et al., 2011). Finally, the poly(A) tails flanking Alu elements may serve as a 
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source for generating microsatellite sequences in human DNA (Arcot et al., 
1995). 
SINE-R/VNTR/Alu (SVA) elements arose in primate lineages ~25 million 
years ago and are present at ~2,700 copies in the human genome (Wang et al., 
2005). They have a composite structure consisting of a variable-length 
hexameric repeat (CCCTCT)n that is sequentially followed by an inverted Alu-like 
sequence, a variable number of tandem repeats (VNTRs) region, a sequence 
derived from the 3' end of a HERV-K10 element (SINE-R), and a poly(A) tail 
(Ono et al., 1987; Ostertag et al., 2003; Shen et al., 1994) (Figure 1.1). Whether 
SVA elements contain functional promoter sequences remains an open question; 
however, it is likely that SVA elements are transcribed by RNA polymerase II and 
that the resultant SVA RNAs are mobilized to new genomic locations by the L1-
encoded proteins (Damert et al., 2009; Hancks et al., 2009; Hancks et al., 2011; 
Ostertag et al., 2003) (Figure 1.2). Indeed, the recent development of a cell-
based assay for SVA mobilization should be instrumental in deciphering 
mechanistic details of SVA trans-mobilization (Hancks et al., 2011). 
 Nonautonomous Retrotransposons: Mobilization of Cellular RNAs 
Cellular messenger RNAs can occasionally use the L1-encoded proteins to 
mobilize to new genomic locations, thereby generating processed pseudogenes 
(Esnault et al., 2000; Maestre et al., 1995; Wei et al., 2001) (Figure 1.1). There 
are ~8,000-15,000 processed pseudogene copies in the HGR, and most are 
derived from genes that are highly expressed in the germline, such as 
housekeeping genes and ribosomal protein genes (Torrents et al., 2003; Zhang 
14 
et al., 2002, 2003). Interestingly, some ribosomal protein processed 
pseudogenes (e.g., RPL21) occur at a relatively high copy number, suggesting 
that some property of these mRNAs allows them to recruit the L1-encoded 
proteins more effectively than other mRNAs (Zhang et al., 2002).   
Most processed pseudogenes are dead on arrival because they lack a 
functional promoter (Vanin, 1985; Weiner et al., 1986). Thus, they can be used 
as molecular clocks to estimate mutational rates between species (Graur et al., 
1989). However, some human processed pseudogenes are expressed, and a 
small number may encode functional genes or serve as sources of small 
interfering RNAs (siRNAs) with gene regulatory functions (Harrison et al., 2005; 
Tam et al., 2008; Vanin, 1985). 
To date, there are no examples of de novo processed pseudogene 
retrotransposition events causing human disease. However, the expression of a 
processed pseudogene has been implicated in human facioscapulohumeral 
dystrophy patients (Lemmers et al., 2010; Snider et al., 2010). Similarly, 
expression of an FGF4 processed pseudogene is associated with 
chondrodysplasia in 19 dog breeds, consistent with the idea that selective 
breeding can enrich for rare mutagenic L1-mediated insertion alleles (Parker et 
al., 2009).   
The L1-encoded proteins also can mobilize other noncoding cellular RNAs, 
such as U6 small nuclear RNA (snRNA), to new genomic locations (Buzdin et al., 
2002). Computational and experimental evidence suggests that the L1 reverse 
transcriptase can switch templates to the U6 snRNA during TPRT to generate 
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U6/L1, and less frequently U6/processed pseudogene chimeras (Buzdin et al., 
2002, 2003a; Garcia-Perez et al., 2007a; Gilbert et al., 2005) (Figure 1.2). 
Interestingly, some U6 pseudogenes, small uracil-rich RNAs (e.g., U1 snRNA), 
and small nucleolar RNAs (e.g., U3 snoRNA) end in poly(A) tails and are flanked 
by target site duplications, suggesting that they also may have been mobilized by 
the L1-encoded proteins (Bennett et al., 2004; Denison et al., 1981; Garcia-Perez 
et al., 2007a; Van Arsdell et al., 1981; Weber, 2006).  
Technologies to Identify Human-Specific LINE-1s 
Overview 
The ability to discriminate human-specific L1-mediated retrotransposition 
events from the large mass of defective retrotransposons in the genome is akin 
to finding a needle in a haystack. However, an elegant combination of 
phylogenetic, molecular biological, computational, and modern genomic 
technologies has revolutionized our ability to identify human-specific L1-mediated 
retrotransposition events in both reference sequences and individual genomes 
(Figure 1.3). Some of the seminal findings allowing these advances are 
discussed below.  
A Brief Historical Perspective  
L1s in the human genome have succeeded one another in a single lineage 
for the last ~40 million years (Boissinot et al., 2000; Boissinot et al., 2004; 
Boissinot and Furano, 2001; Khan et al., 2006). Thus, new L1 subfamilies are 
continuously replacing older ones to dominate the expanding lineage of active 
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elements (Boissinot et al., 2000; Boissinot and Furano, 2001; Deininger et al., 
1992; Khan et al., 2006; Smit et al., 1995). A majority of L1s are shared between 
human and chimp genomes, and likely represent retrotransposition-defective 
molecular fossils. However, studies in human embryonic carcinoma cell lines 
revealed that a subset of expressed L1s contained diagnostic sequence variants 
within their 3' UTR (e.g., an ACA instead of a GAG trinucleotide at positions 5930 
to 5932 of L1.2; accession number M80343) (Skowronski et al., 1988). This 
subset of expressed L1s were designated the Ta (transcribed, subset a) L1 
subfamily (Skowronski et al., 1988). Interestingly, all but one of the ~18 disease-
producing L1 insertions identified to date are derived from the Ta subfamily 
(Goodier and Kazazian, 2008; Belancio et al., 2008). The remaining mutagenic 
insertion was derived from the slightly older, human-specific pre-Ta subfamily of 
L1 (which contains an ACG trinucleotide at positions 5930 to 5932 relative to 
L1.2) (Kazazian et al., 1988). 
The identification of sequence variants peculiar to human-specific L1s and 
the subsequent development of a cultured cell retrotransposition assay were 
instrumental in allowing the identification of RC-L1s in the HGR (Figure 1.4) 
(Beck et al., 2010; Brouha et al., 2003; Lander et al., 2001; Moran et al., 1996; 
Myers et al., 2002). Comprehensive computational studies revealed that the 
HGR contains ~90 L1s with intact ORFs (Brouha et al., 2003; Myers et al., 2002). 
Polymerase chain reaction (PCR)-based cloning revealed that ~44 of these show 
a range of activity in cultured human HeLa cells (Brouha et al., 2003). 
Unexpectedly, six highly active, or “hot” L1s accounted for ~84% of the 
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retrotransposition activity in the HGR. Extrapolation of the ~44 RC-L1s contained 
in the haploid HGR working draft to the scale of a complete diploid genome 
suggested that the average human genome harbors ~80-100 active L1 elements 
(Brouha et al., 2003; Sassaman et al., 1997). Interestingly, limited genotyping 
analyses indicated that many active and retrotransposition-defective Ta 
subfamily L1s in the HGR are polymorphic with respect to presence or absence, 
indicating that many are recent insertions (Badge et al., 2003; Boissinot et al., 
2004; Brouha et al., 2003; Myers et al., 2002).  
Identification of Human-Specific LINE-1s by Mining Genome Sequences 
Large-scale DNA sequencing projects have provided valuable resources to 
identify human L1-mediated retrotransposon polymorphisms. For example, 
comparative genomic analyses between the HGR and the draft chimpanzee 
genome allowed the identification of ~11,000 species-specific transposable 
elements, including 5,530 Alu, 1,174 L1, and 864 SVA elements specific to 
humans (Mills et al., 2006). Comparisons of DNA sequence trace files from 36 
geographically diverse humans also enabled the identification of ~505 Alu 
elements, 65 L1s, 39 SVAs, 2 HERV-Ks, and 5 other polymorphic insertions 
(Bennett et al., 2004). Similarly, comparison of a complete human diploid 
sequence (Levy et al., 2007) to the HGR allowed the identification of ~706 mobile 
element-associated structural variants, including the insertion of 584 Alu 
elements, 52 L1s, and 14 SVA elements (Xing et al., 2009). Mining 8 human 
genome sequences generated by next-generation sequencing yielded 4,342 Alu 
insertions absent from the HGR, 3,432 of which were additionally absent from a 
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number of previous studies (Hormozdiari et al., 2011). Finally, a pilot analysis of 
sequence data obtained from ~200 – 300 individuals as part of the 1000 
Genomes Project allowed the identification of over 1,000 L1 insertions that are 
absent from the HGR (Durbin et al., 2010; Ewing and Kazazian, 2011; Mills et al., 
2011; Rouchka et al., 2010). However, due to the low fold sequence coverage (2-
4 fold for many genomes) and the composite nature of the HGR, it is likely that 
L1s are underrepresented in these analyses. 
Clearly, the exploitation of human DNA sequence resources and nonhuman 
primate comparative genomics has revealed extensive human-specific 
transposable element diversity. A union of the above data has shown that these 
insertions are much more common in the population than once thought. 
Experimental Approaches to Identify Novel Retrotransposon Insertions 
The genomics revolution has revealed how structural variation contributes 
to inter-individual genetic diversity. For example, representative oligonucleotide 
microarray analysis and array comparative genomic hybridization technologies 
have allowed the high-throughput identification of submicroscopic genetic 
differences of ~100kb among individuals (Iafrate et al., 2004; Sebat et al., 2004). 
However, the size resolution of those techniques was not sufficient to permit 
identification of L1-mediated retrotransposition events. 
More recently, a number of methods have been developed that are capable 
of detecting small- and intermediate-scale human structural variants (Figure 1.3). 
These methods include transposon display, array-based hybridization, second-
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generation DNA sequencing, and paired-end mapping of clone libraries (Badge 
et al., 2003; Bentley et al., 2008; Conrad et al., 2006; Durbin et al., 2010; Kidd et 
al., 2008; Korbel et al., 2007; McKernan et al., 2009; Mills et al., 2011; 
Ovchinnikov et al., 2001, 2002; Redon et al., 2006; Sheen et al., 2000; Tuzun et 
al., 2005; Wang et al., 2008; Wheeler et al., 2008). Together, these approaches 
have been instrumental in revealing transposon diversity in the genomes of 
geographically diverse individuals. A somewhat unexpected result is that mobile 
element dimorphisms account for a relatively large proportion of human genetic 
diversity (up to ~20%–25% of the interindividual genetic differences identified in 
some studies) (Kidd et al., 2010; Korbel et al., 2007). The development of 
approaches to specifically identify L1-mediated genetic variation is described 
below. 
PCR-based display methods have allowed the identification of polymorphic 
L1 and Alu insertions in human genomes (Badge et al., 2003; Boissinot et al., 
2004; Buzdin et al., 2003b; Ovchinnikov et al., 2001; Roy et al., 1999; Sheen et 
al., 2000). These methods exploit DNA sequence variants peculiar to human-
specific retrotransposons (e.g., the ACA character present in Ta subfamily L1s) 
in conjunction with a pool of short, arbitrary oligonucleotides or sequences 
complementary to ligated linkers. PCR reactions utilizing this combination of 
retrotransposon-specific and degenerate or linker sequences then are used to 
generate complex amplicon libraries that contain the candidate retrotransposon 
and its immediate 5' or 3' flanking sequences. Sequencing of the flanking DNA 
and subsequent searches for sequence similarity then determines whether the 
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candidate retrotransposon is present or absent in the HGR (Badge et al., 2003; 
Boissinot et al., 2004). Together, these methods have identified numerous L1 
and Alu insertion polymorphisms in individual genomes.  
A derivation of classical display methods that employs suppression PCR 
methodology [amplification typing of L1 active subfamilies (ATLAS)] enabled the 
identification of nine full-length human-specific L1s from individual genomes 
(Badge et al., 2003). Interestingly, three out of seven tested sequences were 
“hot” in the cultured cell retrotransposition assay, and these three L1s were 
present at a minor allele frequency of less than 24% when genotyped in a panel 
of 90 geographically diverse individuals. Thus, these data provided additional 
evidence to support the hypothesis that young, human-specific L1s are 
underrepresented in the HGR.  
Deconvolution of complex amplicon libraries generated by retrotransposon 
display approaches traditionally relied on electrophoretic fractionation using 
agarose or acrylamide gel systems and the subsequent cloning and 
characterization of individual molecules to map insertions to the HGR. The 
advent of new genomic technologies, including high-throughput DNA 
sequencing, now offers a means to revolutionize the discovery of polymorphic 
retrotransposon insertions (see Figure 1.3).   
One method to identify dimorphic retrotransposon insertions, transposon 
insertion profiling by microarray (TIP-chip), employs the principles of transposon 
display to specifically amplify retrotransposons and their associated flanking 
sequences (Gabriel et al., 2006; Huang et al., 2010; Wheelan et al., 2006). The 
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resultant amplicons are hybridized back to oligonucleotide arrays to identify 
sequences flanking the retrotransposons. TIP-chip allowed the discovery of 
numerous L1, Alu, and HERV-K insertion polymorphisms in genome-wide 
analyses. Application of TIP-chip to 69 unrelated individuals with X-linked 
intellectual disabilities also allowed the identification of L1 insertions within 
introns of the NHS and DACH2 genes, and mutations in these genes are 
implicated in intellectual disability (Huang et al., 2010). However, future studies 
are needed to determine whether the L1 insertions play a causal role in the 
observed cognitive phenotypes in these patients. 
 Another method to identify dimorphic L1 and Alu insertion polymorphisms 
employs traditional Sanger capillary sequencing and 454 or Illumina-based 
second-generation DNA sequencing technologies to de-convolute transposon-
derived amplicon libraries (Ewing and Kazazian, 2010; Iskow et al., 2010). Iskow 
et al. identified 152 L1s from 38 ethnically diverse humans and 8 cell lines using 
capillary sequencing. They also identified 650 L1 and 403 Alu insertions in 30 
lung or brain tumors and their matched non-tumor controls via 454-based 
sequencing (Iskow et al., 2010). These insertions were absent from both the 
HGR and a database of retrotransposon insertion polymorphisms (dbRIP) 
(Lander et al., 2001; Wang et al., 2006), yielding 1,145 novel transposable 
elements. Ewing et al. used an Illumina-based sequencing approach to identify 
367 polymorphic L1s from a cohort of 25 humans that contained 15 unrelated 
individuals, individuals from 6 trios, and 3 pairs of monozygotic twins (Ewing and 
Kazazian, 2010). Finally, Witherspoon et al. used an Illumina-based sequencing 
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approach to identify 487 Alu Yb8 and Yb9 insertions in 4 unrelated individuals 
that were absent from the HGR (Witherspoon et al., 2010).  
A third method to identify full-length or near-full-length L1 insertion 
polymorphisms involves paired-end DNA sequencing of fosmid libraries derived 
from individuals belonging to geographically diverse populations, which 
successfully identified intermediate-sized structural variants in human DNA (Beck 
et al., 2010; Kidd et al., 2008; Tuzun et al., 2005). The screening of six individual 
libraries identified 68 L1s that were absent from the HGR. Remarkably, 37 of 
these 68 were “hot” L1s, two of which belonged to the pre-Ta L1 subfamily (Beck 
et al., 2010). Notably, unlike the methodologies described above, paired-end 
DNA sequencing of fosmid libraries does not involve PCR, allows identification of 
L1s in repetitive regions of the genome, and though labor intensive, allows a 
comprehensive and relatively unbiased snapshot of L1 diversity. Together, the 
above methodologies have uncovered a virtual treasure trove of natural 
retrotransposon diversity in human genomes.  
Allelic Heterogeneity in LINE-1 Activity 
In addition to the polymorphic status of an L1, allelic heterogeneity may 
cause different L1 insertion alleles to exhibit different retrotransposition 
efficiencies in cultured cells. For example, L1.2A and L1.2B, which are likely 
progenitor alleles of a mutagenic insertion in the Factor VIII gene, exhibit a ~16-
fold difference in their retrotransposition efficiencies because of amino acid 
substitutions near the ORF2p carboxyl terminus (Dombroski et al., 1991; Farley 
et al., 2004; Kazazian et al., 1988; Lutz et al., 2003). Similarly, the examination of 
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three “hot” L1s from the HGR in a geographically diverse set of individuals 
revealed alleles with a wide range of retrotransposition activities (ranging from 
0% to 390% of a reference L1) (Seleme et al., 2006). Finally, a recent study 
identified an RC-L1 allele in an individual genome which apparently is defective 
in the HGR due to a stop codon in ORF2p (Beck et al., 2010). Thus, both 
presence/absence of polymorphisms and allelic heterogeneity can influence L1 
retrotransposition in an individual genome. 
Impact of Mobile Elements on Mammalian Genomes 
LINE-1 as a Mutagen 
A wealth of data is revealing the consequences of L1-mediated 
retrotransposition events in human genomes. Since their original discovery, 
approximately 65 disease-causing mutations in man have been attributed to L1-
mediated retrotransposition events (Belancio et al., 2008a; Goodier and 
Kazazian, 2008). L1-mediated retrotransposition events can act as mutagens by 
directly disrupting exons (Kazazian et al., 1988). Similarly, insertions into introns 
can induce missplicing or exon skipping, thereby generating hypomorphic or null 
expression alleles (Figure 1.5) (Belancio et al., 2008b; reviewed in Goodier and 
Kazazian, 2008; Ostertag and Kazazian, 2001a). Finally, recent reports suggest 
the L1 endonuclease may cause double strand breaks, which in principle could 
lead to genomic instability (Gasior et al., 2006; Lin et al., 2009). Clearly, 
advances in genomics and the evolution of DNA sequencing technologies should 
allow the rapid identification of other disease-producing insertions in the coming 
years.  
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Effects on Gene Expression 
L1 insertions can impact gene expression by a variety of mechanisms 
(Figure 1.5). For example, experimental studies have revealed that the 
adenosine-rich nature of the L1 transcript can introduce premature 
polyadenylation and/or RNA polymerase II transcriptional pause sites into genes, 
thereby attenuating their expression (Han et al., 2004; Perepelitsa-Belancio and 
Deininger, 2003). Interestingly, transcriptional pausing appears to depend on 
both the length of the L1 insertion and whether it is in the same transcriptional 
orientation as its resident gene (Chen et al., 2006; Han et al., 2004). The L1 ASP 
also can generate transcripts that, in principle, could affect gene expression 
(Matlik et al., 2006; Nigumann et al., 2002; Speek, 2001; Yang and Kazazian, 
2006). Finally, in rare instances, L1 insertions may disrupt genes, leading to the 
generation of distinct transcription units through a phenomenon known as gene 
breaking (Figure 1.5) (Wheelan et al., 2005). 
Approximate Rates of Heritable Retrotransposition Events 
Determining the rate of germline retrotransposition in the human population 
remains an area of ongoing investigation. Estimates suggest that Alu elements 
are the most active retrotransposons in the human genome, with new insertions 
occurring in approximately 1 out of 20 live births (Cordaux and Batzer, 2009; 
Xing et al., 2009). L1 insertions follow, with estimates ranging between 1 out of 
20 and 1 out of 200 births, depending upon the method used in the analysis 
(Cordaux and Batzer, 2009; Ewing and Kazazian, 2010; Huang et al., 2010; Li et 
al., 2001; Xing et al., 2009). SVA insertions may be the least frequent 
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retrotransposition events, occurring in approximately 1 out of 900 births (Cordaux 
and Batzer, 2009; Xing et al., 2009). In spite of disparate rates of 
retrotransposition, the different sizes and unique characteristics of L1, Alu, and 
SVA elements may pose distinctive challenges to the genome. 
The above estimates are subject to ascertainment biases, and may 
represent only minimal estimates of the actual de novo retrotransposition 
frequency. For example, because some studies relied on comparisons with the 
HGR, they may underestimate the contribution of low allele-frequency insertions 
to human genetic diversity (Xing et al., 2009). In fact, Iskow et al. suggested that 
low allele-frequency L1-mediated retrotransposition events, representing either 
rare or perhaps private L1 and/or Alu alleles, may be present in “virtually all 
personal genomes in the human populations” (Iskow et al., 2010). Consistently, 
fosmid-based paired-end DNA sequencing, TIP-chip profiling, and the preliminary 
examination of the 1000 Genomes Project data have readily allowed the 
detection of rare L1 retrotransposition events in geographically diverse 
individuals (Beck et al., 2010; Ewing and Kazazian, 2011; Huang et al., 2010; 
Mills et al., 2011). Clearly, the exhaustive DNA sequencing of parent/offspring 
trios at high coverage should provide more accurate estimates of L1-mediated 
germline retrotransposition events in the near future.  
Somatic LINE-1 Retrotransposition: Insights from Cancer Studies 
In addition to acting as a germline mutagen, studies have revealed that L1 
retrotransposition also occurs in certain somatic cells. Historically, the 
identification of a mutagenic L1 insertion into the adenomatous polyposis coli 
26 
(APC) gene in a colorectal tumor that was absent from adjacent non-tumor tissue 
established that L1 could retrotranspose in somatic cells (Miki et al., 1992).  
Recent data generated using L1 display approaches combined with 454-
based DNA sequencing led to the discovery of 9 de novo somatic L1 
retrotransposition events in 6 of 20 non small-cell lung cancers that were absent 
from matched adjacent normal tissue samples (Iskow et al., 2010). Interestingly, 
tumors containing new L1 retrotransposition events also exhibited global patterns 
of hypomethylation, providing a correlative link between epigenetic changes and 
increased L1 retrotransposition in tumors. Hypomethylation of the L1 5' UTR also 
has been observed in malignant cells and cancer tissues, and is correlated with 
an increase in L1 mRNA and/or ORF1p expression (Alves et al., 1996; Asch et 
al., 1996; Belancio et al., 2010a; Goodier and Kazazian, 2008). Similarly, 5-
azacytidine treatment leads to an elevation of L1-ASP driven chimeric transcripts 
in non-malignant breast epithelial cells (Cruickshanks and Tufarelli, 2009). Thus, 
the above data suggest that the rate of L1 retrotransposition, and by proxy Alu 
and SVA retrotransposition, may be elevated in some cancers. Further studies 
should allow a greater understanding of whether and/or how often L1-mediated 
retrotransposition occurs in cancer and whether these events play a causal role 
in tumorigenesis.  
Somatic LINE-1 Retrotransposition During Normal Development 
Human genetic approaches, experiments conducted in transgenic animals, 
and cell culture models further suggest that L1 retrotransposition can occur in 
normal cells at discrete times during development. For example, genetic 
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analyses have conclusively demonstrated both germline and somatic mosaicism 
of a mutagenic L1 retrotransposition event in the mother of a male patient 
afflicted with X-linked choroideremia (van den Hurk et al., 2007). Thus, the 
mutagenic L1 insertion must have occurred during early embryonic development 
of the mother prior to partitioning of the germline. Consistent with this hypothesis, 
engineered L1s can retrotranspose in human embryonic stem cells (Garcia-
Perez et al., 2007b).  
 Engineered human L1s can also retrotranspose during the early stages of 
mouse and rat embryonic development; however, most of the resultant insertions 
are not heritable (Kano et al., 2009). These findings are remarkable and suggest 
that L1 mRNA may be transferred from the gametes to the zygote to undergo 
retrotransposition at a later time in development, generating somatic mosaicism 
in the resultant offspring.  
Unexpectedly, recent studies also revealed that engineered human L1s can 
retrotranspose at discrete times during neuronal development (Coufal et al., 
2009; Muotri et al., 2005, 2010). These retrotransposition events could, in 
principle, generate somatic mosaicism in the nervous system and have the 
potential to affect intra-individual neuronal variability (Coufal et al., 2009; Muotri 
et al., 2005, 2010). In fact, sensitive TaqMan PCR-based approaches suggest 
that certain regions of the brain have an increase in human-specific L1 content 
relative to heart and/or liver tissues isolated from the same individual (Coufal et 
al., 2009; Muotri et al., 2010). The observed increase in L1 DNA copy number in 
the brain suggests elevated levels of endogenous L1 retrotransposition in brain. 
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However, other non mutually exclusive mechanisms must be considered when 
accounting for these L1 copy number differences (Peterson et al., 2008; Westra 
et al., 2010). Indeed, formal proof of endogenous L1 retrotransposition in brain 
will require the characterization of new L1 insertions from individual neurons. 
Although this remains a daunting task, advances in DNA sequencing 
technologies–including the ability to comprehensively characterize genome 
sequences from single or small pools of cells–should allow rigorous testing of 
these interesting observations.   
Together, the above findings overturned the long-held dogma that L1-
mediated retrotransposition could only occur in germ cells, and has led to 
speculations about how L1-meditated retrotransposition events may affect intra-
individual genetic variation (Kano et al., 2009; Martin, 2009; Muotri et al., 2005, 
2010; Singer et al., 2010). Time and rigorous experimentation will tell whether 
somatic L1 retrotransposition events represent stochastic genetic noise that is 
tolerated by the host genome or whether these events have functional 
consequences in disease pathogenesis and/or neuronal development. 
LINE-1 as an Agent of Genome Diversification 
LINE-1 Retrotransposition by Target-Site Primed Reverse Transcription 
Canonical TPRT generally results in the insertion of an L1 or non-
autonomous retrotransposition event at a new genomic location flanked by short 
TSDs (Figures 1.2 and 1.5). On occasion, TPRT also can lead to small deletions 
of target-site DNA that vary from approximately 2 to 50 bp in length, and/or to the 
addition of non-templated or filler nucleotides at the 5' genomic DNA/L1 junction 
29 
sequence (Athanikar et al., 2004; Lavie et al., 2004; Narita et al., 1993). Similar 
target-site alterations were observed upon examining engineered L1 
retrotransposition events in transformed cell lines, human embryonic stem cells, 
and neuronal progenitor cells (Coufal et al., 2009; Garcia-Perez et al., 2007b; 
Gilbert et al., 2002, 2005; Muotri et al., 2005; Symer et al., 2002). 
Approximately 35% of Ta subfamily L1 retrotransposition events represent 
full-length insertions (Boissinot et al., 2000). The remaining L1s are 5' truncated 
(Grimaldi et al., 1984) and often contain short microhomologies at the 5' genomic 
DNA/L1 junction sequence (Babushok et al., 2006; Gilbert et al., 2002, 2005; 
Martin et al., 2005; Symer et al., 2002; Zingler et al., 2005). Additionally, 
approximately 25% of L1s contain L1 inversion/deletion events that likely are 
generated by a process termed twin priming (Figure 1.5) (Ostertag and Kazazian, 
2001b). The high frequency of 5' truncation associated with new L1 
retrotransposition events remains enigmatic and may reflect host defense or 
DNA repair processes that act to either dissociate the L1 reverse transcriptase 
from the nascent L1 cDNA or degrade the L1 mRNA template prior to the 
completion of reverse transcription.  
LINE-1 Retrotransposition-Mediated Deletion Events 
In addition to acting as an insertional mutagen, L1-mediated 
retrotransposition events can lead to various forms of human structural variation. 
For example, studies conducted in HeLa and HCT116 cells revealed that ~10% 
of retrotransposition events derived from engineered human L1s are associated 
with the formation of chimeric L1s accompanied by intrachromosomal deletions, 
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intrachromosomal duplication or inversions, and perhaps interchromosomal 
translocations (Gilbert et al., 2002, 2005; Symer et al., 2002). Comparisons of the 
pre- and post-integration sites of chimeric retrotransposition events suggested 
that DNA recombination processes such as single-strand annealing, synthesis-
dependent strand annealing, and perhaps nonhomologous end joining are 
involved in the formation of these aberrant structures (Gilbert et al., 2002, 2005; 
Symer et al., 2002).  
L1 retrotransposition-mediated genomic deletions are not peculiar to 
studies conducted in transformed human cells.  For example, comparative 
biological approaches between the human and chimpanzee reference genomes 
enabled the discovery of 30 L1 and 19 Alu retrotransposition-mediated deletion 
events, which together account for a loss of ~26 kb of human genomic DNA in 
the past six million years (Callinan et al., 2005; Han et al., 2005; Salem et al., 
2003).  
L1 retrotransposition-mediated deletion events have also been observed in 
human genetic diseases (Chen et al., 2005b). For example, a full-length L1 
insertion that was accompanied by a deletion of ~46 kb, including 7 exons of the 
PDHX gene, led to a sporadic case of pyruvate dehydrogenase complex 
deficiency (Mine et al., 2007). Similarly, a ~4-kb L1 insertion was accompanied 
by a ~17-kb deletion that disrupted 3 exons of the EYA1 gene, leading to a 
sporadic case of branchio-oto-renal syndrome (Morisada et al., 2010); however, 
the structure of this event suggests that it may have occurred by an 
endonuclease-independent (ENi) L1 retrotransposition mechanism (see below).  
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Alu and SVA retrotransposition-mediated deletion events also have 
impacted the human genome. For example, an Alu retrotransposition-mediated 
deletion approximately one million years ago resulted in the loss of a 92-bp exon 
of the CMP-Neu5Ac hydroxylase gene, leading to a loss-of-function frameshift 
mutation in humans (Hayakawa et al., 2001). Similarly, an SVA 
retrotransposition-mediated deletion apparently resulted in the loss of a 14-kb 
region of genomic DNA encompassing the entire HLA-A gene in three Japanese 
families containing patients afflicted with leukemia (Takasu et al., 2007). Thus, 
although relatively rare, retrotransposition-mediated deletion continues to impact 
the human genome and represents a mechanism that can lead to both human 
structural variation and disease.  
Postintegration LINE-1- and Alu-Mediated Recombination Processes 
The abundance of L1 and Alu retrotransposons in the human genome 
provides numerous potential substrates for post-integration recombination events 
that can lead to disease and/or structural variation in human genomes (reviewed 
in Cordaux and Batzer, 2009; Goodier and Kazazian, 2008). For example, 
nonallelic homologous recombination (NAHR) events between two inverted Alu 
elements originally was observed in a ~5 kb deletion that included exons of the 
Low-Density Lipoprotein Receptor gene, resulting in a case of familial 
hypercholesterolemia (Lehrman et al., 1985). Similarly, NAHR between genomic 
L1s has been implicated in sporadic cases of phosphorylase kinase deficiency, 
Alport syndrome, and Ellis-van Creveld syndrome (Burwinkel and Kilimann, 
1998; Segal et al., 1999; Temtamy et al., 2008). Finally, comparative biological 
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and genomic studies have revealed that NAHR events between L1s or Alus have 
generated structural variants in the chimpanzee and human genomes (Han et al., 
2007, 2008; Kidd et al., 2010; Lupski and Stankiewicz, 2005; Sen et al., 2006). 
Notably, young Alu elements are significantly enriched in regions flanking 
segmental duplications, suggesting that Alu-mediated recombination events may 
be involved in some segmental duplication expansions observed in humans 
(Bailey et al., 2003). Personal genomics and advances in DNA sequencing likely 
will continue to reveal that inter-retrotransposon recombination events represent 
a significant portion of structural variation in human genomes. 
Endonuclease-Independent (ENi) Insertions 
Experiments in XRCC4-deficient and DNA protein kinase catalytic subunit 
(DNA-PKcs)-deficient Chinese hamster ovary cell lines, which are defective in 
the nonhomologous end-joining pathway of DNA repair, revealed an alternative 
mechanism of ENi L1 retrotransposition distinct from conventional TPRT (Morrish 
et al., 2007; Morrish et al., 2002). Characterization of ENi insertions revealed that 
they generally integrated at non-canonical L1 endonuclease cleavage sites, 
lacked TSDs, and frequently were truncated at both their 5' and 3' ends. In 
addition, some ENi retrotransposition events were associated with genomic DNA 
deletions and/or contained cDNA fragments derived from non-L1 cellular RNAs 
that likely were reverse transcribed during the integration process. L1 insertions 
bearing the hallmarks of ENi retrotransposition events have been identified in the 
human genome, again showing how cultured cell models can predict events that 
occur in nature (Sen et al., 2007; Srikanta et al., 2009). Together, these findings 
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suggested that ENi retrotransposition might bypass the requirement for 
endonuclease activity by initiating reverse transcription at endogenous lesions in 
genomic DNA, thereby acting as a molecular bandage (Morrish et al., 2002; 
Voliva et al., 1984). Consistent with the above hypothesis, some ENi 
retrotransposition events in DNA-PKcs-deficient Chinese hamster ovary cells 
integrate at dysfunctional telomeres (Morrish et al., 2007). Thus, ENi 
retrotransposition shows curious similarities to the action of telomerase and may 
represent a form of RNA-mediated DNA repair utilized by retrotransposons that 
lack an endonuclease domain (Curcio and Belfort, 2007; Gladyshev and 
Arkhipova, 2007; Morrish et al., 2007).  
LINE-1-Mediated Transduction 
The examination of disease-producing L1 insertions and experiments using 
the cultured cell retrotransposition assay revealed that L1s are able to mobilize 
genomic DNA sequences flanking their 3' (and less commonly their 5') ends by a 
process termed L1-mediated transduction (Figure 1.5). The transduction of 3' 
sequences is relatively common, and suggests that RNA polymerase II frequently 
bypasses the natural L1 polyadenylation site and instead uses a site in flanking 
genomic DNA (Holmes et al., 1994; Moran et al., 1999; Moran et al., 1996). 
Computational analyses and the examination of L1 structural variants in 
individual genomes have revealed that 3' transductions flank ~20% of human-
specific L1s in the HGR and that some 3' transductions are over 1 kb in length 
(Beck et al., 2010; Goodier et al., 2000; Kidd et al., 2010; Pickeral et al., 2000). 
Extrapolations based on these data suggest that L1-mediated 3' transductions 
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may comprise as much as ~19-30 Mb of the human genome (Goodier et al., 
2000; Pickeral et al., 2000).  
L1 3' transductions create recognizable sequence tags, which can be used 
to infer parent/offspring relationships between full-length L1s and their progeny. 
For example, a ~489 bp region of genomic DNA flanking a mutagenic L1 
insertion into the dystrophin gene was instrumental in identifying an active L1 
progenitor allele (Holmes et al., 1994). Similarly, shared 3' transduction 
sequences were recently used to identify mini families of L1s that contain active, 
rare alleles in the human population (Beck et al., 2010; Kidd et al., 2010). L1s 
from two of these 3' transduction families, LRE3 and L1RP, are responsible for 
disease-producing insertions in sporadic cases of chronic granulomatous disease 
and X-linked retinitis pigmentosa, respectively (Brouha et al., 2002; Kimberland 
et al., 1999; Schwahn et al., 1998). Thus, the examination of transduction 
families that include highly active elements may be used as a way to discover 
novel, rare, and highly active L1s in human populations. 
The cultured cell L1 retrotransposition assay revealed that 3' transduction 
could, in principle, lead to the mobilization of exons and/or regulatory DNA 
sequences to new genomic locations, and may represent a mechanism of exon 
shuffling (Moran et al., 1996, 1999). To date, there are no in vivo examples of L1 
3' transduction leading to the formation of a new gene. However, SVA elements 
are also frequently associated with 3' transductions (Ostertag et al., 2003), and 
SVA-mediated 3' transduction events prior to the divergence of humans and 
great apes led to the dispersion of the AMAC gene to three distinct places in the 
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human genome (Xing et al., 2006). Whether these copies of the AMAC gene are 
functional requires validation, but the potential for genomic diversification through 
mobile element-mediated dispersion is clear. 
The ability of the L1-encoded proteins to mobilize non-L1 RNAs to new 
genomic locations in trans provides another potential mechanism for exon 
dispersal and/or the creation of new genes. For example, retrotransposition of a 
cyclophilin A cDNA into the TRIM5-α locus of New World monkeys led to the 
creation of a chimeric protein that confers HIV resistance to owl monkeys (Sayah 
et al., 2004). Similarly, a novel testes-specific hominoid gene, PIPSL, is a 
chimeric ubiquitin-binding protein derived from a fusion of the PIP5K1A and 26S 
proteasome subunit RNAs that underwent retrotransposition (Babushok et al., 
2007; Ohshima and Igarashi, 2010). The PIPSL gene appears to have been 
subject to positive selection and is conserved among humans, suggesting a 
functional role in modern genomes. Finally, it appears that exons from the CFTR 
and ATM genes have been mobilized in trans to new genomic locations by the L1 
retrotransposition machinery (Ejima and Yang, 2003; Rozmahel et al., 1997). 
However, it remains possible that some of these examples represent L1-
mediated 3' transductions that were so severely 5' truncated they lack L1 
sequences (Ejima and Yang, 2003; Moran et al., 1999).  
In principle, L1 5' transduction can occur if a transcript initiating upstream of 
an L1 undergoes retrotransposition. Because 5' transduction can only be found 
by examining full-length L1s, they appear to be much less common than 3' 
transductions. However, potential examples of L1 5' transduction have been 
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identified in the HGR, in cultured cell experiments, and in a mutagenic mouse 
insertion (Chen et al., 2006; Lander et al., 2001; Symer et al., 2002; Wei et al., 
2001). In contrast, 5' transduction events frequently accompany SVA 
retrotransposition events, which is consistent with the idea that some SVA 
elements rely on host promoter sequences for their transcription (Damert et al., 
2009; Hancks et al., 2009). Indeed, a 5' transduction derived from the MAST2 
gene was used to identify a family of SVA elements (SVAF) that likely are 
amplifying in the human genome (Damert et al., 2009; Hancks et al., 2009). 
Epigenetic Phenomena Related to LINE-1s 
L1s may also play critical roles in the epigenetic regulation of host genes 
(Figure 1.5). For example, recent research suggests that indicator cassettes 
delivered into the genome by engineered L1 retrotransposons can be 
epigenetically silenced either during or immediately after their integration (Coufal 
et al., 2009; Garcia-Perez et al., 2010; Muotri et al., 2005). It will be interesting to 
determine whether silencing is specific for the retrotransposed L1 sequence or 
whether it can affect the epigenetic status of adjacent genes.   
The ability of L1 to affect the epigenetic regulation of genes may not be 
restricted to new retrotransposition events. For example, the ability of L1s to 
accumulate on sex chromosomes over evolutionary time led Mary Lyon to 
speculate that L1s might function as cis-acting booster elements to aid in the 
spreading of heterochromatin formation observed during X-inactivation (Lyon, 
1998). Consistent with this notion, some genes that escape X-inactivation are in 
relatively L1-poor regions of the X chromosome (Bailey et al., 2000; Carrel et al., 
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2006), and L1 density appears to correlate positively with heterochromatin 
spread in X/autosomal translocations (Tang et al., 2010). Indeed, recent 
experiments suggest that L1s might play an active role in nucleating 
heterochromatin formation on the inactive X chromosome (Chow et al., 2010). 
Clearly, although these findings are still in their early stages, further research 
should allow even more discoveries about how L1-associated epigenetic 
changes impact gene expression. 
Closing Remarks  
It is now clear that transposable elements are an integral part of our 
genomes. In the coming years, technological breakthroughs in DNA sequencing 
and genome annotation will undoubtedly uncover many more examples of how 
transposable elements impact biological processes. For example, high-coverage, 
longer-read sequencing of trios and monozygotic twins, and/or the ability to 
sequence the genomes of single or small populations of cells will yield more 
information about the actual rate of L1-mediated retrotransposition events in both 
germline and somatic cells, and should clarify the role of L1-mediated 
retrotransposition events in certain types of human cancers. It will be interesting 
to determine whether genetically distinct populations or particular individuals are 
more prone to L1-mediated retrotransposition events.   
Because transposable elements can be considered intracellular genomic 
parasites, they also provide an ideal means to study host-parasite interactions. 
The availability of new experimental reagents, such as epitope-tagged 
engineered human L1s, combined with cell-culture based retrotransposition 
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assays now allows a way to identify host factors that act to combat the genomic 
effects of continued retrotransposition. We probably will discover even more 
examples where genetic differences in host factors correlate with variation in L1 
retrotransposition rates (e.g., (Chiu and Greene, 2008; Goodier and Kazazian, 
2008; Kidd et al., 2007; OhAinle et al., 2008; Stetson et al., 2008)). 
Finally, future studies will enlighten us about how transposable element-
derived sequences serve as seeds for evolutionary change. There is an ever-
growing number of examples of regulatory elements derived from transposable 
elements that are required for proper gene expression (e.g., (Bejerano et al., 
2006; Jurka, 2008; Sasaki et al., 2008; Wang et al., 2007), and reviewed in 
(Feschotte, 2008)), and we anticipate this list will expand. Indeed, transposable 
elements may provide a mechanism to amplify and distribute cis-acting DNA 
sequences to new genomic locations, which after selection may function in gene 
regulation — a potentially prescient hypothesis put forth by Davidson & Britten 
over 40 years ago (Davidson and Britten, 1979). 
We have come a long way since Barbara McClintock’s discovery of mobile 
genetic elements in maize over half a century ago (McClintock, 1950). In the past 
decade alone, we have witnessed an exponential growth in knowledge about 
how transposable elements have impacted the human as well as other 
mammalian genomes. Though much progress has been made, our work has just 
begun. The coming years likely will identify how transposable elements 
contribute to phenotypic variation and human-specific traits. Clearly, the “junk” in 
our genomes is stepping into the limelight.  It is an exciting time for transposable 
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element research; the human genetics community should take greater notice of 
these dynamic elements. 
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Figure 1.1: Mobile Elements in Human Genomes 
The classes of mobile genetic elements in the human genome, showing the type 
of mobile element, the structure of representative elements, the percentage of 
each element in the human genome reference sequence (HGR), and whether 
each class of elements is currently active (Lander et al., 2001). Abbreviations for 
human endogenous retrovirus-K (HERV-K): LTR, long terminal repeat; Gag, 
group-specific antigen; Pol, polymerase; Env, envelope protein (dysfunctional). 
For LINE-1: UTR, untranslated region; CC, coiled coil; RRM, RNA recognition 
motif; CTD, carboxyl-terminal domain; EN, endonuclease; RT, reverse 
transcriptase; C, cysteine-rich domain. For Alu: A and B, component sequences 
of the RNA polymerase III promoter; AR, the adenosine-rich segment separating 
the 7SL monomers. For SINE-R/VNTR/Alu (SVA): VNTR, variable number of 
tandem repeats; SINE-R, domain derived from a HERV-K. An signifies a poly(A) 
tail. 
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Figure 1.2: A LINE-1 Retrotransposition Cycle 
A LINE-1 retrotransposition cycle. A full-length L1 (light blue bar on gray 
chromosome) is transcribed, the L1 messenger RNA (mRNA) is exported to the 
cytoplasm, and translation of ORF1p (yellow circles) and ORF2p (blue oval) 
leads to ribonucleoprotein (RNP) formation. Components of the L1 RNP are 
transported to the nucleus, and retrotransposition occurs by target-site primed 
reverse transcription (TPRT). During TPRT, the L1 endonuclease (EN) nicks 
genomic DNA, exposing a free 3ʹ′-OH that can serve as a primer for reverse 
transcription of the L1 RNA. The processes of second-strand cleavage, second-
strand complementary DNA (cDNA) synthesis, and completion of L1 integration 
require elucidation. TPRT results in the insertion of a new, often 5ʹ′-truncated L1 
copy at a new genomic location (gray bar on purple chromosome) that generally 
is flanked by target-site duplications (red arrows). Alu, SINE-R/VNTR/Alu (SVA), 
and cellular mRNAs may hijack the L1-encoded protein(s) in the cytoplasm to 
mediate their trans mobilization. U6 small nuclear RNA (snRNA) may be 
integrated with L1 during TPRT. Question marks denote steps in the 
retrotransposition pathway of unknown mechanism. 
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Figure 1.3: Methods to Detect LINE-1-Mediated Polymorphic Human 
Retrotransposition Events in Individual Genomes 
Modifications of these assays can also be used to identify other polymorphic 
retrotransposons in human DNA. (a) Polymerase chain reaction (PCR)-based 
methodologies. PCR using primers specific to diagnostic sequence variants in 
the L1 (red triangles and the corresponding maroon primer) and arbitrary 
oligonucleotides or primers complementary to ligated linkers (yellow line) can be 
used to amplify human-specific L1s and their associated flanking sequences 
(maroon/yellow line flanked by triangles). The amplicon libraries are then 
resolved using electrophoresis, and individual products are cloned and 
sequenced (left). Alternatively, the amplicons can be hybridized to genome tiling 
microarrays (center), or directly characterized using high-throughput sequencing 
methodologies (right). Abbreviations: ATLAS, amplification typing of L1 active 
subfamilies; TIP-chip, transposon insertion profiling by microarray (b) Mining of 
L1s in individual genome sequences. Whole-genome sequences, comparative 
genomics, or mining trace sequence databases can discover dimorphic L1s in 
individual genomes that are absent from reference genome assemblies. (c) 
Paired-end sequencing. Mate-pair reads containing one sequence from a 
uniquely mapping portion of genomic DNA and one sequence from an L1 can be 
used to identify novel retrotransposons (left) in individual genomes. Paired-end 
sequencing of fosmid inserts with restricted size distributions (~40 kb) allows the 
discovery of novel ~6-kb insertions (right) as well as deletions and inversions 
relative to a reference sequence. Fosmids containing insertions can then be 
screened for the presence of human-specific L1s. Abbreviation: HGR, human 
genome reference sequence. These methods are also described in another 
recent review (O'Donnell and Burns, 2010). 
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Human Retrotransposition Events in Individual Genomes 
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Figure 1.4: A Cultured Cell Assay to Detect LINE-1 Retrotransposition 
A cultured cell assay to detect LINE-1 retrotransposition: (a) Candidate active 
human L1s (Beck et al., 2010; Brouha et al., 2003; Moran et al., 1996) are 
tagged in their 3ʹ′ untranslated region (UTR) with an indicator cassette designed 
to detect retrotransposition events in cultured cells. The selectable/screenable 
markers [e.g., NEO (Freeman et al., 1994; Moran et al., 1996), GFP (Ostertag et 
al., 2000), blasticidin (Morrish et al., 2002), and luciferase (Xie et al., 2011)] are 
in the opposite transcriptional orientation compared with the L1 and contain their 
own promoters (backward blue arrow) and polyadenylation sequences (upside-
down filled red lollipop); they also contain an intron in the same transcriptional 
orientation as the L1 [splice donor (SD) and splice acceptor (SA), respectively]. 
This arrangement ensures that the reporter gene (e.g., NEO) will become 
activated only upon a successful round of retrotransposition (bottom). Flags 
represent epitope tags that can be placed on ORF1p and/or ORF2p (Doucet et 
al., 2010; Kulpa and Moran, 2005), and open lollipops represent the 
polyadenylation sequences flanking the L1s. Details regarding the assay can be 
found in (Moran et al., 1996; Wei et al., 2000). (b) Representative results of an 
L1 retrotransposition assay in cultured HeLa cells. WT is an active L1 allele, L1.3 
[accession number L19088 (Dombroski et al., 1993)]. RT− is a retrotransposition-
defective control containing a missense mutation (D702A) in the reverse 
transcriptase domain of ORF2p (Wei et al., 2001). The number of HeLa cells 
transfected in each experiment is depicted below the wells. 
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Figure 1.5: The Impact of Mobile Elements on the Human Genome 
Schematics highlighting the various ways that LINE-1-mediated 
retrotransposition events can impact the human genome. (a) A hypothetical wild-
type gene locus. Light-gray rectangles represent exons, black lines represent 
introns, and helical lines represent flanking genomic DNA sequence. A full-length 
(left), 5ʹ′-truncated (center), and inverted/deleted L1 formed by twin priming (right) 
(Ostertag and Kazazian, 2001b) are shown as intronic insertions. The arrows 
indicate target-site duplications (TSDs), and for simplicity are shown only in this 
panel. (b) Examples of L1-mediated processes that may result in disease. (c) 
Examples of structural variation caused by L1 insertions. The transduction 
figures show a 3' transduction in light purple with its own poly(A) tail, and a 5' 
transduction in orange. The nonallelic homologous recombination figure shows 
L1s at different loci (light and dark gray exons) acting as substrates for aberrant 
recombination (red arrow). (d) Potential effects on gene expression caused by L1 
insertion. Note that L1s in all the depicted events would generally contain TSDs, 
with the exception of endonuclease (EN)-independent retrotransposition events 
and some genomic deletions. Abbreviations: C, cysteine-rich domain; CC, coiled 
coil; CTD, carboxyl-terminal domain; EN, endonuclease; RRM, RNA recognition 
motif; RT, reverse transcriptase; SVA, SINE-R/VNTR/Alu; UTR, untranslated 
region. 
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Chapter 2 
 
LINE-1 Retrotransposition Activity in Human Genomes 
 
Abstract 
Highly active (i.e., “hot”) long interspersed element-1 (LINE-1 or L1) 
sequences comprise the bulk of retrotransposition activity in the human genome; 
however, the abundance of hot L1s in the human population remains largely 
unexplored. Here, we used a fosmid-based, paired-end DNA sequencing 
strategy to identify 68 full-length L1s that are differentially present among 
individuals but are absent from the human genome reference sequence. The 
majority of these L1s were highly active in a cultured cell retrotransposition 
assay. Genotyping 26 elements revealed that two L1s are only found in Africa 
and that two more are absent from the H952 subset of the Human Genome 
Diversity Panel. Therefore, these results suggest that hot L1s are more abundant 
in the human population than previously appreciated, and that ongoing L1 
retrotransposition continues to be a major source of inter-individual genetic 
variation. 
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Introduction 
L1s comprise ~17% of human DNA and have been an instrumental force in 
shaping genome architecture (Lander et al., 2001). Most L1s are molecular 
fossils that cannot move (retrotranspose) to new genomic locations (Grimaldi and 
Singer, 1983; Lander et al., 2001). However, a small number of human-specific 
L1 (L1Hs) elements remain retrotransposition-competent (Badge et al., 2003; 
Brouha et al., 2003; Sassaman et al., 1997). On occasion, their retrotransposition 
has resulted in sporadic cases of human disease (reviewed in Babushok and 
Kazazian, 2007; Kazazian et al., 1988). 
During the past 15 years, computational, molecular biological, and genomic 
approaches have been used to identify and characterize L1Hs elements (Badge 
et al., 2003; Bennett et al., 2004; Boissinot et al., 2000; Boissinot et al., 2004; 
Brouha et al., 2003; Lander et al., 2001; Moran et al., 1996; Myers et al., 2002; 
Ovchinnikov et al., 2001; Sheen et al., 2000; Xing et al., 2009). Several themes 
have emerged from these studies. First, L1Hs elements can be stratified into 
several subfamilies (pre-Ta, Ta-0, Ta-1, Ta1-d, Ta1-nd) based upon the 
presence of diagnostic sequence variants contained within their 5′ and/or 3′ 
untranslated regions (UTRs) (Boissinot et al., 2000; Skowronski et al., 1988; Smit 
et al., 1995). Second, many L1Hs elements are dimorphic in that they are 
differentially present in individual genomes and/or are present in an individual but 
absent from the haploid Human Genome Reference sequence (HGR) (Badge et 
al., 2003; Bennett et al., 2004; Boissinot et al., 2004; Brouha et al., 2003; Lander 
et al., 2001; Myers et al., 2002; Xing et al., 2009). Third, it has been estimated 
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that the average human genome contains ~80-100 active (retrotransposition-
competent) L1Hs elements, and that only a small number of highly active L1Hs 
elements (“hot” L1s) account for the bulk of retrotransposition activity in the HGR 
(Brouha et al., 2003). Those studies, as well as recent efforts to identify insertion, 
deletion, and inversion polymorphisms (structural variants) in humans (Kidd et 
al., 2008; Korbel et al., 2007; Tuzun et al., 2005; Xing et al., 2009), indicate that 
ongoing L1 retrotransposition contributes to inter-individual genetic variation. 
Here, we employed a fosmid-based, paired-end DNA resource to identify 
full-length L1Hs elements in the genomes of six individuals of diverse geographic 
origin. Over half (37/68) of the newly identified L1s were hot for retrotransposition 
when examined in a cultured cell assay (Moran et al., 1996). Genotyping a 
subset of these L1s further revealed that some are likely restricted to Africans, 
whereas others are absent from the Human Genome Diversity Panel (HGDP) 
(Cann et al., 2002), suggesting that they are present at very low allele 
frequencies. 
Results 
An Experimental Strategy to Identify Full-Length Human Specific L1s 
To identify novel, full-length L1s in the genomes of geographically diverse 
individuals, we exploited a fosmid-based, paired-end DNA sequencing strategy 
that previously was used to identify structural variants in human DNA (Kidd et al., 
2008; Tuzun et al., 2005). Fragments of genomic DNA approximately 40 kb in 
size were individually cloned using fosmid vectors (see Experimental 
Procedures). Sequence reads were obtained from both ends of each insert 
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(paired-end sequences) and compared to the HGR. End sequences from 
genomic fragments that do not differ significantly in size from the HGR will map 
~40 kb away from each other. In contrast, paired-end sequences derived from 
genomic fragments containing a full-length, dimorphic ~6 kb L1Hs element will be 
separated by ~34 kb when mapped to the HGR (Figure 2.1) (Tuzun et al., 2005). 
In general, the predicted variants were required to be supported by two fosmid 
clones containing putative insertions from the same individual. The size cutoffs 
used in our screening protocols are biased to allow the identification of full-length 
or near full-length L1 insertion polymorphisms, but not severely 5′ truncated L1 
sequences, which are replication deficient (Table 2.1). Through this scheme, we 
should be able to identify the bulk of full-length L1s in an individual genome that 
are dimorphic when compared to the HGR. 
Fosmids fulfilling the above mapping criterion were subjected to a series of 
screens (Figure 2.1). First, allele-specific oligonucleotide hybridization using 
probes directed against diagnostic sequences in the L1Hs 5′ UTR identified 
insertion fosmids that contained putative dimorphic L1Hs elements (Boissinot et 
al., 2000; Tuzun et al., 2005). Second, Southern blotting with a probe directed 
against the 5′ UTR of L1.3 (Accession# L19088) enabled the identification of 
fosmids that contained putative full-length L1Hs elements (Dombroski et al., 
1993; Sassaman et al., 1997). Third, a suppression PCR-based method (ATLAS) 
(Badge et al., 2003) and/or direct sequencing was used to verify the presence of 
a full-length (or near full-length) L1Hs element in the fosmid. Finally, genomic 
sequences flanking the 5′ and 3′ ends of the newly identified L1Hs elements were 
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used as probes in BLAT searches (http://genome.ucsc.edu/cgi-
bin/hgBlat?command=start) (Kent, 2002) to confirm that the L1 was absent from 
the HGR (NCBI build 36.1/hg18). Flanking sequences also were used to 
determine whether any of the L1Hs elements were present in a database of 
known polymorphic retrotransposon insertions (dbRIP; http://dbrip.brocku.ca/) 
(Wang et al., 2006). Two additional L1Hs elements were identified through direct 
sequencing of the fosmids (#1-(2-1) and 3-(2-1)). 
Identification of Full-Length L1Hs Elements from Geographically Diverse 
Individuals 
We first conducted a pilot study to examine a fosmid library from a female 
individual (G248; NA15510) for full-length L1Hs insertions (Table 2.1) (Tuzun et 
al., 2005). Despite the fact that this library was optimized for identifying ~8 kb 
insertion polymorphisms as part of the Human Genome Structural Variation 
project (HGSV) (Kidd et al., 2008; Tuzun et al., 2005), we were able to identify 
five novel L1Hs elements using our screening protocol (Table 2.1). 
The above data provided “proof of principle” that our strategy was effective 
for identifying full-length, dimorphic L1Hs elements. Thus, we next screened 
fosmid libraries from five females representing four distinct geographic 
populations that were studied as part of the HapMap project (one Japanese 
(NA18956), one Chinese (NA18555), one Western European CEPH (NA12878), 
and two Yoruban individuals (NA19240, NA19129)) (International HapMap 
Consortium, 2005; Kidd et al., 2008). Size cutoffs allowed detection of insertion 
polymorphisms as small as ~4.2-5.5 kb and enabled the identification of an 
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additional 64 L1Hs elements (Table 2.1) (Kidd et al., 2008). As our strategy is 
biased toward finding novel, full-length L1s, we generally observed a decrease in 
the number of L1Hs elements identified in each successive library screen (e.g., 
ABC13 was the last library analyzed and contained relatively few novel L1Hs 
elements). In total, we identified 69 L1Hs elements that were absent from the 
HGR, one of which was identified in two different individuals (#4-1 and 5-77). 
This element also was completely annotated in dbRIP, unlike 65 of the distinct 68 
L1s identified in this study (Table 2.1). The number of elements discovered at 
each stage of the analysis is detailed in the Extended Experimental Procedures. 
Many of the Newly Identified L1Hs Elements are Hot for Retrotransposition 
We next tested if the L1Hs elements identified in our screens were active 
for retrotransposition in cultured cells. Sixty-seven elements were cloned into 
either a pBluescript and/or pCEP4 L1 expression vector that contained an mneoI 
retrotransposition indicator cassette in its 3′ UTR (#2-42 was refractory to 
cloning; details in Experimental Procedures) (Freeman et al., 1994; Moran et al., 
1996). The pBluescript-based L1 constructs lack an exogenous promoter; thus, 
L1 expression is driven from its native 5′ UTR. Elements isolated from libraries 
ABC11-13 were assayed in this context. L1s isolated from the G248, ABC9, and 
ABC10 libraries were assayed in pCEP4 (CMV+/5′ UTR+) and/or pBluescript (5′ 
UTR+) based contexts. The resultant plasmids were transfected into HeLa cells 
and successful retrotransposition events were detected as G418-resistant foci 
(Figure 2.2A) (Moran et al., 1996). Retrotransposition activities are reported 
relative to L1.3, and hot refers to an L1 that jumps at >10% of L1.3 (see Table 
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2.2). Notably, 22 elements yielded similar retrotransposition efficiencies relative 
to L1.3 when tested in either a CMV+/5′ UTR+ or a 5′ UTR+ context (data not 
shown). Since the subcloning procedure does not involve PCR, we truly are 
testing the retrotransposition capability of each of the identified L1Hs elements in 
our screen. 
Each individual contained between three and nine highly active L1s in their 
genome and 55% (37/67) of the L1Hs elements tested were hot for 
retrotransposition (Figures 2.2A and 2.2B; Table 2.1). These 37 highly active 
L1Hs elements represent an approximately 4-fold increase in the number of hot 
L1s identified in previous studies (Badge et al., 2003; Brouha et al., 2002, 2003; 
Kimberland et al., 1999; Lander et al., 2001; Sassaman et al., 1997). 
Examination of the 3′ UTR sequences of the 68 L1s uncovered six elements that 
contain an ACG in place of the Ta subfamily diagnostic ACA characters. These 
elements are termed “pre-Ta” and represent an older L1 subfamily (Boissinot et 
al., 2000; Brouha et al., 2003; Kazazian et al., 1988; Lander et al., 2001; Myers 
et al., 2002; Skowronski et al., 1988). Two pre-Ta L1s (#3-5 and 5-55) were hot 
for retrotransposition (Figure 2.2B; Table 2.2). These data agree with previous 
studies, which showed that a de novo insertion of a pre-Ta L1 into the Factor VIII 
gene resulted in a sporadic case of hemophilia A (Kazazian et al., 1988). 
Hallmarks and Insertion Locations of L1s Identified in This Study 
We next sequenced each L1Hs element in its entirety and compared these 
data to fosmid sequences previously deposited in GenBank (Kidd et al., 2008). 
We annotated each L1 for hallmarks of retrotransposition as well as their 
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chromosomal environment (Table 2.3). In general, the L1Hs elements were 
flanked by target-site duplications that ranged from 6 to 20 bp, inserted into an L1 
endonuclease consensus cleavage sequence (Cost and Boeke, 1998; Feng et 
al., 1996; Morrish et al., 2002), and their 3′ ends had either homopolymeric 
poly(A) tails that ranged from ~8-41 bp in size or interrupted poly(A) tails/3′ 
transductions ranging from ~18 bp to 1,105 bp in length (Table 2.3) (Goodier et 
al., 2000; Holmes et al., 1994; Moran et al., 1999; Pickeral et al., 2000). 
A subset of the elements (~32/68) contained an additional 1-14bp of 
untemplated nucleotides at their 5′ ends, termed 5′ end heterogeneity (Athanikar 
et al., 2004; Lavie et al., 2004). Five of these L1s have an extra G at their 5′ 
ends, and one has three extra Gs when compared to a hot L1Hs consensus 
sequence (Brouha et al., 2003). These extra nucleotides potentially could result 
either from a terminal transferase activity associated with the L1 reverse 
transcriptase or from reverse transcription of the 7-methyl-guanosine cap at the 
5′ end of L1 RNA (Boeke, 2003; Gilbert et al., 2005; Symer et al., 2002). The 
majority of elements identified were full-length; however, we also found seven 
elements (e.g., #1-5 and 2-30) that were truncated within their 5′ UTR. These 
data, along with the fact that the fosmid libraries provided ~4-5 fold coverage of 
each haplotype from the 6 individuals (Kidd et al., 2008), indicate that our 
screening procedure identified the majority of the dimorphic full-length L1s in 
these genomes. 
The 68 L1Hs elements were dispersed throughout the genome. We did not 
identify L1Hs elements on chromosomes 16 or 19 (Figure 2.2C); however, this 
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result probably reflects our small sample size rather than a systematic bias 
against their ability insert on these chromosomes (Lander et al., 2001). 
Consistently, we previously were able to detect the insertion of engineered L1s 
into chromosomes 16 and 19 of HeLa cells (Gilbert et al., 2005). 
Approximately 32% (22/68) of L1Hs elements were present in the introns of 
known RefSeq genes (http://www.ncbi.nlm.nih.gov/RefSeq/), and mutations in 
several of these genes are implicated in human genetic disorders (Table 2.4). 
Thirteen L1 insertions were in the antisense orientation (i.e., were transcribed in 
the opposite orientation to the gene), whereas nine L1 insertions were in the 
same transcriptional orientation as the gene. Since ~26-38% of the genome is 
spanned by genes (Venter et al., 2001), the data suggest that the L1s have 
inserted randomly with respect to gene content, which is in agreement with 
previous studies (Gilbert et al., 2002, 2005; Ovchinnikov et al., 2001; Symer et 
al., 2002). 
Our sequencing studies uncovered several expected trends and some 
unexpected results. All 37 hot L1 elements and the 6 low-level activity elements 
had two intact open reading frames (ORFs). A consensus sequence derived from 
these 37 L1s was identical at the amino acid level to a previously derived 
consensus (Brouha et al., 2003) (data not shown). 
Inactive elements generally had frameshift (5/24) or chain-terminating 
nonsense mutations (9/24) in at least one of the L1 ORFs. However, ten of these 
low-level activity or inactive elements contained two intact open reading frames. 
One L1 (#3-24) contained an S228P missense mutation within the endonuclease 
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(EN) domain of ORF2p (Feng et al., 1996; Weichenrieder et al., 2004). Though 
L1s containing EN mutations are unable to retrotranspose in HeLa cells, they can 
retrotranspose in Chinese Hamster Ovary (CHO) cells deficient in the 
nonhomologous end-joining (NHEJ) pathway of DNA repair, presumably by 
parasitizing a free 3′ OH group to initiate target-primed reverse transcription 
(TPRT) (Morrish et al., 2002, 2007). Interestingly, although #3-24 is inactive in 
NHEJ-proficient cell lines, the L1 retrotransposed at roughly 60% the efficiency of 
the wild-type control, L1.3, in NHEJ-deficient CHO cells (Morrish et al., 2002). 
Introducing the S228P change into L1.3 (Sassaman et al., 1997) also allowed 
efficient EN-independent retrotransposition, indicating that this mutation is largely 
responsible for the inactivity of #3-24 in HeLa cells (Figure 2.7). 
Analysis of genomic sequences flanking the 68 L1Hs elements revealed a 
number of interesting findings. The poly(A) tails of 25 L1s were interrupted or 
contained 3′ transductions (Goodier et al., 2000; Holmes et al., 1994; Moran et 
al., 1999; Pickeral et al., 2000), 17 of which clustered into “subfamilies” of L1Hs 
elements. In one case, we identified an L1 (#2-1) as the likely source element for 
one of these subfamilies. For #1-3, 3-31, and 1-5, these transductions/interrupted 
poly(A) tails were identical to those in L1Hs elements that have caused disease-
producing mutations (e.g., L1RP, LRE3) (Brouha et al., 2002; Kimberland et al., 
1999). In other cases, the transductions denote examples of recently amplified 
subfamilies (Goodier et al., 2000; Lander et al., 2001; Pickeral et al., 2000). 
Examining the 5′ genomic flanks showed that the retrotransposition of a full-
length L1 from the ABC9 genomic library (#2-24) that integrated on chromosome 
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10 was accompanied by ~250 bp of an Alu element that maps to chromosome 
16. The Alu sequence is in the opposite transcriptional orientation to the L1, 13 
bp of unmapped sequence separates the elements, and the whole insertion is 
flanked by target-site duplications (TSDs) (Figure 2.8A). Thus, though most of 
the full-length L1Hs elements identified here have been amplified by canonical 
retrotransposition, recombination- and/or replication-mediated repair processes 
may facilitate the integration of some elements (Gilbert et al., 2002, 2005; Symer 
et al., 2002). Additionally, our screen allowed us to resolve possible sequence 
anomalies in the HGR. For example, one fosmid that lacks a dimorphic L1Hs 
element (#6-105) actually contains two L1s (a PA2 and pre-Ta element) that 
likely were collapsed into a harlequin element during the HGR assembly (Figure 
2.8B). 
Finally, the data also enabled us to examine allelic heterogeneity 
associated with L1Hs elements. For example, one L1 (#5-70) was present in the 
HGR, but contained a stop codon in ORF2 and was not previously tested for 
activity (Brouha et al., 2003). Interestingly, #5-70 retrotransposed at ~8% of the 
level of L1.3, further illustrating how allelic heterogeneity can impact 
retrotransposon activity (Lutz et al., 2003; Seleme et al., 2006). 
Allele Frequencies of Genotyped Elements 
The 68 L1Hs elements identified here are dimorphic with respect to 
presence; thus, we tested if a subset of these L1s represented population-
restricted or potentially private alleles. To address this question, we first compiled 
existing genotyping data (Badge et al., 2003; Myers et al., 2002; Xing et al., 
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2009). Additional genotyping then was conducted on a subset of the L1s 
discovered here (26 in total; see Extended Experimental Procedures for selection 
criteria). The 26 L1s first were genotyped in a CEPH panel of 129 unrelated 
individuals. Nine L1s absent from the CEPH panel then were genotyped in a 
Zimbabwean panel of 72 unrelated individuals. Finally, if the element was absent 
from both panels, it was genotyped on the H952 subset of the HGDP consisting 
of ~1050 individuals from ~51 worldwide populations (Figure 2.3A and Table 2.5) 
(Cann et al., 2002; Rosenberg, 2006). 
Two elements (#3-5 and 3-31) genotyped on the HGDP exist at very low 
allele frequencies and were only found in Africans. Two other L1Hs elements 
(#1-5 and 3-24) were absent from the HGDP (Table 2.5). Element #3-24 (the 
S228P mutant described above) was found in the ABC10 Yoruban library. 
Further genotyping revealed that the L1Hs element containing the mutation was 
present in her mother (but not her father), excluding a de novo origin (Figure 
2.3B). The other putatively “private” L1Hs element was from G248 (#1-5), so we 
could not examine its segregation in a trio. Interestingly, this hot L1 insertion 
occurred into an intron of the ABCA1 gene (Figure 2.3C); mutations in ABCA1 
have been associated with Tangier disease and low serum HDL levels (Frikke-
Schmidt, 2010). 
The Total Number of Active L1Hs Elements Present in ABC13 
To estimate the total number of active L1s in one individual, we carried out 
in silico genotyping of the 68 L1Hs elements in ABC13, the last library examined 
in our subtractive scheme. We identified 20 regions containing distinct L1 
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insertions identified in the first 5 individuals that corresponded to insertion 
fosmids in the ABC13 HGSV track (http://hgsv.washington.edu/) of the UCSC 
genome browser (Figure 2.4A, Table 2.5) (Kent et al., 2002; Kidd et al., 2008). 
PCR genotyping confirmed that ABC13 contained 18 of these 20 elements 
(Figure 2.4B), and was homozygous with respect to presence for 3 of the 
elements. This result suggests that in silico genotyping could be used as a 
screening tool to identify L1Hs elements present at low allele frequencies in the 
population (Table 2.5). 
Adding the 18 L1Hs elements identified by in silico genotyping to the seven 
novel L1Hs elements identified in the ABC13 genome through our fosmid 
screens revealed that this individual contains 25/68 L1Hs elements identified in 
this study. Additional genotyping revealed that this individual contains 2 of the hot 
L1s characterized in a previous study (Table 2.1) (Brouha et al., 2003). 
Combining these numbers with our retrotransposition data indicates that the 
ABC13 genome contains 14 potentially hot L1Hs elements, and that at least 3 of 
these elements are present in a homozygous state. 
Estimates of L1 Age 
Our data suggest that, on average, the 68 L1Hs elements identified here 
are present at lower allele frequencies, are more active, and may be 
evolutionarily younger than those in previous studies (Brouha et al., 2003). To 
test this hypothesis, we derived maximum likelihood estimates for the ages of Ta-
1 L1Hs elements in our dataset and that of Brouha et al. (Brouha et al., 2003; 
Marchani et al., 2009). This analysis revealed that the Ta-1 L1Hs elements 
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identified here are significantly younger (1.0 million years [MY] 95% confidence 
interval [C.I.] 0.98 – 1.01 MY) than those reported previously (2.01 MY 95% C.I. 
2.00 – 2.02 MY) (Marchani et al., 2009) (1.73 MY 95% C.I. 1.69 – 1.77 MY) 
(Brouha et al., 2003). 
The maximum likelihood estimated age (Marchani et al., 2009) (1.0 MY) of 
the L1s reported here differs significantly from that calculated using the ad hoc 
method, which uses sequence divergence within subfamilies of elements to 
determine age (Carroll et al., 2001) (1.18 MY old). These two methods are known 
to be respectively robust (the maximum likelihood method) and sensitive (the ad 
hoc method) to the presence of multiple active lineages in the dataset (i.e., 
departures from the master gene model of L1 evolution) (Cordaux et al., 2004). 
The difference in these two estimates may indicate that members of multiple 
active L1Hs subfamilies are present in our dataset and suggests that the true age 
of the L1s may be younger than either calculation suggests. Indeed, the above 
data are consistent with the hypothesis that the HGR is strongly biased in favor 
of older, fixed L1Hs elements. 
We next used a neighbor-joining approach, rooted with an intact 
chimpanzee L1 element, to generate a phylogenetic tree of the 68 full-length 
L1Hs elements (Figure 2.5, see Experimental Procedures). As predicted, pre-Ta 
elements were located near the root of the tree. Interestingly, two known (L1RP 
and LRE3) and five other currently amplifying subfamilies clustered together on 
the tree (Figure 2.5; see groups of colored elements), even though the 
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interrupted poly(A) tail/transduction sequences themselves were excluded from 
the sequence alignments.  
Discussion 
We have developed a systematic process to identify novel, dimorphic, 
active L1Hs elements in genomes of individuals from diverse geographic 
populations. Many of the newly identified L1Hs elements exist at low allele 
frequencies in the population and four L1Hs elements represent “rare” alleles, 
three of which appear to be restricted to Africans. Sequence-based age 
estimates further reveal that these L1Hs elements appear to be, on average, 
evolutionarily younger than those identified in previous studies (Brouha et al., 
2003; Marchani et al., 2009). These data are consistent with the notion that full-
length active L1s are systematically underrepresented in available genome 
reference sequences (Badge et al., 2003; Boissinot et al., 2004; Brouha et al., 
2003; Sassaman et al., 1997; Sheen et al., 2000; Xing et al., 2009). 
Our study has underscored the effectiveness of fosmid paired-end libraries 
in the discovery of novel, active L1Hs elements. Though a number of 
technologies have been developed to identify polymorphic L1s (Badge et al., 
2003; Bennett et al., 2004; Boissinot et al., 2004; Brouha et al., 2003; Moran et 
al., 1996; Myers et al., 2002; Sheen et al., 2000; Xing et al., 2009), the approach 
described here is not reliant upon PCR fidelity, readily allows the identification of 
active L1Hs elements, and makes sequencing of genomic flanking sequences, 
poly(A) tails, and L1-mediated transductions relatively straightforward. Thus, we 
predict that the fosmid-based approach likely will be superior to second-
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generation, low-coverage genome sequencing methodologies (e.g., many 
individual genomes characterized in the 1000 genomes project; 
http://www.1000genomes.org/page.php) for comprehensively identifying and 
characterizing rare L1 alleles in individual genomes. Indeed, recently published 
genome sequences highlight the difficulties in detecting and unambiguously 
mapping highly repetitive insertions (relative to a reference genome), including 
L1Hs elements (Bentley et al., 2008; McKernan et al., 2009; Wang et al., 2008; 
Wheeler et al., 2008). 
Our analysis revealed that many active L1s cluster in small subfamilies. In 
the strictest sense, these data argue against a master gene model (Deininger et 
al., 1992) and instead support a model in which multiple active source L1Hs 
elements (including members of both the pre-Ta and Ta subfamilies) are 
currently retrotransposing in modern human genomes (Cordaux et al., 2004). We 
cannot formally exclude a “stealth” model, where L1s in unfavorable expression 
contexts sometimes give rise to new retrotransposition-competent source 
elements that can be expressed from a more favorable genomic context (Han et 
al., 2005). However, the most parsimonious explanation of our data is that 
multiple source L1Hs elements and subfamilies with limited “life-spans” exist in 
the genome. We posit that hot L1Hs elements must give rise to new, active 
progeny at a faster rate than they are inactivated by cellular mutational 
processes (see Figure 2.6 for model); this can lead to a scenario where small 
numbers of currently active L1Hs lineages may out-compete older L1s for limiting 
reagents, such as host factors (Boissinot and Furano, 2001). This competition 
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scenario both supports and extends current lineage succession models and 
could potentially explain the monophyletic history of L1s and the appearance of a 
replication-dominant L1Hs subfamily (Boissinot et al., 2000; Cordaux et al., 2004; 
Seleme et al., 2006). 
Our dataset is still relatively small, and it remains difficult to estimate the 
actual number of highly active L1s in the extant population. However, our ability 
to readily identify rare hot L1s in the genomes of geographically diverse 
individuals strongly suggests that these highly active L1Hs elements are more 
abundant in the population than previously appreciated. Indeed, these results are 
in general agreement with recently published studies (Iskow et al., 2010; Huang 
et al., 2010). 
The active L1Hs elements identified here also have the potential to impact 
modern human genomes by retrotransposing flanking genomic sequences to 
new chromosomal locations and by serving as substrates for nonallelic 
homologous recombination (reviewed in Cordaux and Batzer, 2009; Moran et al., 
1999). The proteins encoded by these L1s also may promote the 
retrotransposition of Alu elements and noncoding RNAs (Bennett et al., 2008; 
Dewannieux et al., 2003; Garcia-Perez et al., 2007). Indeed, our data support the 
hypothesis that hot L1s are actively retrotransposing in modern-day human 
genomes and suggest that some of the L1 alleles identified here could serve as 
source elements for disease-producing L1 insertions. 
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Experimental Procedures 
Creation of Fosmid Libraries and Identification of Insertion-Containing Fosmids 
Genomic DNA from the six individuals was obtained from transformed 
lymphoblastoid cell lines (available from the Coriell Cell Repository). The DNA 
was hydrodynamically sheared, end-repaired, size selected for 40 kb fragments 
by pulsed field gel electrophoresis, and ligated into fosmid vectors (Donahue and 
Ebling, 2007). Agencourt Biosciences Corporation constructed all libraries, with 
the exception of the G248 library, which was constructed as part of the human 
genome project finishing effort. From each library, approximately 1 million 
individual cloned fragments were arrayed into 384-well plates. End-sequence 
pairs were obtained from both ends of each DNA fragment using standard 
capillary sequencing and were mapped back to the HGR. Insertion-containing 
fosmids were identified as the subset of fosmids containing an apparent insert 
that was ~3 standard deviations smaller than the library mean (Kidd et al., 2008; 
Tuzun et al., 2005).  
Screening of Fosmid Clones for LINE-1 Insertions 
Insertion-containing fosmids identified in silico were screened for L1Hs 
elements in the following manner. First, all insertion fosmids were subjected to 
allele-specific oligonucleotide hybridization to identify characters in the 5′ UTRs 
of newer L1 subfamilies (Badge et al., 2003; Boissinot et al., 2000). This protocol 
was adapted from “hybridization of bacterial DNA on filters” (Sambrook, 1989). 
Fosmid DNAs were prepared according to the Very Low-Copy Plasmid/Cosmid 
Purification protocol for the Qiagen-tip 100 Midi prep kit (Qiagen). Those DNAs 
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were subjected to Southern blotting followed by ATLAS (Badge et al., 2003) 
and/or direct sequencing to identify L1Hs elements that were absent from the 
HGR. Sequences flanking the L1Hs elements then were used as probes in BLAT 
searches at the UCSC genome browser (http://genome.ucsc.edu/) to determine 
the insertion site in the HGR (Kent, 2002; Kent et al., 2002). Detailed protocols 
for each step of the screening process, as well as the number of fosmids positive 
at each stage of the analysis, can be found in the Extended Experimental 
Procedures. 
Cloning of L1s 
In general, L1Hs elements were cloned directly from insertion-containing 
fosmids by digestion with AccI (Sassaman et al., 1997). The restricted DNA was 
separated on a 0.8% agarose gel, and the ~6 kb L1-containing restriction 
fragment was cloned into an L1 expression vector. This method captures the vast 
majority of the L1Hs sequence, leaving only the first ~35 bp and last ~50 bp of 
the original L1 5′ and 3′ UTRs present in the cloning vector, respectively. One 
element, #2-42, was refractory to this cloning procedure, as it contains a 
polymorphism near the 3′ end of ORF2 that creates an additional AccI site. The 
PDH L1.3 mutant was generated by site-directed mutagenesis. Each L1Hs 
element was sequenced in its entirety. Detailed protocols for the creation of each 
construct are included in the Extended Experimental Procedures. 
L1 Retrotransposition Assays 
We used a modification of a transient transfection protocol to conduct 
retrotransposition assays in HeLa and CHO cells (Moran et al., 1996; Morrish et 
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al., 2002; Wei et al., 2000). Briefly, cells in 6-well dishes were transfected using 
the Fugene 6 agent (Roche) with 1 µg of plasmid (containing the indicator 
cassette) per each well. Cells were fed with media ~24 hours post-plating, and 
daily from 72 hr or 5 days with media containing either 400 µg/mL G418 or 10 
µg/mL blasticidin, respectively. Fourteen days post-transfection, cells were fixed 
and stained with 0.1% crystal violet. Colonies were counted in the appropriate 
wells, and these counts were normalized to green fluorescent protein (GFP) 
transfection efficiency. Detailed protocols for culture and assay conditions are 
found in the Extended Experimental Procedures.  
Genotyping and Panels 
The genomic locations of L1Hs insertions were compared to a database of 
human retrotransposon insertion polymorphisms (dbRIP; http://dbrip.brocku.ca/) 
(Wang et al., 2006). PCR genotyping assays were designed for a subset of L1Hs 
elements that were not completely annotated in dbRIP. Genotyping initially was 
conducted on a CEPH panel of 129 unrelated individuals of Northern European 
ancestry. If an L1Hs element was absent from the CEPH panel, it was genotyped 
on a panel containing genomic DNAs from 72 unrelated Zimbabwean individuals. 
Finally, if an L1Hs element was absent from both genotyping panels, it was 
genotyped on the H952 subset (Rosenberg, 2006) of the HGDP (Cann et al., 
2002) (see Figure 2.3A). In silico genotyping was conducted using the HGSV 
track of the UCSC genome browser (Kent et al., 2002; Kidd et al., 2008). Details 
about these analyses are in the Extended Experimental Procedures. 
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Estimation of L1 Element Age 
Sequences of the 69 full-length L1 elements were classified into subfamilies 
using the L1Xplorer analysis website (Penzkofer et al., 2005). Ta-1, Ta-0 and 
Non-Canonical (NC) (Brouha et al., 2003) elements were separately aligned 
using Muscle 3.52 (Edgar, 2004) on the Phylemon web server 
(http://phylemon.bioinfo.cipf.es/cgi-bin/home.cgi) (Tarraga et al., 2007). Raw 
alignments were manually refined using Jalview to remove all indels, all variable 
CpG sites, and the L1 polypurine tract (Waterhouse et al., 2009). Maximum 
likelihood estimates of the age (T) of each group, the sampling variance of T, and 
its 95% C.I. were calculated using the mleT script (Marchani et al., 2009) running 
under Matlab 7.2 -2007a (The Mathworks Inc., Natick, MA, USA). The subroutine 
CountMutations (Marchani et al., 2009) was also utilized to calculate the number 
of substitutions in the datasets to enable the “ad hoc” subfamily age estimation 
method (Marchani et al., 2009). 
Phylogenetic Tree  
The sequences of the 69 elements were aligned as described above. An 
intact chimpanzee element (BS000022_PTROG) was used to root the tree. The 
alignment also includes an intact Ta-1 L1 (L19088_L1.3), a non-Ta L1 
(AL022171_NTA), a pre-Ta L1 (AL357559), and the “Hot Consensus” L1 element 
from Brouha et al. (2003). Raw alignments were manually refined using Jalview 
(Waterhouse et al., 2009) to remove large indels and truncated elements; this led 
to the exclusion of #6-113 due to a large 5′ UTR deletion. 
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A single neighbor-joining tree of the 68 remaining full-length elements was 
constructed using the PHYLIP package (Felsenstein, 1989). Branch lengths were 
corrected using the Kimura 2 parameter model (Kimura, 1980). To assess the 
reliability of the phylogeny, 1000 bootstrapped resamples of the multiple 
alignment were made using the seqboot program of the PHYLIP package 
(Felsenstein, 1989). The neighbor joining tree derived from the full dataset was 
manually annotated with bootstrap values using Dendroscope (Huson et al., 
2007) (Figure 2.5). Only bifurcations that occurred in more than 70% of bootstrap 
resamples are labeled.  
Accession Numbers 
Accession numbers for all elements are tabulated in Table 2.6. Two L1Hs 
elements (accession numbers (#1-5) GU477636 and (#6-102) GU477637) were 
recently posted in GenBank. 
Extended Experimental Procedures  
Identification of Insertion-Containing Fosmids 
Paired-end sequence analysis was carried out as previously described 
(Kidd et al., 2008; Tuzun et al., 2005). Briefly, end-sequence pairs were mapped 
against the HGR sequence (NCBI build 35/hg17) using megaBLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al., 1990). Any clone having 
an apparent insert size (based on the distance between the mapped positions of 
the reads) approximately 3 standard deviations smaller than the library mean 
was considered to represent a potential insertion event (Kidd et al., 2008; Tuzun 
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et al., 2005). We required that each identified variant be supported by at least 
two clones from the same individual. Since the individual clones from each library 
are retained, the identified cloned segments could be directly retrieved for further 
analysis. For this study, a reduced size threshold (approximately 2 standard 
deviations) was employed to screen the ABC9 library (Table 2.1).  This method 
provides us with a minimal estimate of the fosmids that may contain L1 
insertions. 
Allele-Specific Oligonucleotide Hybridization 
Insertion fosmid containing bacteria were spotted onto Amersham 
Hybond-XL nylon membrane (GE healthcare) and grown on 12.5µg/mL 
chloramphenicol plates over two nights (~40 hours) at room temperature. 
Bacteria then were lysed and the DNA denatured and fixed to the membrane 
using standard methods. Fosmids were screened with two γ-32P end-labeled 
oligonucleotides specific for the 5′ UTR of full-length, recently inserted L1s 
(oligonucleotide sequences available upon request) (Badge et al., 2003). The 
protocol was adapted from ‘hybridization of bacterial DNA on filters’ (Sambrook, 
1989).  
Fosmid DNA Preparation 
 Insertion-containing fosmids that scored positive by oligonucleotide 
hybridization were shipped to the Badge and Moran labs as LB media stabs, and 
subsequently were grown and archived as glycerol stocks. Fosmid-containing 
bacterial cultures were grown in 5-10mL (mini-prep) or 300-500 mL (midi-prep) of 
LB liquid media containing 12.5 µg/mL chloramphenicol overnight (~16 hours) at 
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37oC. Minipreps were carried out using the standard protocol for the Wizard Plus 
SV DNA Purification System (Promega) and DNA was eluted in 60 µl of 
DNAse/RNAse free water (Gibco). Midi-preps were prepared according to the 
Very Low-Copy Plasmid/Cosmid Purification protocol for the Qiagen-tip 100 Midi 
prep kit (Qiagen). Midi-prep DNAs were reconstituted in 150 µl of DNAse/RNAse 
free water (Gibco).  
Southern Blots 
Fosmid DNA mini-preps (50 µl, ~1 µg) were digested overnight at 37oC with 
AccI (New England Biolabs-NEB), which is predicted to cut L1.3 at bp positions 
41 and 5965 ((Accession number: L19088 (Sassaman et al., 1997)). Digests 
were fractionated on 0.7% agarose gels containing ethidium bromide (0.5 µg/ml), 
and digital images were recorded as a fingerprint of each fosmid. Southern 
blotting was carried out using an adaptation of a standard protocol (Sambrook, 
1989). Briefly, gels were treated to depurinate (0.25M HCl) and denature (0.5M 
NaOH/1.5M NaCl) the DNA.  They then were treated with neutralization solution 
(1.5M NaCl/0.5M TrisHCl) and the DNA was transferred to an Amersham 
Hybond-XL Nylon membrane by capillary action. Membranes were baked at 
80oC for 1.5 - 2 hours to fix the DNA. Probe DNA was created from the NotI to 
BglII (NEB) fragment of JM101/L1.3 (bp 1-661 of the 5′UTR of L1.3 (Sassaman 
et al., 1997)), and radio-labeled using [α-32P] dCTP (GE healthcare) with the 
Rediprime II labeling kit (Amersham / GE healthcare). Excess [α-32P] dCTP was 
removed using a G-50 MicroSpin column (Amersham / GE healthcare). 
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ATLAS 
 Putative full-length L1-containing fosmids were screened for newer 
elements using a modification of the previously described technique ATLAS 
(amplification typing of L1 active subfamilies) (Badge et al., 2003). Briefly, 5 µl 
(~100 ng) of fosmid DNA minipreps were digested overnight at 37oC with MseI, 
TaqI, or NlaIII (New England Biolabs-NEB), followed by restriction enzyme 
inactivation at 65oC for 20 minutes (MseI and NlaIII only). Digested fosmid DNA 
was ligated to annealed ATLAS linkers with appropriate terminal sequences, as 
described previously (Badge et al., 2003). After ligase inactivation (20 minutes at 
65oC), DNA was added directly to L1-to-linker amplification reactions using either 
5′ UTR specific (RB5PA2 and RBX4) or 3′ UTR specific (RB3PA2 and RBX4) 
PCR primers (sequences below). Control reactions performed in the absence of 
annealed linker or ligase, reactions lacking digested fosmid DNA, or reactions 
lacking fosmid DNA were used to ensure amplification was specific for reactions 
containing all components and that amplicons were derived from linkered fosmid 
DNA. Amplification reactions were fractionated on 2% agarose gels containing 
0.5µg/ml ethidium bromide. Fosmid-specific amplicons were excised, the DNA 
purified using the Qiagen Gel Extraction Kit (Qiagen UK, Crawley UK)), cloned 
into pGEMT-Easy (PromegaUK, Southampton, UK), and sequenced using 
primers flanking the vector multiple cloning site. Sequencing was carried out 
using an Applied Biosystems 3730 sequencer by the University of Leicester 
PNACL core facility. Sequences flanking the L1 elements then were used to map 
the insertion point in the human genome using BLAT (Kent, 2002) at UCSC (Kent 
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et al., 2002) (http://genome.ucsc.edu/) as discussed below. Insertion fosmids 
from G248, ABC9, and ABC10 were screened using both 5′ UTR and 3′ UTR 
specific ATLAS. 
Sequencing and Analysis 
Fosmid midi-prep DNA was sequenced from the L1 3′ and 5′ UTRs into 
flanking regions using the HS or ORF2L oligos, and the RB5PA2 or 5′ UTR AS 
oligos, respectively. The University of Michigan Sequencing Core Facilities 
performed DNA sequencing using an Applied Biosystems ABI Model 3730XL 
sequencer.  
L1 insertion locations were determined by comparison of 5′ and 3′ flanking 
sequence of the L1s to the HGR (NCBI build 36.1/hg18) using BLAT (BLAST-like 
alignment tool- http://genome.ucsc.edu/cgi-bin/hgBlat) (Kent, 2002), and the 
presence or absence of the element in the HGR was determined using the UCSC 
genome browser (http://genome.ucsc.edu/) (Kent et al., 2002). Where the 
flanking sequence was too short to enable precise mapping, the region of 
genomic sequence corresponding to the region between the mapped end 
sequences of the fosmid was downloaded from UCSC and the best sequence 
match within this region was identified as the most likely insertion point using 
BLAT (Kent, 2002). Sequences of the distal 5′ and 3′ UTRs from the new L1s 
were ascertained from direct sequencing of the fosmid or were obtained from 
fosmid sequences deposited in online databases (NCBI) by the Washington 
University Genome Sequencing Center (St. Louis). Accession numbers for 
fosmid clones sequenced in their entirety (67/69), as well as those created for the 
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two L1 elements that lack sequenced fosmids (#1-5 and 6-102) are reported in 
Table 2.6.  
Screening of Fosmid Clones 
Insertions in two or more clones for a particular region were scored as an 
insertion-containing region in the fosmid genomic library of an individual. For the 
G248 library, these clones were subjected to hybridization and further analysis. 
For all other libraries (ABC9-13), only one insertion-containing clone per region 
was hybridized and subjected to the following steps in our analysis scheme. 
Additionally, regions found in previous libraries were excluded from analysis in 
subsequent individuals, therefore generating a subtractive set of L1 insertions 
where there is minimal overlap of regions between the 6 examined genomes. 
  G248 
In total, 108 predicted insertions for the G248 library were identified by 
paired-end sequence analysis, and 32/108 insertion fosmids were positive by 
oligonucleotide hybridization.  Thirteen of the 32 fosmids were positive by 
Southern blot, and 8 of these 13 were positive by both 5′ and 3′ ATLAS. Five 
fosmids that were positive by Southern blot and negative by ATLAS were 
examined and found, in the case of 3 fosmids, to contain older, full-length 
elements from the L1PA3-4 families already in the HGR. One more of these 
‘false positive’ fosmids yielded equivocal results using primers at both the 5′ and 
3′ ends. Sequencing verified that 7/8 fosmids that were positive for ATLAS were 
dimorphic. Of these 7, 3 were duplicates of a given L1. One allele of each 
element (4 in total) was cloned and tested. Three of these 4 elements were 
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active. One more element from the G248 library was identified in fosmid 
sequencing data from the Eichler lab. This element was not included in the 32 
original clones. The fosmid was acquired, and the element (G248 #1-(2-1)) was 
cloned and found to be active. 
  ABC9 
The ABC9 library contained 186 fosmids with predicted insertions, 64 were 
positive by oligonucleotide hybridization and 38 of the 64 were positive by 
Southern blot. Fourteen of these 38 were positive by 5′ and 3′ ATLAS, 7 were 
positive by 5′ ATLAS only, and 4 were positive by 3′ ATLAS only. The 14 plus the 
four 3′ ATLAS only fosmids were sequenced and cloned. Sixteen were absent 
from the HGR, and 9 were active. 
  ABC10 
In the ABC10 library, 297 fosmids contained predicted insertions and 46 of 
the 297 fosmids were positive by oligonucleotide hybridization. Of the 46, 37 
were positive by Southern blot, 14/37 were both 5′ and 3′ ATLAS positive, 7/37 
were only 5′ ATLAS positive, and 3/37 were only 3′ ATLAS positive. The 14 dual 
positives, the 3 that only were 3′ ATLAS positive, and 3 fosmids that were only 5′ 
ATLAS positive were sequenced and cloned. Nineteen of these elements were 
dimorphic, and of them, 10 were active. One more L1 (#3-(2-1)) was identified via 
sequencing by the Eichler laboratory. The fosmid was obtained, and the L1 was 
shown to be active.  
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  ABC11 
Of 246 fosmids containing predicted insertions, 35 were positive by 
oligonucleotide hybridization. Of the 35, 22 were full-length by Southern blot, 13 
of these 22 were dimorphic by sequencing, and, of these, 9 were active in the 
retrotransposition assay.  
  ABC12 
Of 258 fosmids containing predicted insertions, 52 were positive by 
oligonucleotide hybridization. Of the 52, 18 were full-length by Southern blot, 8 of 
these 18 were dimorphic, and, of these, 4 were active in the retrotransposition 
assay.  
  ABC13  
Of the 265 fosmids containing predicted insertions, 29 were positive by 
oligonucleotide hybridization. Of these 29, 17 were full-length by Southern blot, 7 
of the 17 were dimorphic, and, of these, 6 were active in the retrotransposition 
assay.  
Cloning of L1s 
L1s were cloned directly from fosmids into the context of the mneoI 
retrotransposition indicator cassette without the use of PCR. All pBluescript 
(Stratagene) vectors used in this study contain the 5′ UTR of an L1 and lack an 
exogenous promoter; the pCEP4 (Invitrogen) vectors have the cytomegalovirus 
(CMV) immediate early promoter, the 5′ UTR, and contain the mneoI 
retrotransposition indicator cassette.  
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  G248 
Three G248 fosmids were digested with AccI (NEB) and ligated (T4 DNA 
ligase NEB, overnight at 16oC) into the context of a pBluescript vector (pD100), 
containing the entire L1.3 element with a T7 gene 10 epitope tag on ORF1p (#1-
2, 1-4, and 1-5) (Kulpa and Moran, 2005). The ~6kb AccI restriction fragment 
from element #1-2-1 was cloned into JCC9/L1.3 RT-, a pBluescript based 
plasmid containing both L1.3 with a D702A mutation in the reverse transcriptase 
active site and mneoI cassette in the 3′ UTR (Moran et al., 1996; Morrish et al., 
2002). The first ~35bp and the last ~50bp of the new L1s are thereby replaced 
with those regions of the known active element L1.3 due to the location of the 
AccI sites. Inserts were then verified by diagnostic restriction digest and 
sequencing to identify polymorphisms with respect to L1.3. Due to cloning 
difficulties, #1-3 was cloned into this vector by digestion with KasI and NcoI, 
replacing the first 439bp and the last 346bp of the element with L1.3 sequences. 
These regions contained differences in the 5′ UTR as well as the 3′ end of ORF2 
and the 3′ UTR with respect to L1.3. Both fosmid and cloned #1-3 elements have 
two intact open reading frames; however, there are two non-synonymous amino 
acid changes between the fosmid sequence and the clone. A pBluescript, JCC9-
based clone of  #1-3, generated using an AccI digest, lacks these sequence 
changes, and retrotranspose at a level similar to L1.3 (data not shown). All five 
G248 elements then were cloned into JM105/L1.3 (pCEP4 backbone with an 
L1.3 RT- element), tagging their 3′ UTRs with the mneoI cassette. This was done 
through the use of NotI and BstZ17I (NEB), which cut at either the 5′ end (NotI) 
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or within the 3′ UTR (BstZ17I) of the L1 in pBluescript. Once again, DNA 
sequencing was performed to validate distinguishing polymorphisms in the 
respective 5′ UTR sequences of each clone.  
  ABC9 and ABC10 
Both ABC9 and ABC10 elements were first cloned via AccI into JCC9/L1.2A 
(similar to JCC9 L1.3 RT- described above, but with L1.2A in the pBluescript 
based vector; the first ~35 and last ~50 bp are identical to L1.3) (Moran et al., 
1996) or JCC9/L1.3/RT-. The one exception to this (#2-42) was unable to be 
cloned in this manner due to a nucleotide change producing a third AccI site near 
the 3′ end of ORF2p. This change was verified by sequencing the fosmid insert. 
All elements, except #3-5, were then subcloned into JM105/L1.3 with the use of 
NotI and BstZ17I as described above. All steps were verified through diagnostic 
digests and sequencing to identify distinguishing polymorphisms in the elements.  
  ABC11, ABC12 and ABC13 
ABC11, 12, and 13 elements were cloned via AccI into JCC9/L1.3/RT-. 
These clones were subjected to restriction digests and DNA sequencing to verify 
diagnostic polymorphisms in the respective L1Hs element.  
  L1.3 PDH mutant 
The #3-24 fosmid L1 element containing the PDH mutation was cloned from 
JM #3-24 construct into JJ105/L1.3 (identical to JM105/L1.3, except with an 
mblastI cassette in the 3′ UTR (Morrish et al., 2002)) directly from the JM 
backbone with the use of NotI and BstZ17I. Subsequently, L1.3 S228P was 
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created by a standard site-directed mutagenesis protocol. Briefly, linear PCR was 
conducted using 250ng of pBluescript backbone (JCC5) containing L1.3 
(Sassaman et al., 1997) and both forward and reverse-complementary 49-mer 
primers (IDT, www.idtdna.com) containing the mutation in the center (bp 25) of 
each primer using 5U of Pfu Turbo polymerase (Stratagene), mixed dNTPs 
(10mM, Invitrogen) and 17 cycles with extension for 18 minutes (~2 minutes per 
kb). Amplified plasmids then were incubated with DpnI to digest methylated DNA 
and then were transformed into E. coli. Ampicillin resistant clones were verified 
by diagnostic digest and sequencing, and the mutation was then cloned back into 
JCC5/L1.3 by use of an AgeI to EcoRI digest that allowed a swap of the mutation 
region for bp 1896 to 3431 of L1.3. The resultant construct was sequenced 
across the mutation and restriction enzyme sites used to generate the clone, and 
the L1.3 PDH element was then transferred to JM and JJ pCEP4 based vectors 
using NotI and BstZ17I.  
Cell Culture Conditions   
The cell culture conditions used have been described previously (Moran et 
al., 1996; Morrish et al., 2002). Briefly, HeLa cells (ATCC) were grown at 37oC in 
DMEM-high glucose media with 10% FBS, 20U/mL penicillin/streptomycin and 
0.4 mM glutamine (HeLa complete media) (Gibco) in the presence of 7% CO2 
and 100% humidity (Moran et al., 1996). The 4364a cell line was derived from 
Chinese Hamster Ovary (CHO-K1) cells, and is auxotrophic with respect to 
proline and glycine (Morrish et al., 2002). XR-1 cells were derived from the 4364a 
cell line, lack the XRCC4 gene product, and are deficient in the NHEJ pathway of 
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DNA repair (Morrish et al., 2002). These cells were maintained in DMEM-low 
glucose media with 10% FBS, 20U/mL penicillin/streptomycin and 0.4 mM 
glutamine plus non-essential amino acids (CHO complete media) (Gibco) in the 
presence of 7% CO2 and 100% humidity (Morrish et al., 2002). 
Transfection and Retrotransposition Assays  
We used a modification of a transient transfection protocol (Wei et al., 
2000). Approximately 2x103, 2x104, or 2x105 cells per well of a 6-well plate were 
used in the transfection of HeLa cells. Three wells of each cell concentration 
were transfected with 1 µg of plasmid (containing the mneoI cassette) using 
Fugene 6 transfection reagent (Roche) and Opti-mem media (Gibco) ~24 hours 
post plating. Cells were fed ~18-24 hours post transfection with HeLa complete 
media (described above), and daily from 72 hours with complete media plus 
400µg/mL G418 (Gibco). Fourteen days after transfection, cells were washed 
with phosphate buffered saline (PBS) (Gibco), fixed in a solution of 2% 
formaldehyde/0.2% glutaraldehyde in PBS, and stained with 0.1% crystal violet. 
Colonies of G418 resistant cells were counted on the 2x103 or 2x104 plates as 
necessary. Transfection efficiency was obtained for each plasmid by transfecting 
2x104 and 2x105 cells with 0.5µg of both the construct of interest and pCEP/GFP 
(Alisch et al., 2006). FACS analysis for %GFP positive cells at 72 hours post 
transfection yielded the transfection efficiency for the construct of interest. L1 
retrotransposition in CHO cells was conducted as previously described 
(blasticidin was used at a concentration of 10µg/mL) (Morrish et al., 2002). 
Percent retrotransposition is reported relative to the rate of L1.3, adjusting for 
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transfection efficiency. L1Hs elements were classified as ‘hot’ if they 
retrotransposed with a frequency greater than ~10% of L1.3. This activity reflects 
the retrotransposition efficiency of precursors of mutagenic insertions or full-
length mutagenic insertions themselves (Brouha et al., 2003). 
Genotyping 
After determining L1 insertion locations, we then compared these elements 
to a database of human retrotransposon insertion polymorphisms (dbRIP; 
http://dbrip.brocku.ca/) (Wang et al., 2006). An element was determined to be 
absent from dbRIP if, by January of 2009, there was no completely annotated 
full-length element at a given LINE-1 insertion site (i.e., with respect to sequence, 
size and known TSDs). Seven elements (#2-38, 2-6, 2-7, 3-17, 5-58, 5-66, 5-86) 
in our study had dbRIP entries nearby (within ~1kb), but were not definitively 
mapped/annotated. For a subset of  ‘novel’ elements absent from dbRIP, PCR 
genotyping assays were designed. These novel elements were selected from the 
first three individuals on the basis of a unique genomic insertion location, 
presence of non-repetitive sequence on both the 5′ and 3′ flanking regions for 
primer design, and for the ability to detect a single amplicon of the correct size 
upon PCR. 
 Dimorphism was determined with primers 5′ and 3′ of the insertion to detect 
the empty site as well as the HS or RB3PA2 primers paired with the 3′ flanking 
DNA primer for the filled site (common primer sequences below) (Badge et al., 
2003). When the 3′ filled site was refractory to genotyping, either due to a 
transduction or variant sequences in the 3′ forward primer of the L1 (as in pre-Ta 
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elements), these elements were typed for the 5′ filled site using RB5PA2 and a 5′ 
flanking sequence oligonucleotide. Many of the filled site genotyping reactions 
were carried out at both the 5′ and 3′ ends to control for potentially unidentified 3′ 
transductions (Badge et al., 2003).  
Genotyping Panels 
Genotyping was carried out on a CEPH panel of 129 unrelated individuals 
of Northern European ancestry, a panel of 72 unrelated Zimbabwean individuals, 
or the H952 subset (Rosenberg, 2006) of the HGDP (Cann et al., 2002) as 
shown in Figure 2.3B. The 129 unrelated individuals are a subset of the 
grandparents and parents from the CEPH Pedigree DNA resource, within which 
there are no individuals with previously established lineal relationships. The 
Zimbabwean panel is composed of genomic DNA from 72 unrelated anonymous 
native African male semen donors collected in Harare, Zimbabwe. The H952 
subset of the HGDP comprises all individuals within the 1051 samples that likely 
share no closer relationships than first cousins, as determined by RELPAIR 
analysis of SNP genotyping data (Rosenberg, 2006). Two elements positive for 5′ 
but not 3′ ATLAS, and that were not tested for activity were also genotyped on 
these panels. Allele frequencies are reported in Table 2.5 across all panels 
genotyped (e.g., the four elements typed on the HGDP were calculated as the 
number of L1-containing alleles over the number of alleles genotyped on CEPH, 
Zimbabwean, and HGDP panels). Additionally, if an element was previously 
described in dbRIP or an L1 polymorphism study not included in dbRIP, efforts 
were made to obtain genotyping data from these studies (see Table 2.5). 
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In Silico Genotyping 
As the set of elements that we examined is subtractive, we used the human 
genome structural variation (HGSV: http://hgsv.washington.edu/) track (Kidd et 
al., 2008) of the UCSC browser (http://genome.ucsc.edu/) (Kent et al., 2002) to 
examine whether elements found in the first 5 individuals were present in the last 
person examined in our study (ABC13). This analysis was conducted by 
ascertaining whether the ABC13 genomic library contained ‘insertion’ clones 
where other genomes (G248, ABC9-12) contained a full-length L1 insertion with 
respect to the HGR (Figure 2.4A). Putative insertions in the ABC13 genome were 
tested by genotyping as described above. In silico genotyping was conducted for 
each of the 68 distinct L1Hs insertions in this study, and is detailed in Table 2.5. 
Estimation of L1 Element Age 
The determination of L1 element age using maximum likelihood and ad hoc 
methods are described in the Experimental Procedures section of the main text. 
While the ad hoc method (Marchani et al., 2009) for estimating L1 subfamily age 
through divergence from consensus is simple, the newer maximum likelihood 
measure enables the calculation of 95% confidence limits about the estimate. 
Analysis of 886bp from 191 Ta-1 L1 elements gave an estimated age for this 
subfamily of 2.01 MY (95% C.I. 2.00 – 2.02 MY) using an L1-specific substitution 
rate of 0.25% per million years, based on the human–orangutan divergence 
(Marchani et al., 2009). The 48 Ta-1 elements in the current dataset are 
significantly younger than most Ta-1 L1 elements, with an estimated age of 1.0 
MY (95% C.I. 0.98 – 1.01 MY). Applying the same analysis to 37 previously 
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reported Ta-1 elements (Brouha et al., 2003) gives an estimated age of 1.73 MY 
(95% C.I. 1.69 – 1.77 MY).  
Where multiple lineages of L1 elements within a subfamily are 
simultaneously active, the ad hoc estimate of element age will significantly 
deviate from the maximum likelihood estimate (although both overestimate 
element age under a transposon model). We compared the maximum likelihood 
age of the 48 Ta-1 elements reported here (1.0 MY (95% C.I. 0.98 – 1.01 MY)) 
with the ad hoc estimate of their age (1.18 MY), and found them to be 
significantly different.  
Oligonucleotides 
HS-  5′- ATACCTAATGCTAGATGACACA- 3′ 
ORF2L-  5′- ATAGCAAAGACTTGGAACCAACCC- 3′ 
RB5PA2-  5′- TGGAAATGCAGAAATCACCG- 3′ 
5′UTR AS-  5′- CAGGCAGGCCTCCTTGAGCTG- 3′ 
RB3PA2-  5′- ACCTAATGCTAGATGACACA- 3′ 
RBX4-  5′- GTGGCGGCCAGTATTC- 3′ 
The sequences of additional oligonucleotides (for genotyping assays, etc.) 
used in this study are available upon request. 
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Figure 2.1: A Strategy for Identifying Dimorphic L1Hs Elements in 
Individual Human Genomes 
 
Figure 2.1: A Strategy for Identifying Dimorphic L1Hs Elements in 
Individual Human Genomes 
In silico comparison of the fosmid end sequences (red squares) from individual 
genomic libraries (blue horizontal line) and the HGR (pink horizontal line) enables 
the detection of fosmids that may contain insertions or deletions with respect to 
the HGR (see dashed lines). Insertion fosmids were screened by allele specific 
oligonucleotide hybridization to detect characters that are present in the 5′ UTR 
of newer L1 elements (one discriminating character utilized, a deletion of the G 
residue at bp 74 in recent L1s, is indicated in maroon). Putative L1Hs-containing 
fosmids were analyzed by Southern blotting with a 5′ UTR probe (blue arrow). A 
representative digest and Southern blot is shown. The ~6 kb band is diagnostic 
for the full-length L1. The additional hybridizing band (~1.3 kb band liberated 
from the L1 5′ flank in this Southern blot example) serves to distinguish individual 
fosmids. ATLAS and/or DNA sequencing confirmed the presence of a dimorphic, 
full-length L1Hs insertion. The endonuclease (EN), reverse transcriptase (RT), 
and cysteine-rich (C) domains of ORF2 (blue rectangle) are indicated. 
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Figure 2.2: L1Hs Activity in Six Human Genomes 
(A) Cloning strategy: All but one L1Hs element were cloned directly from fosmids 
using AccI sites in their 5′ UTR and 3′ UTRs, respectively (red vertical lines; see 
Experimental Procedures). The L1s then were ligated into vectors that either 
contain or lack a CMV promoter (black rectangle). Both vectors contain the 
mneoI retrotransposition indicator cassette (light blue) in the L1 3′ UTR. This 
cassette allows for detection of retrotransposition events in a cell culture 
retrotransposition assay. SD = splice donor. SA = splice acceptor. Active 
elements confer G418 resistance to HeLa cells, whereas defective elements, as 
illustrated by the RT mutant control (RT- L1), do not. (B) Representative G418-
resistant foci for the 20 elements from the Yoruban library, ABC10: Nine of these 
elements were highly active (large suns to the left of assay image), and two more 
retained a low level of activity (small suns). One element (#3-5, red box) is a hot 
pre-Ta L1 (#3-5 was tested in a pBluescript backbone (5′ UTR+); all others were 
tested in a pCEP4 (CMV+/5′ UTR+)) backbone (Extended Experimental 
Procedures). Table 2.2 displays retrotransposition efficiencies for each L1 
identified in this study. Figure 2.7 provides details on the EN-deficient element 
#3-24. (C) The 68 distinct L1Hs elements identified in this study and their 
positions in the genome: Red vertical lines and text represent hot or highly active 
elements. Orange vertical lines with black text represent low-level activity 
elements. Blue vertical lines with black text represent ‘dead’ or inactive elements. 
The black line indicates the one untested element (#2-42). Ideograms were 
adapted from UCSC genome browser: http://genome.ucsc.edu (Kent et al., 
2002). 
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Figure 2.2: L1Hs Activity in Six Human Genomes 
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Figure 2.3: Allele Frequencies of L1Hs Elements in the Population  
(A) Genotyping assays: L1s were queried in panels of individuals for their 
absence (solid grey lines), or presence (red line). Genotyping of 26 elements in 
the three panels allowed the discovery of population restricted or potentially 
“private” L1Hs elements. The expected amplicon sizes are diagrammed for 
element #3-24. (B) Pedigrees showing the inheritance of two elements typed in 
the ABC10 trio: Genotyping gels show the heritability of #3-31 (African specific) 
and #3-24 (absent from the HGDP). E and F at the top of the gel image indicate 
PCR results for empty and filled sites. M, F, and C at the bottom of the image 
indicate lanes for the mother, father, and child of the trio. (C) Example data sheet 
for the G248 element #1-5: Empty site: insertion site in the HGR. EN cleavage 
site: the endonucleolytic cleavage site used by L1 EN to initiate 
retrotransposition. pA length: the approximate L1 poly(A) tail length; 3′ 
transductions and interrupted poly(A) tails also are annotated. TSD length: the 
length of the target site duplication flanking the L1Hs element (underlined 
lettering). Table 2.3 contains data sheets for each L1 in this study. Table 2.4 
contains L1Hs insertion locations with respect to genes. Figure 2.8 displays a 
non-canonical L1Hs insertion and documents a possible sequence anomaly in 
the HGR. 
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Figure 2.3: Allele Frequencies of L1Hs Elements in the Population 
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Figure 2.4: An Estimate of the Number of Active L1Hs Elements in an 
Individual (ABC13) Genome 
(A) In silico genotyping: The last library in our study, ABC13, was examined in 
silico (see text) for the presence of insertion fosmids mapping to the location of 
L1Hs elements found in other individuals. Element 3-17 is used as an example. 
All blue lines represent insertion fosmids in the genomes of the 8 individuals on 
the HGSV track (http://hgsv.washington.edu/) of the UCSC genome browser 
(http://genome.ucsc.edu) (Kent et al., 2002). The ABC7, 8, and 14 libraries were 
not investigated in this study. (B) PCR validation: The elements identified in silico 
were genotyped using similar schemes to that shown in Figure 2.3A to validate 
the predictions from the HGSV track of the UCSC browser. Element 3-17 is used 
to illustrate the genotyping. ABC10 and ABC13 are heterozygous with respect to 
the L1Hs insertion. ABC11 lacks the L1Hs insertion. Table 2.5 displays 
genotyping results for all elements in this study. 
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Figure 2.4: An Estimate of the Number of Active L1Hs Elements in an 
Individual (ABC13) Genome 
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Figure 2.5: Phylogenetic Tree of the L1Hs Elements Identified in This Study 
The tree is a single neighbor-joining tree (with branch lengths corrected using the 
Kimura 2 parameter model of nucleotide substitution) with 68 full-length elements 
from our study. The numbers at particular nodes indicate the number of times 
that node was observed in 1000 bootstrap replicates of the dataset. Only 
bootstrap values exceeding 70% are shown. The brackets at the right side 
indicate previously described ‘transduction subfamilies’ (L1RP (labeled RP in the 
Figure) and LRE3) and distinct L1Hs subfamilies currently capable of amplifying 
in human genomes (I-V) (Goodier et al., 2000; Pickeral et al., 2000). Those 
subfamilies are highlighted in the same color to show their clustering on the tree. 
Retrotransposition activity (% relative to L1.3) as well as allele frequency (e.g., 
AF= 0.012), if determined, are appended to the sequence identifiers. Element #4-
17 contains ACG characters in its 3′ UTR, which are diagnostic for pre-Ta L1s; 
however, the element clusters with the Ta0 subfamily. Activities for elements 
AL357559 and AL022171 were previously determined (Brouha et al., 2003). n/a 
= an L1 element not assayed for retrotransposition. The tree and age estimates 
use sequences indicated Table 2.6. 
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Figure 2.5: Phylogenetic Tree of the L1Hs Elements Identified in This 
Study 
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Figure 2.6: Multiple Source Loci Model for Continued L1Hs Activity 
 
 
 
Figure 2.6: Multiple Source Loci Model for Continued L1Hs Activity  
An element (source locus) that is both active and in a conducive genomic 
environment can retrotranspose. Shown here is an example of a progenitor 
element that can be associated with subsequent members of a family through the 
use of interrupted poly(A) tails and/or 3′ transduced sequence (3′ red arrow and 
line). Distinct elements are marked by distinguishing TSDs specific for their new 
integration site (different colored horizontal arrows). There are many of these 
‘families’ active in human genomes, such as L1RP, LRE3, and the 5 ‘families’ 
noted in Figure 2.5. Although host processes (lightning bolt) may inactivate some 
older elements, some of their descendents may retain the ability to 
retrotranspose and could harbor the 3′ transduction/interrupted poly(A) tail.  
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Table 2.1: Summary of Data for the Six Libraries 
 
a Daughters of HapMap trios. 
b Differs from Kidd et al (2008). 
c One element was observed twice, in ABC11 &12- #4-1 and #5-77. Neither 
allele is active, and the element is in dbRIP. 
 
Table 2.1: Summary of Data for the Six Libraries 
Column 1: library identifiers. Column 2: Coriell identifier of individuals analyzed. 
Column 3: population of origin for individuals in the HapMap study. Column 4: the 
average insert size of each individual library (in kb). Column 5: the standard 
deviation in insert size of each individual library. Column 6: the detection limit for 
the size of insertions in each library. For ABC9 a more reduced threshold was 
applied than that used previously (Kidd et al., 2008). Column 7: the number of 
elements found in each library that are absent from the HGR. Column 8: the 
number of elements from column 7 that are not completely annotated in dbRIP 
(Wang et al., 2006). Column 9: the number of elements from column 7 that were 
active in retrotransposition assays. Column 10: elements from column 9 that 
retrotransposed at levels >10% of L1.3, a known active element. Column 11: The 
number of the HGR hot elements that were present in each individual (Brouha et 
al., 2003). 
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Figure 2.7:  Endonuclease-Deficient Element #3-24, Related to  
Figure 2.2 
 
 
 
Figure 2.7:  Endonuclease-Deficient Element #3-24, Related to Figure 2.2 
The endonuclease-dependent and endonuclease-independent retrotransposition 
assays are shown for element #3-24, which contains an S228P mutation in the 
EN domain of ORF2p. 4364a cells are NHEJ proficient, and are parental to the 
XRCC4-deficient XR-1 cell line. Retrotransposition events are detected as 
blasticidin resistant colonies in an assay analogous to that shown in Figure 2.2A. 
L1.3 is able to retrotranspose in both parental and XR-1 cells, whereas a known 
EN mutant (D205A), #3-24, and the S228P L1.3 mutant retrotranspose in XR-1 
cells. An RT mutant (JJ105, D702A) cannot retrotranspose in either cell line 
(Morrish et al., 2002). 
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Figure 2.8: A Noncanonical L1 Retrotransposition Event and a Possible 
Sequence Anomaly in the HGR, Related to Figure 2.3 
(A) A Noncanonical Retrotransposition Event: the retrotransposition of a L1Hs 
element (#2-24) was accompanied by the insertion of a segment of an Alu 
element at its 5′ end. Possible precursors of both the L1 and Alu are shown 
(14,234kb apart on chromosome 16), as is a diagram of the L1Hs insertion (i.e., 
empty) site on chromosome 10. The purple arrows above the ideograms indicate 
the orientation of each element. The empty site on chromosome 10 was PCR 
amplified from the genomic DNA of ABC9, and sequencing showed that it lacks 
the Alu/L1Hs insertion.  
(B) A Possible Sequence Anomaly in the HGR: The fosmid sequence for the 
region of chromosome 18 is shown at the top of the Figure. The L1PA2 and L1Hs 
pre-Ta element are in the same orientation, separated by ~6.8kb of sequence 
that is absent from the HGR, yet is present in a recently completed human 
genome diploid sequence (Venter et al., 2001). Red lollipops signify sequences 
specific for the L1PA2, while grey lollipops indicate sequences peculiar to the 
pre-Ta. The corresponding sequence in the HGR is indicated at the bottom of the 
Figure. Aqua lollipops indicate sequence changes specific to the harlequin 
element. Portions of the TSDs for the two elements present in the fosmid flank 
the harlequin sequence (aqua and light green lettering, respectively). The 
interspersion of red and grey lollipops makes it unlikely that the L1 was formed 
by non-allelic homologous recombination. Instead, it is most likely that a 
sequencing assembly error is responsible for misrepresentation of this region in 
the HGR. However, we cannot formally rule out that the sequence collapse is 
due to an unconventional inter-L1 recombination event. 
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Figure 2.8: A Noncanonical L1 Retrotransposition Event and a 
Possible Sequence Anomaly in the HGR, Related to Figure 2.3 
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Table 2.2: Activity of the L1 Elements, Related to Figure 2.2 
L1 ID Chromosome Activity  L1 ID Chromosome Activity 
1-2 2 0  3-14 10 <1 
1-3 6 69  3-15 15 0 
1-4 12 107  3-36 20 0 
1-5 9 119  3-6 15 0 
1-(2-1) 14 118  3-5 8 74 
2-1 6 141  3-(2-1) 14 3 
2-6 11 0  4-1 6 0 
2-7 9 0  4-5 11 1 
2-12 17 130  4-7 3 69 
2-14 3 101  4-8 5 161 
2-21 X 133  4-15 4 54 
2-24 10 0  4-17 3 0 
2-30 22 46  4-19 22 0 
2-32 7 118  4-20 2 0 
2-39 20 0  4-27 6 79 
2-42 X n/a  4-29 17 38 
2-53 7 86  4-32 1 11 
2-59 22 3  4-34 2 57 
2-25 11 0  4-35 13 191 
2-38 17 63  5-36 10 1 
2-61 3 0  5-54 18 0 
3-1 3 0  5-55 9 21 
3-3 21 15  5-58 2 13 
3-4 4 98  5-66 2 23 
3-7 12 <1  5-77 6 0 
3-10 7 126  5-82 15 <1 
3-17 4 0  5-86 5 0 
3-18 7 62  6-91 3 157 
3-24 2 <1  6-97 4 36 
3-25 2 170  6-100 2 <1 
3-31 15 120  6-102 6 129 
3-34 14 68  6-107 17 139 
3-38 5 6  6-109 X 73 
3-39 18 41  6-113 4 4 
3-40 2 0     
 
Table 2.2: Activity of the L1 Elements, Related to Figure 2.2 
Chart showing the activity of the elements investigated in this study relative to 
L1.3 (Sassaman et al., 1997). First column: the identifier of each element, where 
the number preceding the hyphen indicates the individual library (1=G248, 
2=ABC9, 3=ABC10, 4=ABC11, 5=ABC12, 6=ABC13). Second column: 
chromosomal location of the insertion. Third column: the activity of the element in 
the retrotransposition assay (relative to L1.3 (L19088) (Sassaman et al., 1997)).  
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Table 2.3: Datasheets for the Elements in This Study, Related to Figure 2.3 
Each L1 identified in this study is illustrated in a separate datasheet. Included for 
each element is an ideogram with the location of the L1 insertion, the empty site 
sequence from the HGR, and characteristics of the insertion site (including genes 
in the area). Hallmarks of the L1 retrotransposition event are annotated for the 
following: the endonuclease (EN) cleavage site, the target site duplication (TSD) 
size, the approximate size of the poly(A) tail and 3′ transduction/interrupted 
poly(A) tail details, the activity of the element in the cell culture retrotransposition 
assay, and the allele frequency of the element (if genotyped). Graphs of 
representative retrotransposition assays also are shown (related to Table 2.2). 
Error bars represent the standard deviation of the % retrotransposition, when 
normalized to the activity of L1.3. In some graphs, we report the 
retrotransposition efficiencies of additional positive controls (L1.2A, L1RP, LRE3, 
and #2-12). A L1.3 RT mutant (JM105 or J9105) served as a negative control. L1 
elements from individuals ABC11-13 (J9#1-113) are numbered sequentially. 
Some L1 elements were cloned and assayed for retrotransposition before we 
determined their presence in the HGR. These elements (e.g., #3-8) are present 
in the graph, but not the datasheets. The datasheet for element #1-5 was also 
shown in Figure 2.3. 
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Table 2.3: Datasheets for the Elements in This Study, Related to 
Figure 2.3 
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Table 2.4: L1 Insertions in Genes, Related to Figure 2.3 
First column: the identifier of each element (as defined in Table 2.2 and Table 
2.3). Second column: the RefSeq gene name. Third column: the intron containing 
the insertion, or the distance (5′ or 3′) from the L1 insertion to the nearest gene. 
Fourth column: the transcriptional orientation of the L1 with respect to the gene. 
Fifth column: if annotated, a short summary about whether mutations in the gene 
containing the insertion are implicated in human disease 
(http://www.ncbi.nlm.nih.gov/omim/).
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Table 2.4: L1 Insertions in Genes, Related to Figure 2.3 
L1 ID Gene Intron 
Transcription 
Orientation OMIM data 
1-3 RIMS1 2 Same Synaptic vesicle exocytosis- Cone-
rod dystrophy 
1-4 NOS Upstream 15kb Same Neuronal/neuromuscular signaling 
1-5 ABCA1 5 Opposite Tangier disease-HDL deficiency 
1-(2-1) NPAS3 4 Opposite Psychiatric illness- schizophrenia? 
2-1 PHACTR1 5 Same Expressed in brain 
2-6 SBF2 6 Same CMT 4B2 
2-7 MAMDC2 8 Opposite  
2-12 PRKCA 3 Same Numerous phenotypes associated- 
cancer, myocyte contraction, etc. 
2-14 SCN5A 13 Opposite LQT, Brugada syndrome, cardiac 
arrhythmia 
2-30 TTC28 11 Same  
3-10 SDK1 5 Opposite Neurite laminar targeting 
3-17 SLC10A7 7 Opposite  
3-25 KIF5C 9 Opposite Neuronal kinesin heavy chain 
3-34 RAD51L1 5 Same tumor-suppressor 
3-39 SPIRE1 8 Opposite Actin nucleation/ axis formation in 
oocytes and embryos 
3-40 CTNNA2 2 Same Motility in dendrite spines 
3-15 HOMER2 2 Same KO mice- cocaine sensitization, 
neuronal gene 
4-1 GFOD1 Upstream 15kb Opposite  
4-5 RAG1 Upstream Opposite  
4-8 SPEF2 Downstream Opposite sperm flagellum 
4-27 FOXO3 1 Opposite Apoptotic gene transcription 
4-32 TDRD5 4 Opposite  
4-35 LOC646982 5 Opposite Twelve-thirteen translocation 
leukemia gene 
5-36 C10ORF120 2 kb downstream Opposite  
5-55 ROR2 9 (alt. transcript) Same Chondrocyte growth and patterning 
5-82 RYR3 49 Opposite  
5-86 ADAMTS12 2 Same Cell adhesion- implicated in cancer 
6-91 NEK11 1 kb downstream Same DNA repair, S-phase checkpoint 
6-97 COL25A1 22 kb upstream Same Brain-specific collagen, Alzheimer 
disease 
6-107 PRPSAP2 5 Opposite De novo synthesis of 
nucleotides/some amino acids 
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Table 2.5: Allele Frequencies of L1s, Related to Figure 2.4 
First column: identifier of the L1. Second column: whether the element is active in 
the retrotransposition assay. Third column: Allele Frequency (calculated across 
all relevant genotyping panels). Fourth column: whether the allele frequency was 
determined in this study, and if not, the source of the allele frequency data, as 
well as whether the element was typed in the Zimbabwean panel or the HGDP. 
Fifth column: data from the in silico genotyping of each element. L1Hs elements 
in red text were either not assayed for retrotransposition in this study (5′ ATLAS 
only: #2-17 and 3-30), or were genotyped in other studies (Badge et al., 2003; 
Myers et al., 2002; Xing et al., 2009). 
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Table 2.5: Allele Frequencies of L1s, Related to Figure 2.4 
L1 ID Active Allele Freq. 
Genotyping 
done here In Silico Genotyping 
1-2 N 0.11 yes Insertion in G248, One End Anchored in ABC12, 8, Transchromosomal in ABC8 
1-3 Y 0.21 yes Insertion in G248 & ABC14, Inversion in ABC8  
1-4 Y 0.44 yes Insertion in G248, ABC9, ABC11 ABC12, 14 
1-5 Y 0 Yes- HGDP Insertion and Inversion in G248. Insertion in 
ABC14 (not there when PCR genotyped) 
1-(2-1) Y - - Inversion G248, ABC8, 9 
2-1 Y 0.178 yes Insertion ABC9 & 11 Inversion ABC8 
2-6 N 0.012 yes- Badge has .07 Insertion in ABC9 & 11 
2-7 N - - Insertion in ABC9 only 
2-12 Y 0.223 yes Insertion in ABC9 & 12 Inversion in ABC8 
2-14 Y 0.266 yes Insertion in ABC9 8, 11, 12, 13 
2-17 - 0.605 yes Insertion in ABC8, 9, 12, 14 
2-21 Y 0.209 yes Insertion in ABC9 & 11 
2-24 N - - Insertion in ABC9, 11, 12 Inversion and Deletion in ABC8 
2-30 Y 0.0903 yes Insertion in ABC9 only 
2-32 Y 0.207 yes Insertion in ABC9& 12, Inversion in ABC8 
2-39 N 0.051 yes Insertion in ABC9, 8, 10, Inversion in ABC13 
2-42 - - - Inversion in ABC12, 13 NO Insertion in ABC9 
2-53 Y 0.063 yes Insertion in ABC9, 11, 14 
2-59 Y (low) - - Insertion in ABC9, 11, 14 
2-25 N - - Insertion in G248, ABC9, 8, 12, 13 Inversion in ABC7 
2-38 Y - - Insertion in ABC9, 11, 12, Inversion in ABC7, 8, Deletion in G248 
2-61 N - - Insertion in ABC9 & 8 
3-1 N - - Insertion in ABC10 & 12 
3-3 Y 0.264 yes Insertion in ABC10, 9, 11, 13, Inversion in ABC8, One End Anchored in G248 
3-4 Y 0.00249 Yes- Z Insertion in ABC10, Inversion in ABC8 
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L1 ID Active Allele Freq. 
Genotyping 
done here In Silico Genotyping 
3-7 N - - Insertion in ABC10 and 13 
3-10 Y 0.00249 Yes- Z Insertion in ABC10, Transchromosomal (X) in ABC7 
3-17 N High No- Xing Insertion G248, ABC10, 8, 12, 13, 14, Inversion ABC8 
3-18 Y - - Insertion in ABC8, 10, 13, Deletion in ABC14 
3-24 N 0 Yes- HGDP Insertion in ABC10 only. Inversion in ABC7 
3-25 Y 0.00249 Yes-Z Insertion in ABC10. Inversion in ABC8. 
3-30 - 0? Yes- CEPH only Insertion in ABC10 only, Inversion in ABC7, 8 
3-31 Y 0.00174 Yes- HGDP Insertion in ABC7, 10, Inversion in ABC12 
3-34 Y .078 Yes- Z Insertion in ABC10, 8, inversion in ABC8 
3-38 Y (low) - - Insertion in ABC10, 11, 12, 14 Inversion in ABC9 
3-39 Y 0.0155 yes Insertion in ABC10, 11, 12, 13, Deletion in 
ABC14, Inversion in ABC7 
3-40 N .091 Yes- Z Insertion in ABC10, 7 
3-14 N 0.0944 yes Insertion in ABC10, 13, Deletion in ABC8 
3-15 N 0.43-0.45 
No- Myers & 
Badge 
Insertion in ABC10, 14, Inversion in ABC9, 11, 
12, 13,14 
3-36 N - - Insertion in ABC9, 10, 13, 14 
 3-6 N - - Insertion in ABC10, 13 
3-(2-1) Y (low) - - Insertion in ABC10, 12, 13, G248 
3-5 Y 0.00349 Yes- HGDP Insertion in ABC10, Inversion in ABC7, Deletion in ABC12, Transchromosomal ABC8 
4-1 N 0.58 No- Myers Insertion in ABC8,10,11,12,13,14 Inversion in ABC8 
4-5 Y (low) - - Insertion in G248, ABC11, 13, Deletion in ABC14, Inversion in ABC7 
4-7 Y - - Insertion in ABC9, 11, 12 
4-8 Y - - Insertion in ABC11, 13, Deletion in ABC13, Inversion in ABC9 
4-15 Y - - Insertion in ABC11, Inversion in ABC8 
4-17 N - - Insertion in ABC11 
4-19 N - - Insertion in ABC8, 11, 14 Deletion in ABC9, 11, 12, 14 Inversion ABC8, 13 
4-20 N - - Insertion in ABC11 and G248 
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L1 ID Active Allele Freq. 
Genotyping 
done here In Silico Genotyping 
4-27 Y - - Insertion in ABC11 
4-29 Y - - Insertion in ABC11, Inversion in G248 
4-32 Y - - Insertion in ABC11, 10, 13, 14 
4-34 Y - - Insertion in ABC11, 7, 9, Inversion in G248, ABC7, 13 
4-35 Y - - Insertion in ABC11 
5-36 Y (low) - - Insertion in ABC8, 10, 12, 14, One End Anchored in ABC13, Inversion in ABC7 
5-54 N - - Insertion in ABC11, 12, 13, 14 
5-55 Y - - Insertion in ABC12, inversion in ABC10 
5-58 Y - - Insertion in ABC11, 12, 13, Inversion in G248 
5-66 Y - - Insertion in G248, ABC11, 12, 13, 14 
5-77 N 0.58 No- Myers Insertion in ABC8, 10, 11, 12, 13, 14, Inversion 
in ABC8 
5-82 N - - Insertion in ABC12, 13, Inversion in ABC12 
5-86 N - - Insertion in ABC12 
6-91 Y - - Insertion in ABC13, Deletion in ABC9 
6-97 Y - - Insertion in ABC10, 13, Inversion in ABC7 
6-100 N - - Insertion in ABC13 only 
6-102 Y - - Insertion in ABC9, 13 
6-107 Y - - Insertion in ABC10, 13, Inversion in G248, ABC7, 8, 12, 14 
6-109 Y - - Insertion in ABC13, Inversion in G248, ABC9 
6-113 Y (low) - - Insertion in ABC11, 13, 14 
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Table 2.6- Accession Numbers, Related to Figure 2.5 
Fosmid 
Number 
Accession 
Number 
 Fosmid 
Number 
Accession 
Number 
 Fosmid 
Number 
Accession 
Number 
1-2 AC193155.1  3-4 AC203651  4-17 AC216905 
1-3 AC195775.1  3-7 AC203650  4-19 AC226753 
1-4 AC193146.1  3-10 AC203619  4-20 AC220069 
1-5 GU477636  3-17 AC208506 
 
 4-27 AC215798 
1-(2-1) AC213207.1  3-18 AC225391  4-29 AC226751 
2-1 AC206597  3-24 AC214167  4-32 AC216813 
2-6 AC210891  3-25 AC206420  4-34 AC216112 
2-7 AC212493  3-31 AC209305  4-35 AC217325 
2-12 AC209294  3-34 AC210873  5-36 AC214986 
2-14 AC211854  3-38 AC208067  5-54 AC226067 
2-21 AC207709  3-39 AC206473  5-55 AC226114 
2-24 AC208581  3-40 AC209201  5-58 AC209560 
2-30 AC215719.2  3-14 AC204956  5-66 AC229893 
2-32 AC214812  3-15 AC203593  5-77 AC208509 
2-39 AC209235  3-36 AC207480  5-82 AC206103 
2-42 AC208589  3-6 AC204965  5-86 AC236757 
2-53 AC207969  3-5 AC204967  6-91 AC226062 
2-59 AC209341  3-(2-1) AC203592  6-97 AC236929 
2-25 AC210912  4-1 AC217408  6-100 AC219161 
2-38 AC207965  4-5 AC217815  6-102 GU477637 
2-61 AC209421  4-7 AC217244  6-107 AC216987 
3-1 AC203662  4-8 AC215801  6-109 AC216964 
3-3 AC203635  4-15 AC216136  6-113 AC225317 
 
Table 2.6- Accession Numbers, Related to Figure 2.5 
Accession numbers refer to the fosmid sequence generated at the Washington 
University Genome Sequencing Center (St. Louis) (Kidd et al., 2008). Each L1 
also was sequenced in its entirety as part of this study. Three elements (#1-3, 2-
12, and 4-5) were found to contain changes relative to the NCBI entries. These 
sequences are available upon request. Two new L1 sequences recently 
deposited in GenBank are displayed in red text. 
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Chapter 3 
 
A Natural LINE-1 Mutation Spectrum 
 
Abstract 
We previously characterized 68 distinct full-length L1 polymorphisms, 37 of 
which were highly active in a cell culture retrotransposition assay. Here, we 
examined the 31 elements from this study that were unable to retrotranspose or 
had low-level activities. From the sequences of these L1s, we determined that 
~50% contained chain terminating frame shift or nonsense mutations in one or 
both of the two L1-encoded open reading frames (ORFs). The additional 16 L1s 
contained intact ORF1p and ORF2p coding sequences. However, these 
elements consisted of a 5ʹ′UTR splicing mutation (#6-113), an L1 with an 
endonuclease mutation (#3-24), and 14 L1s with missense mutations in one or 
both ORFs that may impact retrotransposition. We examined the amino acid 
sequences of these 14 L1s to determine potentially causative differences, and 
have tested the elements in a functional assay to elucidate the endonuclease 
function of the L1s. Amino acid changes potentially responsible for low-level 
retrotransposition activity have been identified for at least 2 elements, and 
additional analysis examined the importance of conserved RNA changes and the 
utility of transduction sequences in the identification of highly active L1s.  
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Introduction 
Long interspersed element-1 (LINE-1 or L1) sequences comprise ~17% of 
human DNA and play an important part in the evolution of the human genome 
(Lander et al., 2001). Moreover, it is estimated that ~80-100 L1s per human 
genome retain the ability to mobilize via a copy and paste mechanism known as 
retrotransposition (Brouha et al., 2003). The proteins encoded by 
retrotransposition-competent L1s are also responsible for the mobility of other 
non-autonomous retrotransposons, including Alu, SVA, and U6 (Buzdin et al., 
2002; Dewannieux et al., 2003; Garcia-Perez et al., 2007; Hancks et al., 2011; 
Ostertag et al., 2003), and for processed pseudogene formation by the 
mobilization of cellular mRNAs (Esnault et al., 2000; Wei et al., 2001). Recently, 
a number of groups have identified many L1s and Alus that are polymorphic in 
human populations (Beck et al., 2010; Ewing and Kazazian, 2011, 2010; Huang 
et al., 2010; Iskow et al., 2010; Mills et al., 2011; Xing et al., 2009). Additionally, 
L1-mediated insertions have resulted in ~65 known cases of human disease 
(Babushok and Kazazian, 2007; Goodier and Kazazian, 2008; Kazazian et al., 
1988). Therefore, L1s and the elements they mobilize constitute ~1/3 of our 
genome, and continue to affect the DNA of modern humans.  
Retrotransposition-competent L1s (RC-L1s) are ~6kb in length, contain two 
non-overlapping open reading frames (ORFs) and terminate in a 3ʹ′UTR that is 
punctuated by a poly(A) tail (Dombroski et al., 1991; Scott et al., 1987). The 
5ʹ′UTR contains an internal RNA polymerase II promoter (Swergold, 1990) that 
drives transcription of the L1. ORF1 encodes an ~40 kDa nucleic acid binding 
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protein (ORF1p) with a coiled coil domain (Holmes et al., 1992), RNA recognition 
motif (Khazina and Weichenrieder, 2009), and a carboxyl-terminal basic domain 
(Khazina et al., 2011; Moran et al., 1996). ORF2 encodes an ~140 kDa protein 
(ORF2p) (Ergun et al., 2004) with endonuclease (EN), reverse transcriptase 
(RT), and cysteine-rich (C) domains that are required for retrotransposition 
(Fanning and Singer, 1987; Feng et al., 1996; Martin et al., 1995; Mathias et al., 
1991; Moran et al., 1996) (Figure 3.1).  
Upon transcription from the 5'UTR, the L1 RNA is exported to the cytoplasm 
where translation of ORF1p and ORF2p occurs (Alisch et al., 2006; Leibold et al., 
1990; McMillan and Singer, 1993). The two L1-encoded proteins then bind back 
to their encoding RNA by the process of cis-preference (Esnault et al., 2000; 
Kulpa and Moran, 2006; Wei et al., 2001). The resultant ribonucleoprotein 
particle (RNP) is a presumed retrotransposition intermediate (Hohjoh and Singer, 
1996; Kulpa and Moran, 2005; Martin, 1991). The L1 RNP then enters the 
nucleus through a process that may occur independent of nuclear envelope 
break down (Kubo et al., 2006). Once in the nucleus, the EN domain of ORF2p 
cleaves the genome at a loose consensus site: 5ʹ′-TTTT/A-3ʹ′, with the “/” 
representing the scissile phosphate (Cost and Boeke, 1998; Feng et al., 1996; 
Morrish et al., 2002). This cleavage exposes a free 3ʹ′-OH that serves as a primer 
for the reverse transcription of L1 RNA and the formation of a cDNA L1 copy 
(Cost et al., 2002; Feng et al., 1996; Kulpa and Moran, 2006; Luan et al., 1993). 
In addition to the cleavage and first-strand cDNA synthesis steps, the more 
poorly understood steps of second strand cDNA synthesis and the integration of 
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the nascent L1 into a genomic location must also occur. This mechanism of 
retrotransposition is termed target-site primed reverse transcription (TPRT), and 
it results in a new L1 insertion flanked by variable length and sequence target-
site duplications (TSDs) (Cost et al., 2002; Feng et al., 1996; Luan et al., 1993).  
L1s are present in every mammalian genome studied to date. In primates, 
L1s have arisen in a single lineage over the last ~40 million years of evolution, 
with the newer active subfamily subsequently replacing the previously active 
subfamily (Boissinot and Furano, 2001; Khan et al., 2006). Human specific L1 
(L1Hs) elements can be stratified into several subfamilies (pre-Ta, Ta-0, Ta-1, 
Ta1-d, Ta1-nd) based upon the presence of diagnostic sequence variants 
contained within their 5′ and 3′ UTRs (Boissinot et al., 2000; Scott et al., 1987; 
Skowronski et al., 1988; Smit et al., 1995). The classification of human L1s 
(Boissinot et al., 2000) and the development of consensus sequences from older 
elements present in the human genome reference sequence (HGR) have 
allowed investigation into L1 evolution (Boissinot and Furano, 2001; Khan et al., 
2006; Lander et al., 2001). 
Mutations in conserved residues of ORF1p and ORF2p are associated with 
a loss or decrease in retrotransposition (Doucet et al., 2010; Kulpa and Moran, 
2005; Moran et al., 1996). Indeed, many of the critical functions of the L1-
encoded proteins have been defined through the mutation of highly conserved 
residues (Feng et al., 1996; Khazina et al., 2011; Khazina and Weichenrieder, 
2009; Moran et al., 1996; Weichenrieder et al., 2004). However, it is also 
possible that non-conserved amino acid sequences that separate the highly 
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conserved and well-defined regions of ORF1p and ORF2p may be crucial for 
efficient retrotransposition. In support of this hypothesis, phylogenetic analyses of 
L1s in the HGR indicated that the coiled coil domain of ORF1p displays a strong 
signature of positive selection in the recent evolutionary history of primate L1 
elements, indicating that this region may interact with host proteins (Boissinot 
and Furano, 2001; Khan et al., 2006). In addition, some amino acid residues of 
ORF1p and ORF2p that drastically affect retrotransposition when mutated are 
not highly conserved in mammals (e.g., the putative leucine zipper domain of 
ORF1p) (Doucet et al., 2010). We therefore hypothesized that profiling the 
natural mutations present in the L1-encoded proteins of inactive elements in 
conjunction with evolutionary comparisons could potentially indicate functionally 
relevant domains of ORF1p and ORF2p. 
We previously generated a data set of 68 L1Hs elements that are 
polymorphic in human populations with respect to the HGR (Beck et al., 2010). 
Here, we have investigated the inactive elements from this study using 
nucleotide and amino acid sequence alignments. We identified 16 inactive or 
low-level activity elements that contained intact ORF1p and ORF2p, and in one 
of the L1s identified a splicing-mediated deletion of 5'UTR sequence. We also 
documented potentially deleterious amino acid differences in the two ORFs of 15 
remaining L1s. The alignments developed here may allow identification of highly 
active elements from either the nucleotide or amino acid sequences of ORF1p 
and ORF2p. Additionally, a neighbor-joining tree indicated that highly active L1s 
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may be overrepresented within transduction families, and we show that 
transduction sequences can be utilized to identify highly active progenitor L1s.  
Results 
Identification of Inactive Polymorphic L1s with Intact ORFs 
To identify mutations that were potentially responsible for the inactivity of 
polymorphic L1s, we utilized a previously developed dataset of 68 elements from 
fosmid libraries of 6 geographically diverse individuals (Beck et al., 2010; Kidd et 
al., 2008). High quality capillary sequencing of the 68 L1s was generated and 
compared to the sequence of the fosmid from which each was cloned to ensure 
an accurate representation of each element. The L1s were cloned from fosmids 
without the use of PCR and tested for their ability to retrotranspose in a cultured 
cell assay (Beck et al., 2010; Moran et al., 1996). Of the 68 L1s, 37 were highly 
active (displayed >10% the activity of a known, highly active element, L1.3- 
accession number L19088 (Dombroski et al., 1993)) and 6 additional elements 
displayed low-level activities (retrotransposition efficiencies <6% of L1.3). The 68 
L1s in this dataset were relatively young in comparison to other studies, both with 
respect to the allele frequency of the elements in the population (Brouha et al., 
2002), and via a maximum likelihood estimate of L1 age (Marchani et al., 2009). 
Therefore, the 31 elements with low-level or no activity (Beck et al., 2010) may 
contain mutations in crucial amino acid residues of the two L1-encoded proteins 
that rendered them unable to retrotranspose. 
We first determined if any of the inactive or low-level activity L1s contained 
intact open reading frames. One L1, #2-42, contained an extra restriction site 
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within ORF2p that rendered the element unable to be cloned in the same manner 
as the other 67, and was therefore not tested for retrotransposition activity and is 
excluded from this study. Fourteen of the 30 remaining elements were rendered 
inactive due to in frame nonsense or frame shift mutations in one or both of the 
L1-encoded ORFs (Figure 3.1). The remaining 16 L1s potentially contain 
missense mutations that inactivated ORF1p or ORF2p.  
Next, we developed a nucleotide alignment of the 37 highly active elements 
and the 16 additional L1s that contained intact ORFs (data not shown). The 
alignments of the 53 elements were also compared to a consensus sequence of 
highly active elements (Beck et al., 2010) and to consensus sequences of PA2-
PA5 elements in the HGR (Boissinot and Furano, 2001). This L1 sequence 
alignment identified a large 524 bp deletion in the 5ʹ′UTR of element #6-113 (from 
bp 98 to 621 of L1.3 (Dombroski et al., 1993)). 
A 5'UTR Splicing Mutation Responsible for Low Retrotransposition Activity 
We next sought to determine how the #6-113 5'UTR deletion was 
generated, and if the low level activity of the L1 was due to the loss of promoter 
activity. Intriguingly, a nucleotide alignment revealed the GT immediately 
following the upstream junction in the 57 other L1s to be a previously described 
splice donor (SD) (Figure 3.2A) (Belancio et al., 2006; Belancio et al., 2008). 
Upstream of the 3' junction resides a potential splice acceptor (SA) site. The 
putative SD and SA sequences were examined using the Berkeley Drosophila 
Genome Project splice site prediction webpage 
(http://www.fruitfly.org/seq_tools/splice.html) that uses the NNSPLICE 0.9 
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prediction program trained with human sequences (Reese et al., 1997). The SD 
and SA at bp 98-99 and 620-621 scored above the default 0.4 cut off value, 
indicating that these positions are good candidates for functional splice sites (see 
Table 3.1 for all sites above 0.2). The SD and SA sequences flanking the junction 
in the 5'UTR of #6-113 suggested that a full-length L1 with intact 5'UTR was 
transcribed, spliced in the suggested manner, and inserted into the genome by 
TPRT at a new location with the 5'UTR deletion (Figure 3.2A). In this model, the 
ORFs of the L1 would be competent for retrotransposition. In silico genotyping 
analysis (Beck et al., 2010) showed that insertion fosmid(s) mapped to the 
location of the #6-113 insertion in 3 of the 9 individuals in the human genome 
structural variation project (including the library in which it was discovered, 
ABC13). Therefore, this L1 is not likely to be a private insertion (Beck et al., 
2010; Kidd et al., 2008). 
To determine if the 5'UTR deletion observed in element #6-113 was a 
common L1 splice variant, we conducted BLAT searches using either 60 or 400 
bp flanking the 5'UTR splice junction to query the UCSC genome browser 
(hg19/GRCh37 human genome release http://genome.ucsc.edu/cgi-
bin/hgBlat?command=start) (Kent, 2002; Kent et al., 2002). The >100 potential 
spliced L1 sequences and their genomic flanks were obtained from the 
RepeatMasker track (Jurka et al., 2005) of the HGR for additional analysis. 
Sequences were then aligned to #6-113 to determine whether they contained the 
same splicing event and to assess the presence of TSDs. Ninety-six additional 
L1s contained the same junction as in #6-113, and at least 49 of the 96 L1s 
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contained TSDs (Table 3.2). An alignment of 30 validated 5'UTRs with the #6-
113 splice junction is shown in Figure 3.2B. Interestingly, one of the L1Hs 
elements found in the HGR was previously found to contain two intact ORFs, 
was present at an allele frequency of ~0.87, and retrotransposed with low-level 
activity in a cultured cell assay (~0.3% of a reference element) (Brouha et al., 
2003). 
The L1s found in the BLAT search were all L1Hs or PA2-6 elements, which 
prompted examination of the SD and SA site conservation through primate L1 
evolution. The SD is conserved in consensus sequences of L1Hs through 
L1PA10 elements (Khan et al., 2006), whereas the SA is conserved through 
L1PA6 elements. Therefore, the evolutionary conservation of the #6-113 splice 
site is consistent with the range of L1s found to contain the same junction (data 
not shown). Additionally, we compared the number of L1s with the splice junction 
to the known number of full-length elements from L1Hs or PA2-6 present in the 
HGR (Lander et al., 2001; Myers et al., 2002; Song and Boissinot, 2007). Spliced 
L1s from PA2, PA4 and PA5 families constituted ~1% of the full-length members 
of a given family of L1. There were 8 L1Hs elements that contained the junction, 
constituting ~2.7% of the full-length PA1 elements in the HGR. Additionally, there 
were more spliced PA3 L1s than any other family, and these 46 elements 
corresponded to ~3.0% of the total full-length PA3s. Conversely, the one L1PA6 
element we found represented only ~0.1% of the total full-length PA6 elements in 
the HGR. However, though the PA1 estimate may be inaccurate due to L1Hs 
polymorphisms, and the PA6 estimate may be low due to other 5'UTR changes 
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making identification of spliced sequences difficult, the overrepresentation of PA3 
elements is intriguing and warrants further study.  
Element #6-113 was previously tested with its truncated 5'UTR driving 
transcription and was found to retrotranspose at ~4% of L1.3 (Beck et al., 2010). 
Next, we used an exogenous promoter to determine if the ORFs of this L1 were 
capable of high levels of retrotransposition. Cloning a CMV promoter upstream of 
#6-113 increased the retrotransposition efficiency of this element to >20% of our 
reference element L1.3 in the same vector (Figure 3.2C) (pCEP4, see 
Experimental Procedures). With a CMV promoter upstream of an L1, the 
retrotransposition efficiency of an element completely lacking a 5'UTR is 
significantly lower than an L1 containing a full-length 5'UTR  (~40% decrease- 
Peter Larson and Aurelien Doucet unpublished data). Therefore, the low-level 
activity of #6-113 is primarily due to a promoter deletion rather than a deficiency 
in ORF1p or ORF2p function. The 15 additional L1s that were intact and inactive 
had similar retrotransposition efficiencies in CMV- and + contexts, and therefore 
may contain amino acid changes responsible for their inactivity in cell culture.  
A Primary Screen for Causative Amino Acid Changes in Inactive L1s 
To determine the residues potentially responsible for the inactivity or low-
level activity of some L1Hs elements, we developed ORF1p and ORF2p amino 
acid alignments for the 37 highly active, 16 intact inactive elements, L1.3, and 5 
consensus sequences  (59 elements in total- see Figure 3.3). Highly active 
elements (e.g., L1.3) may contain many differences from a “hot” L1 consensus 
sequence (Beck et al., 2010), and some amino acid changes were present in a 
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number of L1s. Therefore, amino acid changes present in both highly active L1s 
and inactive elements were unlikely to be the cause of an element’s inability to 
retrotranspose in the cell culture assay, and have been eliminated from further 
study. 
 Amino acid sequences of ORF1p and ORF2p were examined for residues 
in the inactive/low-level activity elements that were different from the highly active 
L1s in the study. Amino acid residues identified in this comparison represent the 
subset of changes in 15 L1s that is potentially responsible for the lack of 
retrotransposition in cultured cells (Table 3.3). To prioritize the changes that were 
potentially most deleterious to protein function, differences identified in the 15 
L1s were compared to the evolutionary conservation of ORF1p and ORF2p 
derived from diverse L1 and L1-like elements (Moran and Gilbert, 2002). As 
previous alignments lacked regions of ORF2p, some of the inactive L1s did not 
contain amino acid changes in conserved residues. Therefore, new alignments of 
ORF1p and ORF2p were created from evolutionarily diverse species (Figure 
3.4). The new alignments contained more species than those previously 
generated, and when available, were created with consensus sequence files or 
the sequences of L1s active in cell culture (Experimental Procedures). 
Comparison of all amino acid differences in the intact L1s to the alignments in 
Figure 3.4 yielded 1-7 differences in conserved residues (through L1 Canis lupus 
familiaris - L1_Cf) (Table 3.3) that were potentially responsible for element 
inactivity. Interestingly, many of these residues are in the endonuclease domain 
of ORF2p. 
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Inactive L1s Encode Potential Endonuclease Domain Mutations 
From the comparison of the 15 intact ORF L1 elements to the 37 highly 
active L1s, we determined that at least 7 elements contained mutations that 
could potentially render the L1 EN domain inactive (Table 3.3- conserved residue 
changes from 1-240 in ORF2p). L1s with mutations in conserved catalytic and 
structural residues of this domain are unable to jump in HeLa cells, yet retain the 
ability to retrotranspose in cells deficient in the non-homologous end-joining 
(NHEJ) pathway of DNA repair (Morrish et al., 2002). Endonuclease independent 
(ENi) retrotransposition was examined in NHEJ-incompetent XR-1 cells lacking 
the XRCC4 gene product, and the parental (NHEJ competent) 4364a CHO cell 
line (Morrish et al., 2002). Retrotransposition was detected as a function of the 
reverse transcription, integration, and expression of the mblastI reporter cassette; 
which confers blasticidin resistance to cells with a new L1 integrant (Moran et al., 
1996; Morrish et al., 2002; Wei et al., 2000) (see Experimental Procedures). 
We tested the 15 inactive elements in the endonuclease-independent (ENi) 
retrotransposition assay to discern whether the L1s contained deficiencies in the 
EN domain. Remarkably, this modified retrotransposition assay indicated that 11 
elements were able to jump with high efficiency (>20% of L1.3) in an ENi manner 
(Figure 3.5 and Table 3.3) (Morrish et al., 2002). To confirm that a given mutation 
was causative of the ENi retrotransposition in Figure 3.5, the mutation needs to 
be isolated from other changes in the L1 by introduction into a known 
retrotransposition-competent element. One of the 15 L1s had already been 
validated in this manner (#3-24). In this case, introduction of the S228P mutation 
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into ORF2 of L1.3 conferred the inability to jump in HeLa cells and ENi 
retrotransposition activity to this L1 when tested in XR-1 cells (Beck et al., 2010) 
(Figure 3.5). 
Predictions of Functional Amino Acid Changes 
Using both the alignment data and the results of genetic and biochemical 
functional assays, determining the amino acid changes likely responsible for L1 
inactivity may be possible. Combining this data showed that 7 of the inactive L1s 
contained differences in conserved residues of the EN domain, 2 others 
contained changes in non-conserved EN residues; 6 of these 9 L1s 
retrotransposed in the ENi retrotransposition assay. Additional elements that 
would be predicted to retrotranspose in an ENi manner (e.g., #3-36 or 4-20) also 
contained mutations in conserved residues of the RT or C domains. Thus, some 
L1s from this study may contain mutations in two or more domains important for 
retrotransposition. In contrast, some of the 14 L1s with amino acid changes from 
highly active L1s may have only one difference that is responsible for their 
inactivity in HeLa cells (similar to #3-24). For example, elements #2-59 (T44I) 
and #3-38 (T192P) are good candidates for EN mutations. Therefore, analysis of 
amino acid changes in conjunction with functional assays can identify potential 
causative mutations in inactive L1 sequences. 
 Amino Acid Changes and Highly Active L1s 
Although L1 alignments were created to examine amino acid mutations that 
have inactivated intact elements, these resources can potentially identify 
changes that are shared between highly active L1s. In Figure 3.3, L1s that 
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retrotranspose at greater than 115% the efficiency of a reference element (L1.3, 
shown at top) are highlighted in yellow. Notably, these elements tend to be the 
most dissimilar from PA2-PA5 L1s, and are very close to a consensus sequence 
of active L1 elements (Beck et al., 2010). However, there is no consistent 
difference that is indicative of an adaptive change in the amino acid sequences of 
highly active L1s. Conversely, RNA changes in the 5' and 3'UTRs have been 
used as diagnostic sequences to identify human-specific L1s, and thus differ 
from older elements that are now inactive in human genomes. Therefore, 
conserved RNA changes may have been advantageous to L1Hs elements. 
Highly Active L1s and Conserved RNA Changes 
A consensus of L1s in the human genome contains a GAG at bp 5929-5931 
of the 3'UTR (nucleotide position from L1.3) (Scott et al., 1987). However, most 
L1Hs elements contain an ACA at this position of the 3'UTR, which characterizes 
the transcribed, subset A or L1 Ta subfamily (Skowronski et al., 1988). In the 
dataset examined here, 35 of the 37 highly active elements contain an ACA at 
this position, and the other two contain the intermediate ACG, indicative of the 
human-specific pre-Ta subfamily L1s. The ACA/GAG distinction between human 
L1s and older elements, and the prevalence of ACA-containing L1s in disease-
causing mutations (only one mutagenic human L1 insertion is a pre-Ta element 
(Kazazian et al., 1988)), led us to question if the difference in the 3'UTR is an 
advantage that allowed L1Hs elements to proliferate. Alternately, the three-
nucleotide ACA difference may be a passenger mutation that happened to occur 
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in an element in a permissive expression context, or with other advantageous 
amino acid differences (see above).  
To test this hypothesis, we created allelic versions of L1.3 with an ACA or a 
GAG in the 3'UTR. Other than this difference, there is no other nucleotide change 
between the elements. Assays comparing the two elements (n=4) showed that 
L1.3 GAG retrotransposed at ~95% of the activity of L1.3 ACA in HeLa cells (this 
difference is not significant). Therefore, in this assay the ACA 3'UTR difference is 
not necessarily advantageous for retrotransposition (data not shown). 
Phylogenetic Trees Indicate Clustering of Related L1 Sequences 
We next developed a nucleotide alignment of the 53 L1s with intact ORFs. 
These alignments were subsequently used to generate a phylogenetic tree using 
MEGA4 (Tamura et al., 2007). This tree was generated with the complete 
deletion option, which eliminates all gaps from the comparison and allowed #6-
113 to be placed on the phylogeny. A bootstrap consensus neighbor-joining tree 
of the elements in this study is shown in Figure 3.6A.  
Interestingly, this tree showed clustering of L1s with the same 3′ 
transductions or from the same transduction “subfamily” (e.g., #2-12, 1-2-1, and 
2-1) (Beck et al., 2010). Transductions occur by the read-through of the 
endogenous L1 poly (A) tail and the retrotransposition of 3′ flanking genomic 
sequence (Goodier et al., 2000; Holmes et al., 1994; Moran et al., 1999; Pickeral 
et al., 2000). The phylogeny construction was independent of 3′ transduction 
sequence, but recapitulated element relationships that can be inferred from the 
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likely transfer of transductions from progeny to daughter elements. This 
clustering of transduction subfamilies is indicative of correct ordering of taxa, and 
unlike other alignments is constructed with the inclusion of #6-113 (Beck et al., 
2010).  
Each of the transduction clusters shown in Figure 3.6A contains one or 
more highly active L1s (lightly shaded L1s). Indeed, highly active elements are 
over represented within transduction subfamilies (17/26 vs. 37/68 or 68% of L1s 
with transductions vs. 54% of the total). Therefore, examining genomes for L1s 
from active transduction subfamilies is a potentially useful method for highly 
active element discovery. 
TS-ATLAS Identifies a Potential RP Progenitor Element  
Transduction subfamilies include some of the most highly active L1 
elements (Beck et al., 2010; Brouha et al., 2002; Kidd et al., 2010). Moreover, we 
found that of 37 highly active L1 elements, 17 contained transductions. 
Therefore, we sought to identify the polymorphic L1s from known active 
transduction subfamilies. A transduction-specific modification of the suppression 
PCR-based amplification typing of L1 active subfamilies technique or TS-ATLAS 
was recently developed to specifically locate L1s with a given transduction 
sequence (Richard Badge Laboratory, manuscript in preparation) (Badge et al., 
2003). With a 3' transduction-specific primer, elements were isolated from a 
subfamily that includes a full-length mutagenic insertion into the retinitis 
pigmentosa-2 gene (the L1RP mutagenic insertion contains an 11 bp 3' 
transduction of 5'- AnGTTTTAAATTTAn -3'). Therefore, these elements belong to 
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the RP subfamily of L1s (Kimberland et al., 1999). RP-specific TS-ATLAS 
identified two full-length and two 5' truncated L1s in 9 genomic DNAs from 
unrelated individuals. One of the full-length RP elements was flanked by target 
site duplications that included the transduction sequence and lacked a second 
poly(A) tail 3' of the downstream TSD, indicating that it is the putative progenitor 
L1 for the RP subfamily. 
The putative RP progenitor L1 contained two intact ORFs, and therefore 
may be competent for retrotransposition. The L1, termed AL050308 for the 
accession number of its insertion location on the X chromosome, was PCR 
amplified from the genomic DNA of the blood donor with primers adapted to the 
5' and 3' flanking regions. The element was then digested and cloned into a 
vector that allowed the L1 to be tested in a retrotransposition assay. Sequencing 
the L1 in the vector verified that it was the same as the genomic L1, with no 
nucleotide changes. The L1 RP progenitor was then tested in the cultured cell 
retrotransposition assay, and was found to retrotranspose at ~170% of L1.3 and 
~150% of the mutagenic L1RP insertion itself (Figure 3.6 B). These two RP family 
members contain 11 sequence changes from one another, and no amino acid 
differences. The isolation of an active progenitor element provides proof-of-
principle that transduction-specific PCR-based techniques may indeed be a novel 
method to identify highly active polymorphic L1s. 
Discussion 
Recent studies have focused on the prevalence of L1 polymorphisms (Beck 
et al., 2011), or the affect that mutations in conserved residues have on 
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retrotransposition (Doucet et al., 2010). Here, we used a recently developed data 
set of 68 elements, 53 of which have been tested for retrotransposition efficiency 
and contained intact ORFs (Beck et al., 2010), to explore the cohort of sequence 
differences present in genomic L1s.  
Examination of the nucleotide sequence of #6-113 allowed the discovery of 
a prevalent alternative splice variant of the 5'UTR. The 5'UTR variant was 
present in 96 genomic L1 elements, 30 of which were found in the introns of 
known RefSeq genes, and 21 of the 30 were in the opposite transcriptional 
orientation. This 2:1 preference for the antisense orientation is similar to other 
cohorts of L1 elements (Beck et al., 2010; Ovchinnikov et al., 2001; Smit et al., 
1995), and indicates that intronic insertions in the sense orientation to a gene 
may be more deleterious. Full-length L1s also appear to be more deleterious to 
truncated elements, as they tend to be depleted from the genome over millions of 
years (Boissinot et al., 2001; Boissinot et al., 2004). The deletion of 524 bp in the 
central region of the 5'UTR affects the RUNX3 binding site that overlaps the 
splice donor, the SRY binding sites at bp 472 and 572, and also deletes the 
critical region for the L1 antisense promoter (Athanikar et al., 2004; Speek, 2001; 
Swergold, 1990; Tchenio et al., 2000; Yang et al., 2003). Although upstream 
promoters may transcribe some intronic 5'UTR deletion-containing L1s, many of 
the sequences in Table 3.2 are likely to have been generated by a splicing event 
in the 5'UTR of an intact L1. The prevalence of L1PA3 elements with this junction 
suggests that some L1 families may contain better contexts for a given splice 
donor or acceptor. This splice variant shows that some L1 mRNA transcripts can 
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still readily retrotranspose after the spicing-mediated removal of a large portion of 
the 5'UTR. 
Analysis of the 16 L1s with intact ORFs and low-level or no 
retrotransposition activity allowed discovery of potentially deleterious mutations. 
Although the splicing mutation in #6-113 and the EN mutation of #3-24 are the 
likely cause of their inactivity in HeLa cells, amino acid changes are potentially 
responsible for the inactivity of 14 additional elements. Swapping ORF1p and 
ORF2p from inactive L1s with the corresponding proteins of L1.3 would be 
valuable for determining which changes might be deleterious to 
retrotransposition. Other functional assays, including the examination of protein 
localization to RNPs and the stability of ORF1p and ORF2p or an in vitro 
assessment of L1 reverse transcriptase activity (L1 element amplification 
protocol, or LEAP) could also aid in the determination of a cause for L1 inactivity 
in HeLa cells (Doucet et al., 2010; Kulpa and Moran, 2005, 2006). Finally, to 
pinpoint the mutation in the 14 L1s responsible for their low-level activities, 
introduction of putatively causative amino acid changes into a known, active 
element (i.e. L1.3) will be required. 
Interestingly, 5 of the L1s that retrotranspose with high efficiency in NHEJ 
deficient CHO cells lack mutations in the canonical EN domain, which consists of 
the first 240 bp of ORF2p (Figure 3.5 and Table 3.3- elements #2-25, 3-2-1, 4-17, 
4-19, and 5-36) (Feng et al., 1996; Weichenrieder et al., 2004). While mutations 
directly affecting EN domain function may occur past amino acid 240, other 
differences within ORF2p could potentially affect the function of the 
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endonuclease domain indirectly. Alternately, the 5 elements may be deficient in 
additional domains of ORF2p or ORF1p that could render the L1 active in an ENi 
assay, but inactive in HeLa cells (Kopera et al., 2011). Although further study will 
be required to pinpoint the mutations responsible for the inactivity of many of the 
L1s displayed in Table 3.3, this study has provided an important framework for 
future analysis of both these L1s and new datasets. 
In summary, we have conducted a thorough investigation of the coding 
regions of 53 intact, polymorphic L1Hs elements. These studies have informed 
us about the nature of the mutations present in human L1 sequences. Moreover, 
we have identified numerous amino acid residues that may be important for L1 
activity. This study was the first to analyze an extensive data set of intact and 
inactive L1 elements, and expansion of this analysis to new L1s identified via 
next generation sequencing and the 1000 genomes project is now possible 
(Ewing and Kazazian, 2011, 2010; Huang et al., 2010; Iskow et al., 2010; Mills et 
al., 2011; Xing et al., 2009). The ability to identify defects in L1s unable to 
retrotranspose in HeLa cells has now been shown for two L1s, #3-24 and #6-
113. Element #3-24 was previously determined to contain a mutation in the EN 
domain. Element #6-113 was shown here to have a deletion of the 5'UTR, 
rendering the L1 unable to retrotranspose without an exogenous promoter. 
Although some of the L1s in this study and in further investigations of intact and 
inactive elements may contain numerous domains affected by amino acid 
differences (e.g., #3-36 or 4-20), many may have simple causes for their 
inactivity in HeLa cells and will inform us about novel aspects of L1 biology (e.g., 
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#6-113). Therefore, the mutational spectrum gleaned from these inactive 
elements will likely lead the L1 field in novel directions. 
Experimental Procedures 
L1Hs Sequencing 
Full-length L1Hs elements were isolated, sequenced, and tested with 
respect to retrotransposition activity as previously described (Beck et al., 2010; 
Kidd et al., 2008; Tuzun et al., 2005). Briefly, intermediate-sized insertions (~4-8 
kb) were identified in the genomes of 6 individuals using a fosmid paired-end 
sequencing approach (Kidd et al., 2008; Tuzun et al., 2005). The insertion-
containing fosmids were then screened to find clones with full-length L1s that 
were absent from the HGR (Beck et al., 2010). L1-containing fosmids were then 
sequenced at the Washington University Genome Sequencing Center (St. Louis) 
and/or the L1 itself was sequenced at the University of Michigan Sequencing 
Core Facility using an Applied Biosystems ABI Model 3730XL (Beck et al., 2010; 
Kidd et al., 2010).  
Additional L1 Sequence Resources 
L1PA2, L1PA3b, L1PA4, and L1PA5 sequences (comprising the last ~25 
million years of L1 evolution in the human genome) were obtained from fasta 
format alignments via FTP from 
ftp://ftp.ebi.ac.uk/pub/databases/embl/align/ALIGN_000165.dat (Boissinot and 
Furano, 2001). Previously described consensus sequences (Khan et al., 2006) 
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(Boissinot and Furano, 2001) were generated using full-length elements of a 
given primate L1 family from the HGR (Lander et al., 2001).  
Many of the sequences for the alignments of ORF1p and ORF2p from 
evolutionary diverse species were obtained from RepBase 
(http://www.girinst.org/repbase/) and then deposited into a MEGA 4 alignment 
file. These include consensus nucleic acid sequences for L1 Rn (Rattus 
norvegicus), Ss (Sus scrofa), and Md (Monodelphis domestica), and elements 
that are similar to consensus sequences and flanked by TSDs from Mm (Mus 
musculus), Bt (Bos taurus), Cf (Canis lupus familiaris), Tx1 (Xenopus laevis), 
Sw1 (Oryzias latipes), Dr (Danio rerio), CIN4 (Zea Mays) DRE (Dictyostelium 
discoideum), Tal1 (Arabidopsis thaliana), Zepp (Chlorella vulgaris), and Zorro 
(Candida albicans). Other sequences were obtained from NCBI 
(http://www.ncbi.nlm.nih.gov/guide/), including the polymorphic Homo sapiens 
L1.3 nucleic acid sequence (accession number L19088) and the Nycticebus 
coucang (slow loris) ORF2p amino acid sequence (accession number P08548). 
Amino acid sequences were generated from nucleotide files by translating the 
sequences using the lasergene software package from DNASTAR 
(http://www.dnastar.com/).  
Sequence Alignments 
Alignments were created using MEGA4 (Tamura et al., 2007). CLUSTALW 
(Thompson et al., 1994) was used to find the best alignment of the 53 L1s with 
intact ORFs and both consensus sequences for L1PA2-5 and a ‘hot’ or highly 
active L1 consensus (Beck et al., 2010; Boissinot and Furano, 2001). Regions of 
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the aligned elements (UTRs, ORFs, and the 63 bp intergenic spacer- Figure 3.1) 
were annotated to allow subsequent ORF1p and ORF2p amino acid alignments 
to be generated from the data file in MEGA4. ORF1p and ORF2p alignments with 
the 53 L1Hs elements and the 5 consensus sequences are shown in Figure 3.3. 
CLUSTALW was also used to generate alignments of evolutionarily diverse 
ORF1p and ORF2p amino acid sequences (Figure 3.4). The ORF2p evolutionary 
alignment was then hand curated according to known important residues in Zorro 
(Dong et al., 2009). 
Plasmid Constructs 
L1Hs-containing plasmids in this study are derived from those published 
previously (Beck et al., 2010). L1s in JCC9, a pBluescript-based (Stratagene) 
plasmid, were subjected to restriction digest with NotI and BstZ17i (New England 
Biolabs). Resultant ~6 kb L1 fragments were then ligated into either JM105 L1.3 
or JJ105 L1.3 backbones lacking the same NotI to BstZ17i fragment of an RT 
defective L1.3 (Accession number L19088 (Dombroski et al., 1993)) containing a 
D702A mutation in ORF2p (Wei et al., 2001). JM105 L1.3 consists of a pCEP4 
(Invitrogen) backbone containing an exogenous CMV promoter driving 
transcription of a full-length L1 with a neomycin retrotransposition indicator 
cassette tagging the 3ʹ′UTR of the element (Freeman et al., 1994; Moran et al., 
1996). JJ105 L1.3 is similar to JM105L1.3, but contains a blasticidin indicator 
cassette in the 3ʹ′UTR of the L1 (Morrish et al., 2002). The genomic L1s present 
in the vectors are as sequenced except for the first ~35bp of the 5ʹ′UTR, and the 
last ~50 bp of the 3ʹ′UTR, which are from L1.3.   
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JM101 and 105 L1.3 ACA are L1.3 constructs described above that contain 
either wild type L1.3 or L1.3 with a D702A mutation in ORF2p, respectively. To 
construct JM101 L1.3 GAG, we created a primer extending from 7 bp 
downstream of the BstZ17i site through the desired GAG mutation, and 
continuing 5' of the original ACA nucleotides by 10 bp (spanning bp 5919-5975 of 
L1.3). PCR with this oligonucleotide and a 5' primer that spans bp 5287-5313 of 
L1.3 (ORF2K) was used to amplify a 688 bp fragment of linearized JCC5 L1.3 
(pBluescript-based plasmid with full-length L1.3 sequence) that contained the 
GAG mutation when sequenced. Digestion of the fragment with SpeI and BstZ17i 
allowed cloning of a 532 bp GAG-containing fraction of L1.3 into JCC5 L1.3 ACA, 
and sequencing confirmed that no additional nucleotide changes were introduced 
in the cloning process. The L1.3 GAG allele was then cloned into JM105 L1.3 
ACA using NotI and BstZ17i as described above. 
Cell Culture  
HeLa and Chinese Hamster Ovary (CHO) cells and maintenance were 
previously described (Beck et al., 2010; Moran et al., 1996; Morrish et al., 2002; 
Wei et al., 2000). Briefly, cells were maintained in an incubator at 37°F with 
100% humidity and 7% CO2. HeLa cells were maintained in DMEM high glucose 
media with 10% FBS, 20 U/ml penicillin/streptomycin, and 0.4 mM glutamine 
(Gibco). CHO cells are auxotrophic for proline and glycine, and were maintained 
in low-glucose DMEM with 10% FBS, 20 U/ml penicillin/streptomycin, 0.4 mM 
glutamine, and non-essential amino acids (Gibco).  
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Retrotransposition Assays 
Retrotransposition assays were conducted as previously described (Moran 
et al., 1996; Morrish et al., 2002; Wei et al., 2000). Briefly, 3 wells (per construct 
to be tested) of a 6-well tissue culture plate were seeded with 2x103, 2x104, and 
2x105 HeLa cells the day before transfection. Additionally, 3 wells per construct 
were seeded with 2x104 and 2x105 cells to test for transfection efficiency. Each 
experimental well is transfected with 1 µg of plasmid (L1 constructs with 
retrotransposition indicator cassettes are prepared with the Qiagen tip-100 midi 
prep kit and analyzed on agarose gel) using Fugene 6 transfection reagent 
(Roche) and Opti-mem media (Gibco). Efficiency is obtained for each construct 
by transfection with 0.5 µg of the plasmid of interest, and an additional 0.5 µg of 
pCEP green fluorescent protein (GFP) per well (Alisch et al., 2006). Twenty-four 
hours post transfection, cell culture media is aspirated and replenished. Seventy-
two hours post transfection, cell culture media is aspirated and replaced with the 
original media plus 400 µg/ml G418 (for JM backbone plasmids). Thirteen-
fourteen days post transfection, cells are fixed with a solution of 2% 
formaldehyde/0.2% glutaraldehyde in PBS and stained with 0.1% crystal violet. 
For Blasticidin-resistant constructs (JJ backbone), cells are fed with fresh media 
at 72 hours, and at 120 hours media is aspirated and replaced with media plus 
10 µg/ml Blasticidin. Twelve-thirteen days post transfection cells are fixed and 
stained as above. GFP-containing cells are harvested at 72 hours and subjected 
to FACS analysis for % GFP-positive cells, which is used as an estimate for the 
efficiency of the accompanying retrotransposition indicator cassette-containing 
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construct. CHO cells are seeded with 1x103, 1x104, and 1x105 cells/well, 
transfected 6-8 hours later, and assays are then performed as above. 
Putative L1RP Progenitor Cloning and Retrotransposition Assays 
TS-ATLAS is a modification of Amplification Typing of L1 Active 
Subfamilies, or ATLAS (Badge et al., 2003). The protocol is similar to the 
previously published method, with the replacement of the 3' primer for one that 
specifically anneals to a transduction sequence of interest (RP, in this case). RP-
specific TS-ATLAS was used to isolate the putative progenitor of the lineage that 
includes L1RP (Kimberland et al., 1999) (insertion AL050308). Sequencing the 
genomic DNA flanking the L1 identified the insertion location and allowed the 
generation of primers. The L1 was then amplified from 50ng genomic DNA of a 
volunteer sperm donor by long-range PCR using flanking genomic primers 
JM0308D (5'- TTTGGATTAAAAAGTTTTAAATTGGG- 3', which includes the 5 
Gs at the 5' end of the L1) and CM0308A (5'- GACTCTTTCAGTTGCCAGATGC -
3', to the 3' flanking region of the insertion site in the HGR). Direct sequencing of 
the PCR products confirmed this allele of AL050308 had intact open reading 
frames and was likely to be retrotransposition competent. To facilitate successful 
amplification of relatively error-free PCR products, long range PCR using the 
Expand Long Range polymerase system (Roche) was employed using 50ng of 
template DNA and buffer 2. PCR products were then cloned by digesting PCR 
fragments with AccI, performing PCR clean up with the Zymoclean DNA gel 
recovery kit from Zymo Research, and ligation of fragments into appropriate 
restriction sites in the pBluescript-based vector JCC9 containing the mneoI 
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retrotransposition indicator cassette. Cloned L1RP progenitor elements were 
sequenced in their entirety to identify clones with minimal sequence variation 
from the directly determined consensus. The RP progenitor clone that was tested 
for activity in Figure 3.6B contained no nucleotide changes from the genomic 
DNA PCR sequence of the L1. Retrotransposition assays comparing L1.3 to the 
RP progenitor and L1RP mutagenic insertion were conducted as discussed 
above, however cell concentrations of 5x103, 2x104, and 2x105 are used. 
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Figure 3.1: The Coding Potential of 68 Full-Length L1s 
 
 
 
Figure 3.1: The Coding Potential of 68 Full-Length L1s 
Full-length L1s are ~6 kb in length, encode their own promoter within the 5′UTR 
(grey rectangle), end in a 3′UTR (dark grey rectangle), and are punctuated by a 
poly(A) tail (An). Retrotransposition-competent elements also encode two 
protein-coding ORFs separated by a short (63 bp) intergenic region: ORF1 
(yellow rectangle) and ORF2 (blue rectangle). ORF2 contains endonuclease 
(EN), reverse transcriptase (RT), and cysteine-rich (C) domains. Thirty-seven of 
the L1s in this study were previously found to retrotranspose at >10% of a 
reference element (L1.3)	  (Beck et al., 2010). The remaining 30 L1s had low-level 
retrotransposition efficiency in the cell culture assay: 14 elements contain 
nonsense or frameshift mutations resulting in the premature termination of one or 
both ORFs, and 16 elements potentially encode amino acid differences. Red 
lines indicate the approximate location of the differences in ORF1 and ORF2, 
and are labeled with the previously described element name (Beck et al., 2010). 
The orange line indicates a CpG to TpG change present in two separate L1 
elements changing a CGA (R residue) to a TGA (stop codon). 
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Figure 3.2: Splicing Within the 5′UTR of Element #6-113 
(A) Element #6-113 contains a 524 bp deletion in the 5′UTR that is consistent 
with a splicing event.  (B) The putative splicing event in #6-113 is a common 
splice junction in many genomic L1s. Thirty of the 96 L1s from the human 
genome reference sequence that contain the same splice as #6-113 are depicted 
with the original element. The red arrow indicates the splice junction for each of 
the 31 L1s.  C) The deletion in the 5′UTR of #6-113 causes a loss of 
transcriptional activity that can be partially rescued by cloning an exogenous 
CMV promoter upstream of the L1. Two independent clones of #6-113 with a 
CMV promoter were tested. CMV #6-113 retrotransposes at ~20% of CMV L1.3 
(JM101 L1.3), and an RT- negative control is shown (JM105 L1.3- D702A 
mutation in ORF2p) (percent retrotransposition efficiency relative to L1.3 is 
shown at the bottom of the panel). 
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Figure 3.2: Splicing Within the 5′UTR of Element #6-113 
 
 
 
2x103 
cells/well 
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Figure 3.3: Amino Acid Alignments of ORF1p and ORF2p 
(A) The figure depicts an alignment of ORF1p from 53 L1s as well as consensus 
sequences of older L1s derived from the human genome and L1.3 (Beck et al., 
2010; Boissinot and Furano, 2001; Dombroski et al., 1993; Khan et al., 2006). 
Amino acid residues in bold red differ from a consensus amino acid sequence. 
Yellow highlighting denotes the L1s that retrotranspose >115% of L1.3.   (B) An 
alignment of ORF2p from the 59 elements with the same demarcations for 
sequence differences and highly active elements as in ORF1p. 
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Figure 3.3A: Amino Acid Alignment of ORF1p 
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Figure 3.3B: Amino Acid Alignment of ORF2p 
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Figure 3.4: Conservation of ORF1p and ORF2p 
(A) An alignment of 10 ORF1p amino acid sequences from human through 
zebrafish (danio rerio). Highlighted amino acids are those that have a strong to 
moderate affect on RNA binding, and residues in red indicate highly conserved 
amino acids (Khazina and Weichenrieder, 2009).  (B) An alignment of 17 ORF2p 
amino acid sequences from human through Zorro (candida albicans). Residues 
in red are highly conserved, and the grey shading indicates the regions of the RT 
domain (Fanning and Singer, 1987; Moran and Gilbert, 2002; Weichenrieder et 
al., 2004). Species in both of the alignments and their corresponding 
abbreviations in the Figure are listed in the Experimental Procedures. Alignments 
of ORF1p and ORF2p have been published previously (Moran and Gilbert, 
2002).	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Figure 3.4A: Conservation of ORF1p 
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Figure 3.4B: Conservation of ORF2p 
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Figure 3.5: Inactive L1s Contain Potential Endonuclease Mutations 
 
 
Figure 3.5: Inactive L1s Contain Potential Endonuclease Mutations 
Endonuclease dependent (4364a) and independent (XR-1) L1 retrotransposition 
assays for all 15 elements containing putative amino acid mutations. The figure 
includes a positive control (JM101 L1.3), a negative RT- control with a D702A 
mutation (JM105 L1.3), and L1.3 with a previously characterized EN mutation 
(D205A) (Feng et al., 1996; Moran et al., 1996; Morrish et al., 2002; Wei et al., 
2001). Retrotransposition events are detected as Blasticidin-resistant colonies. 
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Figure 3.6: L1Hs Subfamilies Cluster in a Phylogenetic Tree 
(A) Relationships between the 53 L1Hs elements in this study were inferred 
using the Neighbor-Joining method (Saitou and Nei, 1987). The bootstrap 
consensus tree inferred from 1000 replicates is taken to represent the 
evolutionary history of the L1s analyzed (Felsenstein, 1985). The percentages of 
replicate trees in which the associated taxa clustered together in the bootstrap 
test are shown above the branches (Felsenstein, 1985). The tree is drawn to 
scale, with branch lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. Phylogenetic analyses were 
conducted in MEGA4 (Tamura et al., 2007). Brackets at right indicate individual 
transduction “subfamilies” that are shaded on the tree. Light shading indicates 
active transduction-containing L1s, and dark shading indicates inactive elements 
in the subfamily.  (B) Putative RP progenitor retrotransposition assay results. 
Percentage retrotransposition efficiencies at the bottom of the figure are reported 
relative to L1.3. 
227 
Figure 3.6: L1Hs Subfamilies Cluster in a Phylogenetic Tree 
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Table 3.1: 5′UTR Splice Site Predictions From BDGP 
The Table depicts splice sites present in the 5′UTR of L1.3 within a 0.2 cutoff 
value from the Berkeley Drosophila Genome Project (BDGP) splice site website 
(http://www.fruitfly.org/seq_tools/splice.html). Both sense and antisense strands 
were examined. The first and second columns indicate the beginning and end of 
the donor or acceptor sequences. The third column is the score as given by the 
BDGP site. The fourth column is the sequence of the site with the donor GT or 
acceptor AG nucleotides indicated in capital letters. Nucleotides that would be 
spliced out of the final insertion are indicated in red. 
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Table 3.1: 5′UTR Splice Site Predictions From BDGP 
Sense Strand 
Donor Sites: 
Start 
(L1.3) 
End 
(L1.3) 
Score Sequence 
48 62 0.52 tcccagcGTgagcga 
67 81 0.24 gaagacgGTgatttc 
91 105 0.81 atctgagGTaccggg** 
461 475 0.83 tgctttagGTaaacaa 
688 702 0.54 tcctcaaGTgggtcc 
 
Acceptor Sites: 
Start 
(L1.3) 
End 
(L1.3) 
Score Sequence 
26 66 0.34 aggaacagctccggtctacAGctcccagcgtgagcgacgca 
98 138 0.66 gtaccgggttcatctcactAGggagtgccagacagtgggcg 
282 322 0.86 cccgaatattgcgcttttcAGaccggcttaagaaacggcgc 
447 487 0.27 ccattgcccaggcttgcttAGgtaaacaaagcagccgggaa 
 
521 561 0.52 gaggcctgcctgcctctgtAGgctccacctctgggggcagg 
601 641 0.46 ttaagtgtccctgtctgacAGctttgaagagagcagtggtt** 
Anti-Sense Strand 
Donor Sites: 
Start 
(L1.3) 
End 
(L1.3) 
Score Sequence 
798 784 0.22 gctgcagGTctgttg 
351 337 0.61 gagccagGTgtggga 
266 252 0.95 tttccagGTgcgacc 
203 189 0.99 ttcccagGTgaggca 
 166 152 0.59 gcgcacgGTgcgcac 
 108 94 0.44 gaacccgGTacctca   
Acceptor Sites: 
Start 
(L1.3) 
End 
(L1.3) 
Score Sequence 
846 806 0.86 gatgtcctttctggttgttAGttttccttctaacagacagg 
 
831 791 0.89 tgttagttttccttctaacAGacaggaccctcagctgcagg 
812 772 0.27 agacaggaccctcagctgcAGgtctgttggaataccctgcc 
 
684 644 0.97 agtctgtctgcccgttctcAGatctccagctgcgtgctggg 
642 602 0.36 gaaccactgctctcttcaaAGctgtcagacagggacactta 
571 531 0.41 ttgtctgtgccctgcccccAGaggtggagcctacagaggca 
483 443 0.31 cggctgctttgtttacctaAGcaagcctgggcaatggcggg 
430 390 0.70 agcctcgttgccgccttgcAGtttgatctcagactgctgtg 
419 379 0.29 cgccttgcagtttgatctcAGactgctgtgctagcaatcag 
280 240 0.45 gggagtgacccgattttccAGgtgcgaccgtcacccctttc 
250 210 0.86 tcacccctttctttgactcAGaaagggaactccctgacccc 
217 177 0.95 ctgaccccttgcgcttcccAGgtgaggcaatgcctcgccct 
135 95 0.31 ccactgtctggcactccctAGtgagatgaacccggtacctc 
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Table 3.2: Elements in the HGR With the Same Splice Junction as #6-113 
Table 3.2 depicts the 96 L1s from the HGR that contain the same splice variant 
seen in #6-113 (the location of #6-113 is listed in row 1 of the table). Column 1 
lists the chromosome with the L1 insertion. Column 2 indicates the approximate 
nucleotide position of the beginning of the L1 in the hg19 version of the human 
genome reference sequence. Column 3 is the family to which the L1 belongs. 
L1P1 contains L1 PA2-PA3 elements and L1P2 contains L1 PA4-PA6 elements. 
Column 4 is the strand on which the insertion occurred. Column 5 is the length of 
the L1, from the first nucleotide after the 5′ target site duplication to the beginning 
of the poly(A) tail. Column 6 is the target site duplication sequence, if one could 
be discerned. Column 7 indicates whether an L1 resides in an intron of a RefSeq 
gene. Column 8 is the orientation of the L1 with respect to the transcript of the 
gene. * indicates three L1s with the same TSDs that are duplicated in a 
segmental duplication. # indicates an L1 element that is prematurely 
polyadenylated within the poly purine track of the 3′UTR. 
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Table 3.2: Elements in the HGR With the Same Splice 
Junction as #6-113 
 
Chr. Loc. Start L1 Strand Length TSD Gene Orient. 
4 98103775 L1Hs - 5489 AAAGATTGTGTGTCCGG - - 
X 100795911 PA3 + 5508 T/AGGAGATATACCTAATGTA - - 
X 68683760 PA3 - (1) 5488 T/AAAGACATTGC - - 
X 140536457 PA5 + 5652 None Discernable SPANX Opp. 
X 112689296 PA3 + 5491 T/AAAAGCAGTATTCCC - - 
X 151493771 PA5 + 5612 T/AAAAATATAATTTATG C1orf146 Opp. 
*1 206506538 PA2 - 5490 T/AAATGATTCAGTGTAG - - 
*1 144043832 PA2 - 5490 T/AAATGATTCAGTGTAG SRGAP2P
2 
Opp. 
1 92703162 PA3 - 5607 T/AAAAATATAATTTATG C1orf146 Opp. 
1 104464687 L1Hs + 3398 N/A  (3' Truncation/Interrupted) - - 
1 101147989 PA3 - 5634 C/AAAATTATGTTATA - - 
1 228843130 PA3 + (12) 5493 T/AAAATACCCAAAGC RHOU Same 
1 71681575 PA3 + 5488 T/AAGAAACAATGTAA BC054887 Same 
1 37673603 PA3 + 5496 N/A  (3' Truncation/Interrupted) - - 
1 197798854 PA4 + 5614 None Discernable - - 
2 193902611 PA3 - 5485 C/AGAATGATACATGTATT - - 
2 162392756 PA3 + 5468 C/AAGAAAATGA - - 
2 132131447 PA3 + (1) 5622 T/AAAGTTATAAGG - - 
2 49309217 PA4 + 3494 N/A  (3' Truncation/Interrupted) FSHR Opp. 
2 48285530 PA5 - (8) 5620 C/A20  (?) - - 
2 77132072 PA3 + 5615 T/GAAAAGGCATCATTCTT LRRTM4 Opp. 
2 77363207 PA5 + (12) 5604 T/AAAAGGTTTAAC LRRTM4 Opp. 
2 97106917 PA3 + 5494 T/AAGAAAATGTGACAC - - 
2 21071902 L1P1 + 238 N/A  (3' Truncation/Interrupted) - - 
3 158808095 PA3 - 5505 C/AGAACTTATG IQCJ/SCH
IP1 
Opp. 
3# 12074759 PA2 - 5413 C/AAGAATTACTTATAACC SYN2 Opp. 
3 23343273 PA4 - 5578 None Discernable UBE2E2 Opp. 
3 135541406 PA3 + (8) 5621 C/AAAAATACAAAAATT - - 
3 57592577 PA5 + (14) 5609 T/AAAGATGTATATA - - 
3 24321653 PA3 + 5486 T/AAGCTATAGAACC THRB Opp. 
4 99241647 PA2 + 5489 None Discernable RAP1GDS
1 
Same 
4 78440449 PA3 - (1) 5600 T/GAGATACCATCTCAT CXCL13 Opp. 
4 53371019 PA4 - 5594 None Discernable - - 
4 167187141 L1Hs + 5651 None Discernable - - 
4 116093594 PA3 + (6) 5499 G/AAATAGTGCTT (?) - - 
4 128781276 PA3 + 5985 None Discernable - - 
5 132521520 PA3 - 5501 C/AATATAGGAATC - - 
5 139895099 PA3 + (8) 5487 T/AAAGACTATCCAG ANKHD1 Same 
5 8159239 PA3 + 5493 None Discernable - - 
5 147989815 PA3 + 5493 G/AAAGCTCCTAAAGGT (?) HTR4 Opp. 
5 108962814 PA3 - 5434 T/AAAAGA10 - - 
5 125422248 PA6 + 5593 None Discernable - - 
6 30215666 PA5 + 5483 None Discernable - - 
6 27911128 L1Hs + 859 N/A  (3' Truncation/Interrupted) - - 
6 77460735 PA3 - 5480 None Discernable - - 
6 115330203 PA3 + (8) 5497 T/AGAAACATAGCTATCATT - - 
6 108712068 L1P1 - 2759 N/A  (3' Truncation/Interrupted) LACE1 Opp. 
6 83342545 PA3 + 5425 T/AAATAAAATAA (?) - - 
6 81530533 PA3 + (3) 5377 T/AAAATTTTGACTT - - 
7 86868039 PA3 + 5525 G/AAAGGCC (?) - - 
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Chr. Loc. Start L1 Strand Length TSD Gene Orient. 
7 62521183 L1Hs + 3822 N/A  (3' Truncation/Interrupted) - - 
7 89531589 PA3 - 5484 T/AAGAAAATGTGGCA - - 
7 14744169 PA2 + 5488 C/A17GA6GA7 (??) DGKB Opp. 
7 148086130 L1P1 - 254 N/A  (3' Truncation/Interrupted) CNTNAP2 Opp. 
7 83378570 PA3 - 5621 None Discernable - - 
7 140413905 PA4 - 5602 None Discernable - - 
8 69274711 PA2 + (20) 5546 T/GAAAAAAGTACATC C8orf34 Same 
8 3133822 PA3 - (4) 5485 T/AAGATGTGACTTGC CSMD1 Same 
8 129724704 PA2 - 5545 None Discernable - - 
8 130336608 PA3 + 5485 T/AAAATGTAAAAATCA - - 
9 129755912 PA4 + 5568 None Discernable RALGPS1 Same 
10 7105374 PA2 - 5532 G/AAAGAAGGCAGAGATC - - 
10 55557481 PA3 - 5487 C/GAAAGAAAGG - - 
10 111365269 PA3 + 5526 T/AAGATATTAAA - - 
10 7179477 PA2 + (23) 5515 T/AAAATGATCACTGAATC - - 
*10 44983643 PA2 - 5490 T/AAATGATTCAGTGTAG - - 
10 36302543 PA4 - 5604 None Discernable - - 
10 15712011 PA4 - (5) 5608 T/AAGAGTAAATG ITGA8 Same 
10 50454262 PA3 + (1) 5491 T/AAAAATACCACAAAG - - 
11 13820761 PA3 - 5493 T/AAAAATAGCTTTC - - 
11 100523814 PA3 + (3) 5496 T/GAAAGCATA - - 
11 29437736 PA3 + 5495 T/AAAATTTTT (?) - - 
11 48588630 PA4 - (1) 5612 C/AATAGCAGAAC - - 
11 26314480 L1P2 - 3236 N/A  (3' Truncation/Interrupted) ANO3 Opp. 
12 61160617 PA3 - 5481 T/AAAATTTTT (?) - - 
12 10502325 L1Hs - (1) 5490 G/AAAGAAATACTATACAGC - - 
12 77658270 L1P1 - 4120 N/A  (3' Truncation/Interrupted) - - 
12 55939663 PA5 - 2609 N/A  (3' Truncation/Interrupted) - - 
12 23674088 PA4 - 5612 T/AAAAATGATTCTTTGA - - 
12 108116495 PA5 + (5) 5612 T/AAATGTCATTTCCT - - 
13 47952847 PA3 + (11) 5621 T/CAAAAGTA (?) - - 
13 82039211 PA4 - 5580 None Discernable - - 
14 66327054 L1Hs + 191 N/A  (3' Truncation/Interrupted) - - 
14 50539629 L1P1 + 245 N/A  (3' Truncation/Interrupted) - - 
14 44945865 PA4 - 5565 None Discernable - - 
14 35649420 PA5 - (6) 5570 T/AAGAATGAACTG KIAA0391 Opp. 
15 71022057 L1Hs + 5494 None Discernable UACA Opp. 
15 51465762 PA2 + 5530 T/AATATTT (?) - - 
16 63181637 PA3 + 5566 None Discernable - - 
17 31391710 PA5 - (5) 5647 C/AAAAGACATACTGAGTTT ACCN1 Same 
17 15258595 PA5 + 5591 None Discernable - - 
18 47302813 PA3 - 5482 None Discernable - - 
18 44508546 PA4 - 5632 None Discernable DKF7 ? Opp. 
19 35348866 L1P2 + 2269 N/A  (3' Truncation/Interrupted) - - 
20 24538447 PA3 - 5630 T/AAAGCCCTCTTCC TMEM90B Opp. 
20 12643382 PA3 + (1) 5563 G/AAAAAAGGGTAAACT - - 
21 18535869 PA3 + 5477 None Discernable - - 
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Table 3.3: Mutations in Inactive L1 Elements Often Occur in Conserved 
Residues 
The Table depicts the 15 L1 elements from a previous study that contain two 
intact ORFs, and yet are either inactive or display low-level activities in HeLa 
cells (Beck et al., 2010). Column 1 depicts the element number as it appears in 
Beck et al., 2010. Column 2 lists mutations in ORF1p that are not seen in any of 
the highly active L1s. Column 3 lists mutations in ORF2p that are not seen in any 
of the highly active L1s. Columns 4 and 5 are the amino acids from 2 and 3 that 
are conserved through at least canine lupus familiaris in evolutionary 
comparisons (Moran and Gilbert, 2002) (Figure 3.4). Column 6 is efficiency of the 
L1 in the ENi retrotransposition assay when compared to L1.3 (Figure 3.5).  
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Table 3.3: Mutations in Inactive L1 Elements Often Occur in 
Conserved Residues 
Element  
ID 
All  
ORF1p 
All 
ORF2p 
Conserved 
ORF1p 
Conserved 
ORF2p 
ENi          
(% L1.3) 
#2-6 E 41 K I 31 V - I 31 V 32 
  D 289 N  D 289 N  
  V 582 I  V 813 M  
  V 813 M    
  T 1034 I    
    M 1110 V       
#2-25 C 111 Y T 525 A Q 277 H T 744 N 90 
 Q 277 H D 635 G  A 1205 P  
 Y 282 F T 744 N    
  A 1205 P    
#2-59 - T 44 I - T 44 I 257 
    K 240 E       
#3-6 S 254 L I 10 V S 254 L I 10 V 21 
 R 328 W T 224 R  I 517 T  
  E 323 D    
    I 517 T       
#3-7 K 3 I V 208 L I 181 N E 310 K 0 
 M 91 I E 310 K P 278 T P 611 R  
 I 181 N P 611 R  S 698 T  
 P 278 T A 650 V  L 1141 S  
 S 290 N S 698 T    
  E 783 D    
    L 1141 S       
#3-24 - S 228 P - S 228 P 66 
#3-36 T 222 N R 49 T - N 147 S 3 
  R 134 K  Y 181 C  
  N 147 S  D 403 N  
  Y 181 C  I 679 M  
  T 220 A  T 1139 K  
  L 257 P  L 1140 I  
  D 403 N  C 1193 R  
  D 434 N    
  I 679 M    
  T 1139 K    
  L 1140 I    
    C 1193 R       
#3-38 - T 192 P - T 192 P 250 
  T 1109 A  T 1109 A  
    I 1268 V       
#3-2-1 T 95 I N 279 S N 327 K N 279 S 339 
 N 327 K A 290 T   I 340 V  
  I 340 V  R 440 T  
  T 392 R  R 855 C  
  R 440 T  Y 1232 H  
  R 855 C    
  L 1114 F    
  N 1128 Y    
    Y 1232 H       
235 
 
Element 
ID 
All 
ORF1p 
All 
ORF2p 
Conserved 
ORF1p 
Conserved 
ORF2p 
ENi  
(% L1.3) 
#4-5 E 199 K P 197 S E 199 K P 376 L 328 
  S 231 T  T 1228 S  
  R 311 G    
  P 376 L    
  T 431 K    
  K 764 R    
  K 790 N    
  M 908 T    
  A 1100 V    
  V 1150 I    
    T 1228 S       
#4-17 T 9 A Y 305 H - R 375 G 33 
 N 68 I R 375 G  P 611 R  
  P 611 R  R 775 W  
  R 775 W  C 936 W  
  K 876 R  A 1234 T  
  C 936 W    
  I 943 L    
  M 1002 I    
    A 1234 T       
#4-19 A 17 T K 280 N - A 1199 V 289 
  M 908 T  P 1211 L  
  A/D/T1006V    
  A 1199 V    
    P 1211 L       
#4-20 F 268 L H 45 Y - H 45 Y 0 
 T 308 A I 98 L  I 98 L  
  L 347 W  F 476 L  
  K 397 E  L 495 R  
  F 476 L  N 544 S  
  L 495 R  P 611 R  
  N 544 S    
  P 611 R    
  K 727 E    
  A 762 T    
    K 1190 E       
#5-36 R 24 H S 498 T I 197 T I 761 T 86 
 R 49 L I 761 T Y 282 C   
 I 197 T      
 Y 282 C     
 R 325 S     
 Q 333 K       
#6-100 L 90 R H 331 Q - N 669 I 9 
    N 669 I       
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Chapter 4 
 
Conclusion 
 
Overview 
Clearly, LINE-1 elements continue to impact human genomes. Though the 
interspersed, repetitive nature of L1s has inhibited studies on a genome-wide 
scale, the extent of the effects of these mobile elements on human genomes are 
beginning to be understood. L1s can mediate the retrotransposition of other 
elements, act as substrates for ectopic recombination, disrupt genes, and impact 
genome structure and function in a number of other ways. In this concluding 
Chapter, I will discuss how findings presented in this thesis elucidate the role of 
L1 in inter-individual human variation. Results from Chapter 2 provide new 
insights regarding the model of L1 subfamily succession. The use of L1 
sequences from this study to investigate splicing, amino acid changes, and the 
discovery of active L1 elements through transduction sequences is explored in 
Chapter 3. I will also propose future experiments to analyze the impact of L1 
retrotransposition in humans, the importance of specific amino acid or RNA 
changes to retrotransposition, and the prevalence of splicing mutations in the 
5'UTR. 
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LINE-1 in Human Variation 
How Prevalent is L1 Retrotransposition in Humans?  
Mutagenic L1 and Alu insertions indicate that retrotransposon activity 
continues to impact modern humans (see Chapter 1) (Beck et al., 2011; 
Kazazian et al., 1988). Additionally, genotyping and PCR-based methodologies 
have illustrated that there are hundreds if not thousands of polymorphic L1s 
resident in human genomes (Badge et al., 2003; Boissinot et al., 2004; Sheen et 
al., 2000). In Chapter 2, we identified 68 full-length L1s in the genomes of 6 
geographically diverse humans. This publication (Beck et al., 2010) and other 
recent profiles of L1 and Alu sequences from genome-wide studies have begun 
to characterize the retrotransposon diversity present in humans (Ewing and 
Kazazian, 2011, 2010; Huang et al., 2010; Iskow et al., 2010; Mills et al., 2011; 
Witherspoon et al., 2010; Xing et al., 2009). These findings have underscored the 
importance of L1s and Alus in human variation, and have added to the single 
nucleotide polymorphisms and copy number differences that populate our 
genomes. 
In Chapter 2, we specifically identified full-length L1 polymorphisms. These 
~6 kb elements represent only ~1/3 of the human-specific L1 Ta subfamily yet 
are responsible for L1 amplification in humans (Boissinot et al., 2001). The 
fosmid paired-end sequencing strategy utilized in Chapter 2 also provided us with 
~40 kb segments of an individual’s genome that contained the L1. Thus, instead 
of previous methods that had relied upon PCR to amplify L1 sequences, we were 
able to clone the L1s from their fosmid genomic context. Overall, the strategy we 
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undertook in this study allowed a highly accurate and thorough view of the ability 
of each L1 to retrotranspose in cultured cells and a careful documentation of the 
genomic location of each L1 insertion. 
We additionally illustrated that many of the 68 full-length polymorphic L1s 
are highly active in a cultured cell assay for retrotransposition efficiency, and that 
some elements are quite rare when examined in a diverse panel of individuals. 
Approximately 55% of the L1s in Chapter 2 retrotransposed at >10% of our 
reference element, L1.3, and 4 of the 26 genotyped L1s were either African 
specific (3) or potentially private elements (1) when genotyped on the H952 
subset of the human genome diversity panel (HGDP) (Cann et al., 2002; 
Rosenberg, 2006). Therefore, L1 retrotransposition continues to diversify human 
genomes, and many full-length L1 polymorphisms are retrotransposition-
competent. Indeed, it is interesting to speculate that most humans likely contain 
different cohorts of L1s. It is also thought provoking to consider the genomic 
environments that are permissive to L1 expression from their endogenous 
genomic location, and not solely from a plasmid expression context.  
Though it is clear that inter-individual human variation in L1 exists, the rate 
of L1 retrotransposition and the number of retrotransposition-competent elements 
in an average individual genome remain poorly understood. In Chapter 1, studies 
estimating de novo retrotransposon rates were discussed, and they range from 1 
in every 20 to 1 in every 200 live births for L1 (Ewing and Kazazian, 2010; Huang 
et al., 2010; Li et al., 2001; Xing et al., 2009). Additional studies have estimated 
the number of active L1 and Alu elements in an average human genome. These 
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approximations began with the estimate of ~30-60 active L1s in a diploid human 
genome (Sassaman et al., 1997). This estimate was revised to ~80-100 active 
elements per genome with a survey of the activity of 83 of the 90 full-length L1s 
from the human genome reference sequence (HGR) that contained two intact 
ORFs (Brouha et al., 2003; Lander et al., 2001). In Chapter 2, we focused on the 
highly active subset of elements, as these L1s comprise the vast majority of the 
activity present in an individual genome (Brouha et al., 2003). Though only 6 of 
the 40 active L1s in the HGR were highly active or “hot” (Brouha et al., 2003), in 
this study, we determined that the library of an African female, ABC13, contained 
at least 17 L1 alleles that are potentially highly active (Figure 2.4). This study 
represents the most comprehensive estimate to date of the highly active L1 
alleles present in an individual. Highly active L1s are important, as they 
demonstrate retrotransposition efficiencies in cell culture similar to those of most 
progenitors of mutagenic insertions or the full-length disease-causing insertions 
themselves (Brouha et al., 2003; Moran et al., 1996). Therefore, the activity of L1 
in humans was likely underestimated in previous studies of reference genomic 
sequences, and our study furthers the understanding of retrotransposition activity 
in extant human genomes (Beck et al., 2010; Beck et al., 2011). 
Can Individuals or Populations Vary With Respect to Retrotransposition Rate? 
In addition to individual variation in retrotransposon absence vs. presence, 
it may be possible that individual humans or populations can vary with respect to 
rate of retrotransposition. An APOBEC3B (A3B) gene deletion that is present at 
an allele frequency of ~22% in humans, yet is nearly fixed in Oceanic 
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populations, has been hypothesized to contribute to individual differences in the 
ability to repress retrotransposition (Kidd et al., 2007). A3B is expressed in 
developmentally relevant cell types, where L1 mobilization would need to be 
restricted in order to prevent accumulation of new insertions in the population. 
Moreover, the knockdown of A3B increases L1 retrotransposition efficiency ~2-
3.7 fold in human embryonic stem cell lines (Wissing et al., 2011). Additionally, 
two APOBEC3H alleles present in many individuals are unable to restrict viruses 
and transposable elements due to a lack of protein stability, yet an allele of this 
gene present at high frequency in Africans inhibits L1 retrotransposition (OhAinle 
et al., 2008). Although they are not correlated with one another, population 
stratification of the APOBEC3B and 3H active alleles suggests that there may be 
a higher rate of retrotransposition in some populations or individuals than in 
others. Other L1 restriction factors likely exist, and may also vary with respect to 
individuals or populations (Stetson et al., 2008). Interestingly, the high frequency 
of inactive APOBEC3 alleles in some populations suggests that these proteins 
may have deleterious effects on the host genome. 
Most of the individuals who have been characterized for genome-wide 
retrotransposon polymorphisms to date have been from a handful of populations 
(primarily CEPH Northern European, Yoruban African, Japanese, or Han 
Chinese) due to the ease of obtaining HapMap DNA samples (Consortium, 
2005). Broadening the base of ethnicities for these studies is an important goal in 
completing the picture of L1 variation in the human population.  
Allelic Heterogeneity Affects Individual Variation 
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In addition to individual and population-level variation with respect to 
retrotransposon insertions, a given allele of an L1 can also have variable activity. 
Chapter 2 discusses an element (#5-70) present in the HGR that had a nonsense 
mutation resulting in premature termination of ORF2p. When the L1 was cloned 
from the library of ABC12, a Northern European CEPH individual, it contained 2 
intact open reading frames and was active in the cultured-cell retrotransposition 
assay (~8% the efficiency of L1.3). Though allelic heterogeneity in L1 activity has 
been described previously (Lutz et al., 2003; Seleme et al., 2006), our findings 
further document the fact that dismissing an L1 as “inactive” after testing one 
allele may be premature.  
Location and Effects of L1 Insertions in Human Genomes 
Insertion Sites of De Novo and Inherited L1s and Alus 
Though both L1 and Alu insertions likely occur through target-site primed 
reverse transcription (TPRT), where the degenerate target endonuclease 
cleavage site is 5'- TTTT/A -3' (the “/” indicating the scissile phosphate) 
(Dewannieux et al., 2003; Luan et al., 1993), these elements have different 
patterns of residence in the genome (Smit, 1996). Alu sequences tend to 
accumulate in GC-rich regions of the genome, while L1s remain relegated to AT-
rich regions. The similarity in insertion mechanisms of the two elements contrasts 
with their eventual genomic locations, and indicates that selective pressures play 
a large role in the pattern of transposable element insertion sites present in the 
human genome (Lander et al., 2001; Smit, 1996). Interestingly, L1s in introns 
appear in the antisense orientation over the sense orientation to the transcript of 
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the gene in an ~2:1 ratio (Smit et al., 1995). The 2:1 preference for the antisense 
orientation is even detectable in polymorphic L1s (Chapter 2 Table 2.4). 
Therefore, selection against certain insertion loci or orientations within genes 
might occur rapidly at the level of a whole organism.  
An L1 insertion site is inherently limited by the preference of the 
endonuclease domain for certain cleavage sites, but the recognized sequence is 
short, and degenerate sites are tolerated (Cost and Boeke, 1998; Feng et al., 
1996; Morrish et al., 2002). Therefore, L1 insertion sites would be assumed to be 
fairly random in mammalian genomes, with perhaps a slight preference for AT-
rich sequences. However, some studies have proposed that in addition to the 
changes in element location over time, there may be preferred genomic loci for 
L1 insertions as well as transposon-intolerant regions of the genome (Levin and 
Moran, 2011). Though no one has found a true genomic insertion site preference 
for L1, two L1-mediated insertions of an Alu and an SVA element occurred in the 
same location in exon 9 of the BTK gene, resulting in independent cases of X-
linked agammaglobulinemia (Conley et al., 2005). Additionally, an abundance of 
Ta subfamily L1s on chromosomes 4 and X and the clustering of insertion 
locations throughout the genome also suggest the existence of potential 
‘hotspots’ for insertions (Beck et al., 2011; Boissinot et al., 2004). Conversely, 
there are also ~1000 regions of the human genome greater than 10 kb that lack 
transposon insertions throughout metazoan evolution, most notably near the Hox 
gene clusters (Lander et al., 2001; Simons et al., 2006).  
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Characterization of both polymorphic and de novo insertion sites in humans 
and in cell culture models is needed to increase our understanding of L1 
endonuclease targeting to either random or specific sites of retrotransposition. 
The ENCODE project has expanded our understanding of non-coding elements 
in the human genome, and these features have even been cataloged for human 
embryonic stem cells. This resource may be exploited to investigate the overlap 
of DNAse hypersensitivity sites, chromatin state, and other features of global 
genomic architecture that coincide with L1 integration locations (ENCODE 
Consortium, 2004; Myers et al., 2011). The investigation of epigenetic marks in 
conjunction with examination of insertion sites in different cell lines could 
potentially shed light whether chromatin state may affect L1 endonuclease 
cleavage. Indeed, the use of Drosophila modENCODE data (Roy et al., 2010) in 
conjunction with analysis of ~20,000 insertion locations was recently used to 
determine that P element insertions show a preference for replication origins 
(Spradling et al., 2011). 
Effects of L1 Insertions on Gene Expression  
De novo L1 insertions can disrupt genes by interrupting coding sequences, 
affecting splicing or transcription, acting as substrates for non-allelic homologous 
recombination, and may attenuate transcription or affect the local epigenetic 
state (see Chapter 1 for a review) (Beck et al., 2011). Consistent with this 
observation, the 2 to 1 preference for intronic L1s in the antisense orientation 
with respect to genes may indicate that L1 insertions are more deleterious to 
genes when inserted in the sense orientation (Smit et al., 1995). Additionally, 
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though approximately 30% of L1Hs elements are full-length, successively older 
L1 subfamilies consist of fewer and fewer 6kb elements. This pattern indicates 
that the full-length L1 insertions may be more deleterious than truncated L1s 
(Boissinot et al., 2001; Boissinot et al., 2004). Although L1Hs length and 
prevalence within introns of genes are similar to those in cell-culture studies 
(Beck et al., 2010; Gilbert et al., 2005; Iskow et al., 2010; Ovchinnikov et al., 
2001), polymorphic elements still display the antisense bias within genes (Table 
2.4). 
The above data suggest that L1s are subject to selective pressures. Given 
that full-length L1s are less tolerated in human genomes than 5' truncated 
elements, it is reasonable to hypothesize that the L1-encoded RNA polymerase II 
(pol II) promoter or the anti-sense promoter may interfere with the natural 
expression of genes. This interference could occur through improper expression 
from either of the L1-encoded promoters, or through the phenomena of “gene 
breaking”, where an intronic L1 insertion may result in two separate 
transcriptional units from both forward and antisense promoters (Wheelan et al., 
2005). However, in Chapter 3, we showed that the 96 L1s that contain a 524 bp 
5'UTR deletion appear to have the same preference for the antisense orientation 
in introns of genes as L1s that have intact 5'UTRs (Table 3.3) (Smit et al., 1995). 
The 524 bp deletion disrupts the minimal L1 antisense promoter and the RUNX3 
and SRY binding sites of the L1 sense promoter (Athanikar et al., 2004; Speek, 
2001; Swergold, 1990; Tchenio et al., 2000; Yang et al., 2003). These data 
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suggest that the two L1-encoded promoters may not be the primary force of 
selection against sense-orientation, full-length insertions in introns. 
L1s may also contain sense strand RNA polymerase II pause sites or even 
premature polyadenylation sites that could interfere with gene expression (Chen 
et al., 2006; Han et al., 2004; Perepelitsa-Belancio and Deininger, 2003). 
Interestingly, the A-richness of the sense strand of L1 is thought to play a role in 
these effects on gene expression, an the 524bp deletion in the 5'UTR of #6-113 
in Chapter 3 is more G-C rich than the entire L1 (Han et al., 2004). Therefore, the 
5'UTR loss in L1 splicing events (Table 3.2) affects promoter activity of the L1 
(Figure 3.2) and decreases the length of the element that can act as a substrate 
for ectopic recombination, but it does not decrease A-rich regions of the L1. This 
data suggests that spliced L1 insertions may also introduce pol II pause sites or 
premature polyadenylation sequences within genes (Chen et al., 2006; Han et 
al., 2004), leading to the 2-fold preference for the antisense orientation when 
located in introns.  
In order to discern if the transcriptional disruption of genes is important to 
the distribution of L1 in the genome, many insertions in cell culture would have to 
be recovered, and the distribution of both full-length and truncated L1s examined. 
If insertions within genes in cultured cells exhibit the same 2-fold preference for 
the antisense orientation, this would be evidence supporting non-random 
insertion into introns. Such a scenario could invoke a potential association of the 
RNA polymerase II transcriptional machinery with nascent L1 insertions, directing 
the element to the antisense strand of a transcribed gene (Boissinot et al., 2004). 
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This cultured cell experiment could also allow a more thorough examination of L1 
attenuation of transcription or premature polyadenylation (Chen et al., 2006; Han 
et al., 2004; Perepelitsa-Belancio and Deininger, 2003). Using a cell-culture 
model will alleviate other genetic factors that could vary between individuals in 
trios, and will allow the best chance of capturing L1-mediated interference of pol 
II transcription or RNA processing by full-length or truncated insertions. This 
experiment would be further facilitated through the use of modern high-
throughput sequencing technologies, which have been used previously to 
determine hundreds of L1 and Alu insertion sites in human genomes (Beck et al., 
2011). 
L1 Poly(A) Tails as Substrates for Microsatellite Repeats  
Poly(A) tails of Alu insertions are substrates for microsatellite formation and 
vary in length with time spent resident in the genome (Arcot et al., 1995). The 
poly(A) tails of L1 sequences are generally shorter with increasing age of the 
element, and both disease-causing de novo insertions and cell culture insertions 
generally have much longer A tails than polymorphic L1s (Gilbert et al., 2002; 
Ovchinnikov et al., 2001). Therefore the poly(A) tail lengths of L1s are likely 
variable between individuals, may be highly common polymorphisms, and are 
also likely substrates for microsatellite formation (Ovchinnikov et al., 2001). 
Discerning the poly(A) length of an L1 in multiple genomes is difficult due to the 
repetitive nature of L1 elements and the challenges in accurately characterizing a 
homopolymeric nucleotide stretch in the genomes of many individuals. In 
particular, some approaches for characterizing polymorphic L1s use PCR, which 
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can be error prone, or are directly constrained with regard to accurate 
sequencing of homopolymeric stretches of DNA (Wheeler et al., 2008). 
 One way to investigate the length polymorphism of L1 poly(A) tails would 
be through the examination of different alleles of the same element using 
standard capillary sequencing. With the fosmid libraries, sequencing of the 
different alleles can be accomplished with high fidelity, allowing determination of 
changes in the L1 that may contribute to allelic heterogeneity in activity and 
characterization of differences in poly(A) tail length (see Figure 2.4 and Table 2.5 
for in silico genotyping of the L1s in 9 individuals) (Kidd et al., 2008). An 
additional method to approach both poly(A) length polymorphism and the genesis 
of microsatellite repeats associated with L1 would be through the examination of 
poly(A) sequences from older L1s in both our genomes and the orthologous loci 
in chimpanzees. A similar method was used to identify Alu-associated 
microsatellite repeats (Arcot et al., 1995). The use of both methods would give us 
both an estimation of the rapidity with which the L1 poly(A) tail degenerated 
(through examination of human alleles), and of the prevalence of changes when 
measured over millions of years. 
Sequencing Elucidates LINE-1 Biology 
Transduction Subfamilies in Active L1 Identification and Subfamily Succession  
Transductions are generated when L1s read through their endogenous 
poly(A) tails and transfer 3' flanking genomic DNA to new insertion locations. This 
transfer tags the new insertion in a consistent manner, where one target-site 
duplication (TSD) directly flanks the 5'UTR, but the poly(A) tail following the L1 is 
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flanked by the transduced sequence and a second poly(A) tail that precedes the 
3' TSD (Goodier et al., 2000; Holmes et al., 1994; Moran et al., 1999; Pickeral et 
al., 2000). These sequences are prevalent in human genomes, with ~21% of full-
length L1s in the HGR containing 3' transductions (Lander et al., 2001).  
In addition to 3' transductions being a common feature of many genomic L1 
sequences, they are also present in a large number of polymorphic L1s (Beck et 
al., 2010; Kidd et al., 2010). Indeed, some of the 3' transductions have been 
repeated in numerous genomic L1s, generating transduction “subfamilies”, and 
some of the transductions appear to tag L1s that are currently amplifying in 
humans (Beck et al., 2010; Kidd et al., 2010). Moreover, the percent of highly 
active L1s that contain transductions in Chapter 2 (17/37 “hot” L1s or ~46%) vs. 
the percent of full-length L1s with transductions in the HGR (~21%) additionally 
suggests that these sequences may tag highly active L1s. In support of this data, 
many highly active, full-length, mutagenic L1 insertions contain 3' transductions 
(Brouha et al., 2002; Holmes et al., 1994; Kimberland et al., 1999).  
In Chapter 3, I discussed a transduction-specific mapping technique (TS-
ATLAS) that was used to identify an additional four elements from the same 
subfamily as L1RP. This method identified an element with the genomic structure 
consistent with being a progenitor of the L1RP family. The L1 had a 3' poly(A) tail 
directly flanked by the 3' TSD, and the TSD included the L1RP transduction 
sequence. The putative L1RP progenitor element was highly active in a cultured 
cell retrotransposition assay, providing a proof of principle that TS-ATLAS is 
effective at identifying highly active transduction alleles and progenitors.  
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The examination of multiple human genomes using additional transduction 
sequences for the TS-ATLAS protocol may identify further highly active L1s. In 
addition to the currently amplifying L1 transcribed subset A (L1 Ta) subfamily of 
elements, older pre-Ta L1s are also polymorphic in the human population 
(Skowronski et al., 1988). In the 68 L1s examined in Chapter 2, six elements 
contained sequence characteristics consistent with the pre-Ta subfamily. Three 
of these elements (#3-5, 3-24, and 5-55) had the same 3' transduction that 
distinguished their poly(A) tails from other L1s (Figure 2.5). Interestingly, two of 
the three were highly active in a cultured-cell assay and two were African-specific 
when examined in the HGDP (Cann et al., 2002) (Chapter 2). One of the 
genotyped pre-Ta L1s (#3-24) was absent from the HGDP and contained an 
inherited serine 228 to proline mutation in the EN domain of ORF2p responsible 
for its inactivity in cell culture (Chapters 2 and 3). Thus, the examination of 
additional transduction subfamilies may help elucidate the prevalence of active 
pre-Ta L1s, and may be used to identify highly active, potentially rare L1 lineages 
in humans that are also informative to L1 evolution and biology.  
Related L1 sequences within transduction families may also be exploited to 
determine amino acid or nucleotide changes that modulate the activity of L1. 
Comparing sequences within transduction families can pinpoint changes 
responsible for more subtle differences in retrotransposition competence, as 
opposed to the differences between highly active and inactive L1s, and may lead 
to insights into the amino acid changes that make some L1s more highly active 
than others. A transduction cluster (roman numeral IV) that contains elements 
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#4-27 and 4-35 is closely related in sequence to #4-8, and all three of these L1s 
are highly active (Figure 2.5). However, #4-27 retrotransposes at ~79% the 
efficiency of L1.3, whereas #4-35 and 4-8 both retrotranspose at >160% of L1.3 
(Table 2.2). An examination of the three sequences shows that there is one 
ORF1p change (R130Q) and two ORF2p changes (T316I and I515T) in #4-27 
when compared to #4-35 and 4-8. Of the three amino acid residues with 
changes, none are conserved past L1PA5 in the consensus alignments (Figure 
3.4). Additionally, the 5' and 3' UTR sequences of the three L1s lack insertion or 
deletion sequences with respect to one another. Therefore, a nucleotide change 
in the UTRs of L1 #4-27 or a change in an amino acid residue that is not well 
conserved (e.g., R130Q in ORF1p) may have modulated the retrotransposition 
activity of this element. Further examination of transduction families, especially 
with the identification and characterization of additional family members, may be 
able to pinpoint the causes of these more subtle L1 activity differences. 
In addition to the ability of L1 3' transductions to tag highly active elements, 
in Chapter 2 we used related L1 sequences to inform the model of L1 subfamily 
succession. Others had proposed that a very limited number of L1 “master” 
genes may give rise to many progeny elements, and in this way promote the 
success of L1s with specific sequence features (Deininger et al., 1992). This 
succession pattern would propagate a single lineage of L1s, as has existed for 
the last ~40 million years of primate genome evolution (Khan et al., 2006). In 
Chapter 2, the presence of multiple active elements within 6 transduction families 
gave rise to a modified hypothesis for subfamily succession, where numerous 
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progenitors may exist at one time, including active L1s from both Ta and pre-Ta 
subfamilies (Figures 2.5 and 2.6) (Cordaux et al., 2004). Moreover, we suggest 
that L1 progenitor elements would have “life-spans” limited by mutation, and 
would have to generate retrotransposition-competent progeny in permissive 
genomic contexts prior to their inactivation by cellular processes to continue the 
specific L1 lineage.  
Splicing of L1 Transcripts  
Splice sites within the L1 sequence have been characterized previously 
(Belancio et al., 2006; Belancio et al., 2008). In Chapter 3 I document the 
widespread presence of a novel 5'UTR deletion present in ~100 copies in the 
HGR (Table 3.2). This deletion was first seen in element #6-113, and is 
presumably generated through splicing (Figure 3.2). The presence and ubiquity 
of this 5'UTR deletion suggests that other L1 splicing events may have populated 
the genome. Many additional splice donor/acceptor combinations can be 
predicted through the examination of Table 3.1. Though the splicing event shown 
in Figure 3.2 is common, it remains to be seen whether this feature is a de novo 
event, or if a spliced L1 in a permissive expression context can give rise to new 
retrotransposon insertions. This possibility is suggested through the 
retrotransposition efficiency of #6-113 (~20% of L1.3- Figure 3.2) with an 
exogenous CMV promoter upstream. Overall, these data suggest that both 
spliced and unspliced L1 transcripts can undergo retrotransposition (Garcia-
Perez et al., 2007). 
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The Role of Non-Conserved Domains in L1 Retrotransposition   
In Chapter 3, we developed resources to identify amino acid changes in L1s 
with two intact ORFs that lacked high levels of activity in the cultured cell assay. 
This natural mutagenesis experiment identified putative sequence changes 
responsible for the low retrotransposition efficiency of 16 L1s from Chapter 2. 
Additionally, we identified the splicing mutation described above in one L1 and an 
endonuclease domain mutation (S228P in ORF2p) in element #3-24. 
Identification of causative amino acid mutations in ORF1p and ORF2p of the 14 
remaining L1s will require further study, but the alignments and analysis 
developed in Chapter 3 will be invaluable. To determine causative amino acid 
changes in the 14 remaining L1s, I propose exchanging ORF1p and ORF2p from 
the retrotransposition defective elements with the protein coding regions of a 
known, highly active element (L1.3 (Dombroski et al., 1993)). This domain swap 
would create chimeric L1s that could pinpoint whether mutations in ORF1p, 
ORF2p, or both of the L1-encoded proteins were responsible for the inability of 
an L1 to retrotranspose with high efficiency in HeLa cell culture (Figure 4.1).  
It is also important to note that the data set being explored in this study 
provides us with an unbiased view of mutations throughout the body of the L1. 
When paired with information from both the literature and our lab, these 
mutations may provide important data on poorly understood regions of ORF1p 
and ORF2p. Mutations in the amino terminus of ORF1p and the carboxyl 
terminus of ORF2p were present in some of the inactive elements, and these 
domains may prove interesting in spite of (or perhaps because of) their low 
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evolutionary conservation (Table 3.3). In fact, the amino terminus of ORF1p is a 
potential site for host-L1 interactions, as it has been found to be under positive 
selection in primate L1 lineages (Boissinot and Furano, 2001; Khan et al., 2006). 
Interestingly, recently published immunofluorescence and western blotting 
experiments (Doucet et al., 2010) have shown that mutations in the cysteine-rich 
domain affect the amount of ORF2p localization to L1 RNPs. The carboxyl-
terminus of ORF2p should be explored to determine if other mutations in this 
region interfere with the localization of ORF2p to RNPs. Such studies would 
elucidate the region of ORF2p that is potentially involved in efficient binding to 
the L1 RNA or in the stability of the protein itself. Interestingly, mutations in the 
cysteine-rich domain of ORF2p render the L1 unable to retrotranspose in HeLa 
cells, but allow mobilization in Chinese Hamster Ovary (CHO) cells deficient for 
nonhomologous end joining (unpublished data, thesis of Tammy Morrish). 
Therefore, the cysteine-rich domain or the carboxyl-terminus of ORF2p may 
participate in folding ORF2p to allow the endonuclease to function. Such a 
scenario would additionally lead to the idea that the global conformation of 
ORF2p is involved in protein stability, as indicated by reduced ORF2p in RNPs 
derived from L1 cysteine-rich domain mutants. Alternately, the cysteine-rich 
domain may be involved in an upstream step prior to the endonuclease cleavage 
of DNA, such as binding to potential genomic DNA target sites or even altering 
local chromatin states. The mutations identified in Chapter 3 expand the scope of 
amino acid changes throughout the L1-encoded proteins that can be similarly 
explored through functional studies and analyses.  
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Altering and/or Deletion of the 3'UTR 
Alterations of the L1 3'UTR are consistent with retrotransposition. Deletion 
of the 3'UTR or insertion of the neomycin retrotransposition indicator cassette 
within the region does not disrupt an element’s ability to retrotranspose (Moran et 
al., 1996). In Chapter 3, Table 3.2 details splicing mutations in the 5'UTR, and 
also depicts the presence of a premature poly(A) tail, immediately downstream of 
the poly purine tract in an L1 on chromosome 3. I identified 5 additional elements 
with similar poly(A) sites in BLAT searches (data not shown). Moreover, LEAP 
results indicate that the reverse transcription of L1 RNA can occur at sites 
internal to the L1 (Kulpa and Moran, 2006). However, though the 3'UTR may not 
be strictly necessary for retrotransposition of L1, it may be involved in other 
aspects of L1 mobility or regulation that are not readily assayed in HeLa cells. 
 Although 3'UTR deletions and alterations are tolerated in 
retrotransposition, the 3'UTR may be important in competition for the L1-encoded 
ORF2 protein. Therefore, conserved RNA changes present in human L1s may be 
advantageous. Indeed, though older L1s shared between human and primate 
genomes contain a 3'UTR GAG trinucleotide at base pairs 5929-5931, L1 Ta 
elements contain an ACA at this location (positions relative to L1.3) (Scott et al., 
1987; Skowronski et al., 1988). To address the importance of this difference, 
L1.3 with a GAG trinucleotide in the 3'UTR was cloned and tested with respect to 
the activity of the wild type L1.3 ACA. This experiment showed that a conserved 
RNA change in humans (exhibited by L1.3 ACA) is potentially dispensable for 
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retrotransposition (Chapter 3). Equivalent retrotransposition efficiencies of the 
two variations of the 3'UTR indicate that the ACA difference is potentially a 
passenger mutation that was carried along with other beneficial changes in the 
human specific L1 sequence. However, the lack of a difference in the efficiency 
of retrotransposition in cis does not preclude a competitive advantage conferred 
by the 3'UTR ACA character in Ta subfamily elements. This advantage could be 
elucidated through examination of the relative efficiencies of GAG and ACA-
containing alleles at competing for host proteins. In order to study this dynamic, 
an experiment would need to be conducted testing the retrotransposition of one 
allele in the presence of the other element. One experimental methodology would 
be to co-transfect an mneoI tagged ACA L1.3 with a no-neo version of GAG L1.3, 
and then switch the tag to the other L1 for a converse retrotransposition assay. 
The efficiencies of the different tagged L1 constructs should be the same if the 
two alleles are similar in their ability to co-opt host proteins for retrotransposition. 
If one allele of L1.3 has significantly higher retrotransposition efficiency than the 
other in this experiment, it would imply that the 3'UTR difference present in the 
more “active” allele imparted a competitive advantage to the L1 (Figure 4.2). 
Another way to analyze the importance of 3'UTR changes would be to make use 
of fluorescent primer-extension constructs of JM101 L1.3 ACA (developed 
previously in the Moran Lab) and L1.3 GAG to discern the ratio of integrants 
(Garcia-Perez et al., 2007). 
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Summary  
In this thesis, I addressed the role of full-length L1s in inter-individual 
human variation. A majority of these elements are retrotransposition competent, 
and therefore may affect the genomes of future human generations through their 
mobility. In addition, highly active L1s were shown to be more prevalent than 
previously appreciated, and some of these elements were rare when genotyped 
in diverse individuals. The examination of the sequences of these polymorphic 
L1s has led to an expanded understanding of L1 subfamily succession and the 
cohort of amino acid or nucleotide changes that can affect retrotransposition. 
Overall, these results have illustrated the importance of L1 in genomic variation, 
and to the continuing evolution of the human genome. Clearly, advances in high-
throughput sequencing technologies will further expand upon the results 
presented here, and will likely be used to address some of the currently open 
questions in L1 biology. 
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Figure 4.1: Domain Swap Constructs to Determine Location of 
Deleterious Amino Acid Changes 
 
Figure 4.1: Domain Swap Constructs to Determine Location of Deleterious 
Amino Acid Changes 
The Figure depicts the construction of chimeric L1 elements from the 14 putative 
missense mutation-containing elements in Chapter 3 and the “hot” reference 
element, L1.3. In this scheme, elements that are inactive in the retrotransposition 
assay that contain amino acid changes in both ORF1p and ORF2p (red stars) will 
be digested, and the 5'UTR through ORF1p fragment will be exchanged with that 
region of L1.3, and vice-versa. This generates two new L1 domain swap 
constructs (bottom of figure) that can be tested in the retrotransposition assay. If 
one of these chimeric L1s retrotransposes with high efficiency in HeLa cells, it 
indicates that the other ORF contains a putative missense mutation. 
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Figure 4.2: A LINE-1 Competition Experiment 
 
 
Figure 4.2: A LINE-1 Competition Experiment 
Though L1.3 ACA and GAG alleles retrotranspose with similar efficiencies in 
HeLa cells, it may be possible that the 3'UTR change present in human L1s 
(ACA) can confer a competitive advantage to the element when tested against a 
GAG-containing allele. Testing one allele (ACA at top) for efficiency when 
transfected with an equal amount of a GAG allele without an indicator cassette 
(0.5 µg each when transfecting a well of a 6-well plate) will allow comparison with 
the opposite competitive transfection, as shown in the bottom of the Figure. If 
one of the mneoI containing constructs retrotransposes with a higher efficiency in 
this competition assay, it would imply that the 3'UTR conferred an advantage to 
the element when transcribed at the same time as a different (i.e. older) L1. 
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